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Abstract 
The toxicity and bioaccumulation potential of chemicals are properties that need to be 
assessed in risk assessment. In the context of the aquatic environment, both properties were 
traditionally evaluated in the whole fish. However, due to the reluctance to use a large 
number of animals for experimentation and high cost of in vivo testing, alternative 
techniques have been developed to assess these properties. This thesis describes three 
distinct investigations towards the development of alternative methods for predicting the 
toxicity and bioaccumulation potential of chemicals.  
The first study of this thesis is centred on the development of a list of reference compounds 
to evaluate non-animal methods to in vivo bioaccumulation studies in fish. The selection of 
representative chemicals was developed following a novel strategy built from previous 
criteria proposed for the validation of experimental tests and considering relevant aspects 
for the bioaccumulation of organic chemicals. A revision and a comparison of the most used 
alternative approaches to in vivo bioaccumulation studies were undertaken in this thesis. In 
particular, a variety of in vitro and in silico methods were explored and compared in terms 
of their reliability to predict the whole body biotransformation rate and bioconcentration 
factor of chemicals in fish. As a consequence of this investigation, an insight into the main 
challenges and future perspectives for each of the methods evaluated was conducted to 
provide a foundation for future research. The last research study is focused on the 
verification of the prediction of protein binding for cyclic compounds and the development 
of a decision tree strategy to prioritise chemicals for in vivo toxicity testing. The last two 
objectives were developed based on the integration of different alternative methods to 
assess the toxicity of chemicals.  This thesis concludes with a summary and a discussion of 
the work undertaken and suggestions for future work. 
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Chapter 1. Introduction 
1.1. Chemicals in the Aquatic Environment and Their Risk Assessment 
Man-made and naturally occurring chemical substances can ultimately enter into the aquatic 
environment. Aquatic ecosystems act as a major recipient of chemical substances and their 
transformation products, resulting in a significant pollutant burden. In particular, there are 
four possible origins of chemical substances in the environment [1]:  
1. Chemicals from Anthropogenic Production and Use. Man-made chemicals are 
produced from different types of industries (e.g. agricultural, chemical, 
pharmaceutical and electronic industries) and have a wide range of uses (e.g. 
cosmetics, fertilisers, food additives, pharmaceuticals and biocides). These 
chemicals are also called xenobiotics and represent a risk to aquatic organisms that 
are exposed to them. 
2. Inert Materials. Inorganic compounds are the essence of geological systems such as 
metals from rocks. The heavy metals represent substances of concern due to their 
potential adverse effects.  
3. Fossil Fuels. Fossil fuels contain mainly organic compounds such as hydrocarbons. 
Hydrocarbons are used for several processes such as electricity generation and 
production of a broad range of synthetic substances (e.g. pesticides, dyes and 
plastics). 
4. By-products of Organisms. These are produced from biochemical reactions in the 
organism itself. Generally, substances produced by organisms are readily 
biodegradable in the environment.  
Of these sources, the most significant in terms of the potential harm to aquatic ecosystems 
are organic chemicals arising from anthropogenic use and these will be the focus of this 
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thesis. Modern society has a conundrum: man-made chemicals are needed to maintain 
health and a high quality of life, however the adverse effects of these on the environment 
are a potential problem. Therefore, chemicals undergo a process of risk assessment in an 
attempt to ensure that they are used and disposed of safely [1]. A fundamental component 
of risk assessment procedures is the measurement of the potential hazardous effects of 
chemicals on aquatic species through toxicity tests [2]. Aquatic toxicity tests should be 
conducted according to good laboratory practice (GLP). When conducting a toxicity test, the 
following aspects should be taken into account [2]: 
1. Dose Selection. The selection of the dose level depends on the study. There should 
be at least three dose levels (low, middle and high), in addition to control groups. 
The high dose should produce evidence of toxicity, the middle dose should be 
moderately toxic and no toxicity is expected for the low dose.  
2. Test Species. The selection of appropriate species is based on several considerations 
such as how well they represent the environment and knowledge and experience of 
their maintenance. Although there is a diversity of aquatic model organisms, fish are 
the most commonly tested species in ecotoxicological studies due to their high 
trophic position and similarities with mammals. Danio rerio (zebrafish) and Oryzias 
latipes (medaka) are commonly used in ecotoxicology and biomedical research due 
to their following advantages: 1) ease of maintenance and manipulation in the 
laboratory; 2) high fecundity and rapid development; and 3) transparency of the 
chorion (eggshell) that enables ready identification of abnormalities induced by 
chemicals [3, 4]. 
3. Endpoint and Test Duration. The endpoint measured is the biological response of the 
test organism to a concentration of a chemical over a defined period of time. 
Examples of toxicological endpoints include the median lethal concentration (LC50) 
and the median effective concentration (EC50). In terms of test duration, toxicity 
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studies can be divided into acute and chronic tests. In acute toxicity tests, the 
adverse effect is measured over a relatively short timeframe (between 2 and 7 days), 
whereas chronic studies are carried out over a prolonged period and usually consider 
sub-lethal effects.  
4. Test Substance Characteristics. This refers to the physico-chemical properties of the 
substance of concern. Before conducting a toxicity test, all available information 
related to the test substance should be gathered. Water solubility and volatility in 
solution are the most relevant chemical properties considered in waterborne 
exposures [5].  
In order to ensure high quality toxicity data, experiments should be conscientiously planned 
and carried out according to standardised test protocols issued by international bodies such 
as the Organisation for Economic Cooperation and Development (OECD). In vivo testing 
methods, which imply the use of the whole fish, have been widely used to assess the 
potential toxicity and bioaccumulation of chemicals. Table 1.1 lists the toxicity and 
bioaccumulation tests in fish that are conducted in compliance with the OECD guidelines. 
Due to their reliance on animal use, however, in vivo methods have been continually 
criticised by animal welfare organisations. In addition, other factors such as the high cost of 
maintaining animals in laboratory conditions have led to the development other methods 
which apply the 3Rs (reduction, refinement and replacement of animals in experiments) 
concepts [12]. Alternatives are explained in the next section. 
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Table 1.1 Toxicity and bioaccumulation tests in fish 
Test  
No. OECD 
guideline  
Fish, Acute Toxicity Test  203 [6] 
Fish, Prolonged Toxicity Test 14-day Study 204 [7] 
Fish, Early-life Stage Toxicity Test 210 [8] 
Fish, Juvenile Growth Test 215 [9] 
Bioaccumulation in Fish Aqueous and Dietary Exposure 305 [10] 
Fish Sexual Development Test (FSDT) 234 [11] 
1.2. The REACH Legislation: An Opportunity for Change 
The Registration, Evaluation, Authorisation and restriction of Chemical substances (REACH) 
regulation is the European Union (EU)’s largest piece of legislation for the assessment of 
chemicals [13]. REACH entered into force on 1st June 2007 and eliminates the distinction 
between existing and new substances, subjecting all substances to the same standards. One 
of the main goals of REACH is the protection of the environment and human health from 
chemicals produced, used or imported in quantities of 1 tonne or more a year [14]. Since 
there are complete sets of toxicity and bioaccumulation data for fewer than 5% of chemicals 
on the market, an increased use of experimental animal testing has been reported to be 
likely in the coming years. Consequently, REACH advocates the use of alternative methods 
to in vivo fish testing to assess the toxicity and bioaccumulation of chemicals.  
There are several alternatives proposed to in vivo testing using fish. While some approaches 
imply the use of toxicity tests in aquatic invertebrates to assess the toxicity of chemicals (see 
examples in Table 1.2), others rely on the use of in vitro and in silico (computer-based) 
techniques to prevent unnecessary testing with fish. In vitro and in silico methods represent 
the focus of this thesis. 
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Table 1.2 Toxicity tests in aquatic invertebrates 
Test  
No. OECD 
guideline  
Daphnia magna, Acute Immobilisation Test 202 [15] 
Daphnia magna, Reproduction Test 211 [16] 
Freshwater Alga and Cyanobacteria, Growth Inhibition Test 201 [17] 
 
In vitro methods are becoming widely used in aquatic ecotoxicology to reduce the number 
of fish required in scientific research and risk assessment [18]. In vitro approaches involve 
the use of test systems based on lower levels of biological organisation such as fish embryos, 
tissues, cells, subcellular fractions and molecules. Of these, toxicity tests with embryos 
provide a feasible alternative to experimentation with adult fish as they possess similarities 
in physiology to the adult [18]. 
In silico methods are considered to be an efficient alternative due to their low cost and speed 
with respect to testing methods [19]. In silico approaches encompass Quantitative Structure-
Activity Relationship (QSAR) models, structural alerts, grouping chemicals and read-across. 
Of these, QSAR models are one of the most powerful tools in aquatic toxicology. The principle 
of QSAR is the development of relationships between the physico-chemical properties of 
chemicals with their given biological activity by using a mathematical model. Developing a 
QSAR model involves the following steps [20]: 
1. Selection of the Endpoint of Interest. 
2. Gathering Data from Available Resources.  
3. Assessment of the Quality of the Gathered Data. Not only should data relating to 
chemical structure be checked (correct identification of a compound by its 
nomenclature, CAS number or chemical structure), but also toxicological data 
gathered should be assessed for quality. This is because high quality data are needed 
to generate accurate models. There are formal scoring methods for data quality 
assessment, for instance the Klimisch criteria can be used to allocate data to one of 
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four classes for quality [21].  Similarly, the ToxRTool scheme, based on the use of 
Klimisch criteria, can be used to assess the quality of toxicological data [22]. 
4. Obtaining Descriptors of Chemical Structure and Properties. Software such as EPI 
Suite, from the United States Environmental Protection Agency (US EPA) 
(www.epa.gov), is able to calculate a set of physico-chemical parameters relevant to 
the modelling and prediction of toxicity. Amongst them, the octanol-water partition 
coefficient (KOW) is the main descriptor used in aquatic toxicity prediction due to its 
good correlation with biological and environmental processes [20]. This is because 
log KOW acts as a surrogate for the hydrophobicity of a substance. Other valuable 
descriptors are Henry’s Law Constant (HLC) which gives an indication of the volatility 
of a chemical compound in solution and descriptors for water solubility (S). 
5. Generating the Model. Although there are many different ways to create a model 
using various statistical analysis techniques, linear regression analysis is the most 
common method used to build QSAR models. 
Another in silico approach to predict toxicity and especially specific interactions is based on 
the use of structural alerts. Structural alerts are chemical sub-structures or molecular 
fragments that are associated with toxicological activity [23]. Initially, structural alerts were 
developed and introduced for human toxicology, in particular for endpoints such as 
mutagenicity and carcinogenicity, and subsequently they were applied to aquatic toxicology 
[24]. Although the structural alert approach does not provide a quantitative estimate of 
toxicity (e.g. LC50 and EC50), it can be used to identify chemicals with a potential for binding 
to biological molecules such as protein and DNA, and hence may be related to specific modes 
of toxic action [25,26]. Structural alerts have been compiled within programs such as the 
OECD QSAR Toolbox (www.qsartoolbox.org) to allow for their use within the REACH 
framework for various purposes, such as prioritising chemicals before conducting an in vivo 
toxicity test and category formation. Grouping for category formation, is another in silico 
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approach by which chemicals with similar structural physico-chemical for toxicological 
properties, particularly those that follow a regular (quantitative) pattern, are grouped in the 
same category [27]. Once a chemical category has been formed, data gaps for properties 
(e.g. those related to toxicology) can be filled by other techniques, such as QSAR models and 
read-across. Read-across is a method by which toxicological data available for a reference 
set of chemicals are used to interpolate the toxic activity of a query compound [28]. In the 
context of non-animal approaches, read-across represents an effective approach as it allows 
for extrapolation of data from chemicals with test data to those with no data.  
1.3. Persistence, Bioaccumulation and Toxicity Potential of Chemicals 
Compounds are characterised by physico-chemical and molecular shape properties which 
determine their persistence, bioaccumulation and toxicity potential [5]. There is an interest 
in identifying and regulating persistent, bioaccumulative and toxic chemicals due to their 
adverse impacts on human health and the environment. The persistence of a substance can 
be defined as its presence in the environment before its degradation by physical, chemical 
and biological processes [29]. This section describes in detail the assessment of the toxicity 
and bioaccumulation of chemicals in aquatic ecotoxicology. 
1.3.1 Bioaccumulation of Organic Chemicals 
Information on chemical accumulation in aquatic organisms is important for understanding 
the environmental behaviour of a compound and its possible biomagnification throughout 
higher trophic levels [29]. Two different terms are used with regard to chemical 
accumulation in fish: bioaccumulation and bioconcentration. Bioaccumulation is the 
accumulation of a substance from all routes of exposure (from the solution and diet), 
whereas bioconcentration refers only to its accumulation from the environment that occurs 
in a waterborne exposure i.e. across the gills and skin [30]. 
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The potential of a compound to accumulate is usually expressed by the bioconcentration 
factor (BCF). Traditionally, BCFs were determined in the whole body of fish by a flow-through 
test according to OECD Test Guideline (TG) 305 [31], which required the use of at least two 
test concentrations per substance. To comply with the 3Rs principles, this guideline was 
modified, providing a list of recommendations such as the use of only one test concentration 
per substance to reduce the number of fish required for experimentation [10]. Cyprinus 
carpio (common carp) and Oncorhynchus mykiss (rainbow trout) are the most common fish 
species used for in vivo testing [32]. In particular, common carp has been used in Japan to 
test chemicals to meet obligations under the Chemicals Substances Control Law [33]. 
Unfortunately, although approximately 300 chemicals are tested every year in Japan, only 
data for about 800 “existing” chemicals are available online at the Chemical Risk Information 
Platform of the National Institute of Technology and Evaluation (NITE)’s website 
(www.nite.go.jp). 
In vitro methods for bioaccumulation mainly involve the use of cells or subcellular fractions 
to study the processes governing chemical bioaccumulation, i.e. Absorption, Distribution, 
Metabolism and Excretion (ADME) [30]. Whilst in vitro methods for absorption are based 
predominantly on mammalian species, a variety of cell-based assays has been developed to 
study xenobiotic biotransformation in fish. In vitro tests for xenobiotic metabolism include 
the use of microsomes [34], subcellular fractions such as S9 [35,36], freshly isolated 
hepatocytes [37,38], cryopreserved hepatocytes [39,40] and aggregates cultures [41]. 
Primary hepatocytes can form tree-dimensional spheroidal cultures under specific 
laboratory conditions (e.g. constant rotation speed over exposure of one day) [41].The 
majority of such assays are derived from rainbow trout liver due to the fact that such species 
possess a standardised procedure for isolation of hepatocytes. In an in vitro scenario, the 
potential biotransformation of a compound is usually expressed by the intrinsic clearance 
(CLINT), which is calculated from a substrate-depletion approach. CLINT data can be 
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incorporated into established Physiologically-Based ToxicoKinetics (PBTK) models [42,43] to 
estimate the whole body biotransformation rate (KMET). Figure 1.1 shows the key steps and 
calculations required for the calculation of KMET from a clearance assay using freshly isolated 
hepatocytes from rainbow trout. It should be stressed that although information on 
xenobiotic biotransformation can be determined using in vitro assays, their applicability is 
currently limited due to lack of assay validation and technical limitations [44].  
Only a couple of studies have investigated the feasibility of fish embryos to assess chemical 
bioaccumulation [45,46]. This could be explained by the difficulty in determining the internal 
chemical concentration in such small test organisms. To overcome this, a simplistic approach 
has been proposed by which the chemical concentration in embryos was determined 
indirectly by quantifying the depletion of chemical concentration in the exposure solution 
[46]. The applicability of such an approach, however, was limited for compounds with 
significant biotransformation potential whose BCF values were overestimated. 
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Figure 1.1 Steps required for the calculation of whole body biotransformation rate (KMET) (d-1) (days). 
CHEP = Concentration of hepatocytes used in the clearance assay; Log Co = Initial concentration of test 
chemical (µM); Log Ct = Final concentration of test chemical; PBTK = Physiologically-Based 
ToxicoKinetics Model. 
Due to the limited applicability of in vitro methods, some governmental agencies rely on 
predictive models to estimate BCF. Computer-based models for bioaccumulation have been 
developed over more than 30 years [47]. Traditionally, QSAR models for bioaccumulation 
were focused on regression analysis between in vivo log BCF values and hydrophobicity 
expressed by log KOW, although with poor correlations being found for ionic substances, 
those prone to metabolism and hydrophobic substances (Log KOW > 6).  Dimitrov et al. [48] 
established a non-linear relationship model between log KOW and in vivo log BCF data to 
11 
 
estimate the maximum bioconcentration potential (log BCFmax) of organic chemicals, which 
is shown in Figure 1.2.  This non-linear model was later modified to correct for the effects of 
metabolism, molecular size, ionisation and water solubility on the maximum 
bioconcentration potential [49]. However, despite the novelty of such approach, Dimitrov’s 
models were not available to the public. As a consequence, governmental agencies and 
industry usually rely on the predictions made by the log KOW-based model developed by 
Meylan et al. [50], which is available in the EPI Suite Software (www.epa.gov). In contrast to 
the numerous models built for BCF, there have been only few attempts to model the 
bioaccumulation factor (BAF) [51,52]. 
 
 
 
 
 
 
 
 
 
Figure 1.2 The relationship between log BCF and log KOW illustrating the maximal bioconcentration 
(log BCFmax) model developed by Dimitrov et al. [48] shown as a solid line. 
Other in silico approaches have been focused on building kinetic mass balance models to 
take into account the ADME processes to predict chemical bioaccumulation [53,54]. By using 
this approach, BCF is calculated as follows: 
Bioconcentration factor (BCF) = K1 ф/ (K2 + KE + KG + KMET) (L/Kg)             (1.1) 
Where ф is the fraction that is bioavailable to the fish in water (unitless); K1 is defined as the 
gill uptake rate constant (L/Kg x day (d)); KE corresponds to the faecal egestion rate constant 
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(d-1); K2 is the elimination rate constant (d-1); KG is the growth dilution rate constant (d-1); and 
finally KMET corresponds to the metabolic rate (d-1). All these parameters are usually 
estimated for a fish of 1 Kg. Compared to conventional log KOW-based models, the kinetic 
approach offers the advantage of incorporating KMET data estimated from in vitro clearance 
assays to refine BCF.  The refinement of BCF using in vitro data has been conducted using S9 
fractions [36,55,56], freshly prepared hepatocytes [37,38] and cryopreserved cells [40]. 
However, the chemicals that have been tested in these clearance assays were not supported 
by high quality in vivo BCF data, and consequently it was not possible to explore the effect 
of metabolism on the total bioconcentration. 
It should be added that the prediction of metabolic susceptibility of chemicals in fish is 
usually based on predictions for mammalian metabolic data [49]. Nonetheless, the QSAR 
model of Arnot et al. [57] can be used to predict KMET of a compound in fish. This model was 
created from metabolic biotransformation data estimated from in vivo data for 
bioaccumulation. In particular, data for BCF, elimination rate constant and whole body 
biological half-lives (HL) were used to estimate KMET by re-arranging Equation 1.1. The 
predicted KMET data were modelled in a multiple linear regression using similar descriptors to 
those employed in biodegradation models [57]. The QSAR model of Arnot et al. [57] is 
available in the EPI Suite Software (www.epa.gov) and predicts KMET for a range of fish 
weights (10, 100 and 1000 g). 
 1.3.2 Toxicity of Organic Chemicals 
As many toxic effects are dose-dependent, the potential hazard of chemicals has been 
assessed though a dose-response evaluation to determine, for acute effects, the 
concentration causing 50% lethality (LC50). Traditionally, the potential hazardous effects of 
chemicals were assessed in the whole fish according to official guidelines (see Table 1.1.). 
Approximately half of the in vivo LC50 data in fish have been reported for rainbow trout, 
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Pimephales promelas (fathead minnow) and Lepomis macrochirus (bluegill), contrasting with 
the low percentage of data (< 1%) for model species such as medaka (Oryzias latipes) and 
zebrafish (Danio rerio)[58]. At present, the effect of biological factors (e.g. fish species and 
life stage) and test conditions (e.g. temperature and pH) on in vivo data are not well-
understood due to the fact that such variables are not reported in toxicity tests.  
A variety of in vitro methods have been developed to assess the toxicity of chemicals. To 
date, the Fish Embryo Acute Toxicity Test (FET) [59] provides a viable alternative to 
experimentation on adults. Moreover, good correlations have been reported between acute 
toxicological data to embryos and adults [14]. Cell cultures are another promising alternative 
to acute fish toxicity tests [24]. In order for cell-line-based toxicity assays to reflect in vivo 
conditions, they should be derived from the tissues where chemicals exhibit toxicity and 
account for the chemical fraction available to cells [60,61]. It should be noted that alternative 
approaches have mainly been proposed for acute fish toxicity testing. This contrasts with the 
lack of alternatives developed for chronic toxicity tests due to their lack of in vivo data, and 
hence the difficulty in their replacement [24]. Nonetheless, molecular assays could play an 
important role in predicting the chronic effects of chemicals. This could be assisted, for 
instance, by using molecular biomarkers to predict endocrine disruption, genotoxicity and 
immune modulation [4]. In particular, toxicogenomic techniques such as microarrays can 
identify genes that are associated with long-term toxic response [62]. 
1.4. Mechanism of Toxic Action 
A key aspect for understanding the toxicity of chemicals is unravelling their mechanism of 
toxic action. This process involves the identification of the toxicant-biological target 
interaction, also called the molecular initiating event (MIE), and knowledge of the 
toxicological responses at higher levels of biological organisation. All this information, from 
the MIE processes to downstream physiological responses, is framed into the concept 
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recently termed the “Adverse Outcome Pathway” (AOP), which is represented schematically 
in Figure 1.3 [63].  
Figure 1.3 Conceptual diagram of the Adverse Outcome Pathway adapted from Ankley et al. [63]. 
The most common mechanism of acute aquatic toxicity is narcosis; approximately 60% of all 
industrial organic chemicals act via this mechanism. Toxicity due to narcotic mechanisms 
results from a reversible hydrophobic interaction between the toxicant and cellular 
membranes [64]. Non-polar narcosis corresponds to an unspecific minimum level of toxicity 
exerted by any chemical (also referred to as baseline toxicity). Log KOW has been used in QSAR 
models to estimate the acute toxicity of narcotic chemicals, which include a diversity of 
compounds such as aromatic and aliphatic hydrocarbons, alcohols, ketones, aromatic nitro 
and amino compounds [65]. Over the past three decades, numerous QSAR models have been 
developed for acute aquatic toxicity for three trophic levels [66]. Other chemicals can initiate 
the toxicological response by electrophilic mechanisms. In such mechanisms, the toxicant 
forms covalent bonds with proteins and DNA resulting in a specific and irreversible toxic 
response. One example of an electrophilic reaction is Michael type addition that involves the 
addition of a SH group from a protein (for instance on the fish gill, causing membrane 
irritation) at an electron-deficient β-carbon of an electrophile, known as a Michael acceptor 
(MA). This reaction ultimately forms a chemical-protein adduct. The net result of this 
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covalent interaction is the permanent disruption of proteins, which can be observed as an 
increased toxicity above that elicited by narcosis (often termed excess toxicity).  
Structural alerts for Michael acceptors from the literature, as well as other reaction 
mechanistic domains, were reviewed and compiled by Enoch et al. [25,26].  In particular, the 
structural alerts within the Michael addition domain were classified into four classes: 
polarised alkenes, polarised alkynes, quinones and related chemicals and acid imides [25]. 
Table 1.3 shows examples of substructures of structural alerts for Michael acceptors encoded 
into SMILES strings [67]. It should be stressed that structural alerts can be developed based 
on mechanistic knowledge related to protein binding, which is gained from the analysis of 
the chemical structure, and does not necessarily involve empirical evidence [25,26]. 
Therefore, the verification of structural alerts based on experimental data is required before 
reactivity predictions become applied for regulatory purposes [68]. Here, in chemico 
reactivity data could play an important role for the verification of the prediction of chemical 
reactivity. For instance, Schultz et al. [67] employed a set of Michael acceptors for the 
verification of the structural alerts.  In chemico assays involve the use of proteins such as 
glutathione (GSH) or peptides to determine the reactivity of chemicals based on a depletion 
of substrate approach [69].  
Table 1.3 Examples of structural alerts for Michael acceptors, adapted from Schultz et al. [67] 
SMILES strings Message 
C≡CC=O ethynylene or acetylenic with a carbonyl 
[CH2]=C(C)C=O α-C atom alkyl-substituted with a carbonyl 
C=CN(=O)=O olefinic nitro 
C=CS=O vinyl or vinylene with a S=O group 
C≡Cc1ncccc1 ortho-ethynylene azaarene 
O=C1C=C[CH]=CC1=O ortho-quinone 
[CH3]=[CH][CH]=O acrolein (2-propenal) 
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1.5. Integrated Testing Strategies (ITS) in Aquatic Toxicology 
Integrated Testing Strategies (ITS), also referred to as Intelligent Testing Strategies, represent 
another promising approach to reduce the number of fish required for experimentation 
[70,71]. These are built from the combination of a set of alternative methods to provide a 
Weight of Evidence (WoE) with regard to the toxicity and/or bioaccumulation potential of a 
query compound. The components of ITS can be divided into two categories: non-testing 
approaches (e.g. read-across, QSARs and waiving decision schemes built from cut-off values 
for key chemical descriptors [72,73]) and testing approaches (e.g. tests using fish surrogates 
and in vitro methods). When results from alternative methods are in concordance for a given 
examined compound and ecotoxicological endpoint of interest, conducting in vivo tests in 
fish are thus less likely to be required for its risk assessment. It should be noted that risk 
assessment requires very high confidence concerning the toxicity and bioaccumulation 
potential of an examined compound. As a consequence, although ITS have been proposed 
to evaluate the toxicity [74] and bioaccumulation potential [30,75] of chemicals, there is a 
need to formalise ITS to provide potential hazard information with high reliability [24].  
1.6. Validation: The Final Step for the Implementation of Alternative Methods 
Validation is the key to obtain regulatory status of alternative methods [76,77]. Validation 
has been defined as the process by which the reliability and relevance of a procedure are 
established for a particular purpose. Depending on the type of non-animal method 
developed, specific validation requirements should be applied. For instance for in silico 
models, a validated QSAR should incorporate [78]: 1) a defined endpoint; 2) an unambiguous 
algorithm; 3) a defined domain of applicability; 4) appropriate measures of goodness-of-fit, 
robustness and predictivity; and 5) a mechanistic interpretation, if possible. The validation 
of in vitro assays are more difficult than for in silico models, since they need to be designed, 
managed and conducted to very high standards [24].  At present, the Fish Embryo Acute 
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Toxicity Test (FET) [59] is the only alternative that has been validated as an accepted in vitro 
method. The validation principles for in vitro testing include, amongst others: 1) an 
assessment of a quality of overall design; 2) demonstration of the intra- and inter-laboratory 
reproducibility of the test method; and 3) to demonstrate the assay performance in relation 
to existing toxicity data [76,77]. To accomplish the latter, test compounds that are used in 
the validation of in vitro methods should be supported by in vivo high quality toxicity data to 
facilitate a better understanding of the relationship between in vivo and in vitro data. 
Therefore, lists of reference compounds selected based on their high quality in vivo toxicity 
data should be developed to facilitate future inter-method correlations and data 
comparison. Whilst such a reference list has been provided for developing alternatives to 
acute fish toxicity [79], there are no reference lists proposed for chronic toxicity and 
bioaccumulation studies. 
1.7. Objectives of this Thesis 
This research has been undertaken within the AlterREACH project. This project is funded by 
the Norwegian Research Council (NRC) and is coordinated by the Norwegian Institute for 
Water Research (NIVA) in Oslo, Norway. Framed into the REACH legislation, the AlterREACH 
project aims to develop and evaluate non-animal methods to assess the adverse effects of 
chemicals and their bioaccumulative potential to aquatic species, particularly in fish. In 
particular, the following objectives were achieved in the present thesis: 
1. The establishment of a list of reference compounds to develop and evaluate 
alternative methods to in vivo bioaccumulation studies in fish (Chapter 2). 
2. The development of log BCFmax models for rainbow trout and common carp that 
assisted in the creation of the reference list for bioaccumulation studies (Chapter 2). 
3. The development of an in vitro clearance assay using freshly prepared trout 
hepatocytes to study the metabolic biotransformation for a set of reference 
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chemicals supported by high quality in vivo BCF data (Chapter 3).  
4. The evaluation and comparison of available alternative methods in terms of their 
reliability to estimate KMET and BCF for a set of reference chemicals. Alternative KMET 
methods include the clearance assay (objective 3) together with different PBTK 
calculation models derived from the literature and the QSAR model of Arnot et al. 
[57] to predict KMET. Alternative BCF methods include log BCF-based and kinetic mass 
balance models (Chapter 3). 
5. The verification of structural alerts for Michael acceptors using the growth inhibition 
assay in Tetrahymena pyriformis (protozoan) and in chemico GSH reactivity data 
(Chapter 4). 
6. The development of an ITS for prioritising chemicals for in vivo testing. This ITS was 
built from the combination of the non-animal methods used for the verification of 
structural alerts for Michael acceptors (Chapter 4). 
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Chapter 2. Development of a List of Reference Compounds to 
Evaluate Alternative Methods to In Vivo Fish 
Bioaccumulation Tests1 
2. 1. Introduction  
The potential of a compound to bioaccumulate is one of several properties that need to be 
evaluated in risk assessment procedures. Although bioaccumulation refers to the 
accumulation of a substance in an organism from all routes of exposure (from the solution 
and diet), the potential bioaccumulation of a compound is usually expressed by the 
bioconcentration factor (BCF) that refers only to its accumulation through waterborne 
exposure. In aquatic risk assessments, BCFs have been measured in fish according to the 
Organisation for Economic Cooperation and Development (OECD) Test Guideline (TG) 305 
“Aqueous and dietary exposure” [10,31].  This test is demanding in terms of resources and 
the use of a large number of animals per test substance. Coupled with this, compliance with 
legislation such as the European Union Registration, Evaluation, Authorisation and restriction 
of Chemicals (REACH) regulation [13] has the potential to increase the demand for animal 
testing to assess BCFs for a large number of chemicals unless further action is taken to limit 
animal testing. In order to reduce cost and limit animal use, other methods such as in silico 
(computer-based) and in vitro techniques have been proposed as alternatives to in vivo 
testing in fish to comply better with the principles of the 3Rs (reduction, refinement and 
replacement) for animal testing [12]. 
In silico models for bioaccumulation have been developed over more than 30 years, mostly 
in the form of Quantitative Structure-Activity Relationships (QSARs) [47]. As chemical uptake 
is mainly a steady-state phenomenon controlled predominantly by passive diffusion 
processes and lipid partitioning, early QSAR models were built from the relationships 
                                                 
1 This Chapter is based on a publication whose link to the source is provided in the Appendix III. 
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between the observed log BCF and hydrophobicity, often represented by the logarithm of 
octanol/water partition coefficient (log KOW). Although there is a strong relationship with 
hydrophobicity, the maximal bioconcentration potential of a compound may be reduced by 
poor chemical bioavailability, ionisation and other factors that are associated with the 
Absorption, Distribution, Metabolism and Excretion (ADME) of chemicals [48]. Consequently, 
more recent approaches have developed mass balance models for a better interpretation of 
the ADME processes governing the bioaccumulation of neutral compounds [53,54] and 
ionisable compounds [80].  
Of the ADME processes, absorption and metabolism have been implicated as the most 
important factors introducing uncertainty into predictive models for bioaccumulation [30]. 
To deal with factors affecting chemical absorption, in silico approaches have considered 
molecular properties to screen for chemicals that may have limited bioaccumulation as a 
result of molecular constraints. In particular, molecular weight (MW) and the maximum 
inter-atomic distance between two atoms in the chemical structure (Dmax) have been 
demonstrated to be useful descriptors [81,82]; however, there has been little consensus in 
their use [83]. This can be explained partly by the fact that other features such as low 
bioavailability and metabolic biotransformation may also contribute to reduce the 
bioaccumulation of large molecules [83]. To deal with uncertainties associated with 
metabolism, modelling studies have incorporated chemical biotransformation data into log 
KOW-based prediction models to correct for the effect of metabolism in aquatic 
bioaccumulation [49]. Although partly successful, these predictions of metabolic 
susceptibility have been based on models for mammalian systems due to the lack of in vivo 
metabolic data for fish. Models for predicting the metabolic susceptibility in fish include: 1) 
a QSAR model developed by Arnot et al. [57] for the whole body biotransformation half-lives 
KMET(HL) built from predicted in vivo KMET rate data, which were estimated from measured 
BCF and total elimination rate constant in fish [84,85]; and 2) a more sophisticated 
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biotransformation half-lives model that was developed using the Iterative Fragment 
Selection method to identify fragments associated with chemical degradation [86].  
A variety of in vitro methods have been developed to study the absorption and metabolism 
of chemicals [30]. Whilst in vitro methods for absorption are based predominantly on 
mammalian systems, test systems for metabolism have also been developed for fish. Current 
biotransformation assays are based on a substrate-depletion approach for the calculation of 
the hepatic clearance rate which can be incorporated into established physiologically-based 
models for the estimation of KMET [42,43]. Although standardised protocols for in vitro 
methods such as subcellular fractions (S9) and primary hepatocyte cell assays have been 
proposed [35,41], standardised protocols for other biotransformation assays are still to be 
developed. It should be stressed that, despite the fact that information on absorption and 
metabolism properties can be obtained through in vitro methods, their applicability for 
assessing chemical bioaccumulation is currently limited by the lack of assay validation [44]. 
There is a need, therefore, to enable the development, standardisation and validation of in 
vitro methods for the prediction of in vivo bioaccumulation within a regulatory context. 
In order to ensure that non-animal methods can be used as surrogates for, or as a 
complement to, in vivo fish testing, the establishment of a high quality and well-
parameterised relationship between in vivo and in vitro data is required. A small number of 
such comparisons have been reported for BCFs [36-40], but they have been applied to a 
limited selection of chemicals. A representative list of chemicals, chosen on the basis of 
defined criteria for chemical diversity and data quality, is thus required to facilitate targeted 
comparison of the different approaches used in bioaccumulation testing.  
The aim of the present study, therefore, was to develop a list of reference compounds for 
future development and evaluation of the applicability of alternative test methods to assess 
bioaccumulation in fish. The selection of reference compounds was conducted according to 
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a number of criteria that were integrated into a three tiers strategy. The selection strategy 
was applied to identify a diverse set of chemical classes supported by high quality in vivo data 
for BCF, KMET and analysed metabolites for rainbow trout (Oncorhynchus mykiss) and 
common carp (Cyprinus carpio). In addition, broad coverage of bioconcentration potential, 
molecular properties (MW, Dmax), and metabolic properties (metabolic pathways, KMET (HL) 
were also required for the selected compounds. This Chapter describes the chemical 
selection process and the use of in silico techniques that were employed to assist in the 
creation of the reference list of chemicals.  
2.2. Materials and Methods  
2.2.1 Chemical  Selection Strategy 
The selection of reference chemicals was conducted according to a set of criteria organised 
into three Tiers as shown in Figure 2.1. The criteria were established using expert judgement 
based on previous criteria of the validity of the test procedures [77], and relevant 
considerations for the assessment of chemical accumulation in aquatic organisms. In 
essence, the purpose of Tiers I and II was to obtain high quality in vivo data for key 
bioaccumulation endpoints, whereas the purpose of Tier III was to ensure chemical diversity. 
The three tiers of chemical selection are described in detail below.  
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Figure 2.1 The three tier selection strategy used for the development of a list of reference 
compounds for evaluating alternative methods to fish bioaccumulation tests. 
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2.2.2 Starting Points for Chemical Selection 
Before data compilation, the first step in the strategy was the selection of relevant in vivo 
bioaccumulation endpoints, fish species and chemical classes for the development of a 
reference list of chemicals (Figure 2.1).  
Data for in vivo BCF, KMET and characterisation of the metabolic pathway of the chemicals 
(expressed by metabolite identification) were selected from in vivo measurements related 
to bioaccumulation for two reasons. Firstly, the many BCF data that were available for 
organic chemicals and which were determined according to official guidelines [10,31]; and 
secondly, the possibility of measuring such properties through in vitro metabolic test systems 
such as S9 and isolated hepatocytes [35-40]. In vitro test systems can also provide specific 
information on the metabolic pathway of test chemicals by identifying and quantifying their 
resulting metabolites [87]. With regard to fish species, rainbow trout and common carp were 
chosen in the present study as being OECD recommended test species for in vivo 
bioaccumulation studies [10,31] and for which different alternative testing approaches have 
been proposed [30]. With regard to chemical classes, only organic chemicals were 
considered in the present study since mechanisms other than hydrophobicity driven by 
passive diffusion could be involved in the bioaccumulation of organometallic compounds and 
organic salts [49]. As the use of in vitro metabolism assays may become more common in 
bioaccumulation studies in the future, the selection of relevant chemical classes was based 
on the inclusion of structurally diverse chemicals that span known biotransformation 
reactions in fish [29,88]. Table 2.1 lists the 19 chemical classes that were considered for the 
development of the reference list with their main biotransformation pathways and enzymes 
involved. The metabolism of xenobiotics is often classified into Phase I and Phase II 
biotransformation reactions [29,88]. In Phase I, reactive and polar groups are added to 
compounds that are being metabolised. There are three types of Phase I reactions: oxidation, 
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reduction and hydrolysis. Phase II reactions increase the polarity of chemicals by conjugation 
with a polar molecule (e.g. uridine diphosphate (UDP) glucuronic acid). Another crucial 
aspect for the creation of a reference list was the inclusion of chemicals of environmental 
concern. These included persistent organic compounds such as Polycyclic Aromatic 
Hydrocarbons (PAHs) and Polychlorinated Biphenyls (PCBs), and others with known 
industrial applications such as aliphatic halogenated hydrocarbons that have been used as 
industrial solvents, organophosphates and amides (pesticides), azo compounds (dyes) and 
heterocyclic compounds.  
Table 2.1. Chemicals classes considered for the development of a reference list of chemicals for 
alternatives to in vivo BCF tests [29,88] 
No. Chemical classes Major Phase I Metabolic Reactions 
(Enzymes) 
Major Phase II Metabolic 
Reactions (Enzymes) 
1 Aliphatic hydrocarbons Oxidative dehalogenation (CYP), 
Epoxidation of alkenes (CYP), 
Hydroxylation (CYP) 
Glutathione conjugation (GST) 
2 Benzenes Hydroxylation (CYP) Glucuronidation (UGT) 
3 Biphenyls Hydroxylation (CYP) Glucuronidation (UGT) 
4 Polycyclic aromatic 
hydrocarbons  
Hydroxylation (CYP), Epoxidation 
(CYP), 
Hydrolysis (EH) 
Glutathione conjugation (GST), 
Glucuronidation (UGT) 
5 Ethers  Dealkylation (CYP)  
6 Carboxylic acids and esters Hydrolysis of esters Amino acid conjugation (Acetyl-
CoA, AAT),  
Glucuronidation (UGT) 
7 Alcohols Oxidation (ADH) Sulfonation (SULT) 
8 Phenols  Glucuronidation (UGT), 
Sulfonation (SULT) 
9 Aldehydes Oxidation (ALDH), Oxidation of 
aromatic aldehydes (AO) 
 
10 Quinones Reduction (DTD)  
11 Nitroaromatic compounds Reduction (CYP NRT)  
12 Azo compounds Reduction (CYP AzoRT)  
13 Amines Oxidation of secondary amines 
(MAO), Oxidation of  tertiary 
amines (FMO), Reduction (CYP) 
Glucuronidation (UGT), 
Sulfonation (SULT), Acetylation 
(Acetyl-CoA) 
14 Amides and carbamates Oxidation (FMO) Glucuronidation (UGT) 
15 Organosphosphates Oxidation (CYP)  
16 Organosulfur compounds Oxidation desulfuration (FMO)  
17 Epoxides Hydrolysis (EH)  
18 Polyunsaturated fatty acids Oxidation (LPO)  
19 Heterocyclic compounds Oxidation (CYP), Reduction (CYP), 
Epoxidation (CYP) 
Glucuronidation (UGT) 
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AAT: Aminoacyl transferase, Acetyl-CoA: Acetyl-coenzyme A, ADH: Alcohol dehydrogenase, ALDH: Aldehyde 
dehydrogenase, AO: Aldehyde oxidase, CYP: Cytochrome P450, CYP AzoRT: Cytochrome P450 azoreductase, CYP 
NRT: Cytochrome P450 Nitroreductase, DTD: DT Diaphorase, EH: Epoxide hydrolase, FMO: Flavin-containing 
monooxygenase, GST: Glutathione S-transferase, LPO: Lipoxygenase, MAO: Monoamine oxidase, SULT: 
Sulfotransferase, UGT: Uridine diphosphate glucuronosyl transferase. 
 
2.2.3 Data Collection 
The next step in the strategy was the compilation of BCF, KMET and metabolite data for 
rainbow trout and carp from different information sources. A thorough scientific literature 
search was conducted to compile chemicals supported by KMET data and information on 
identified metabolites. BCF values were obtained from established databases including the 
Environment Canada’s Domestic Substance List (DSL) and non-DSL databases, both reviewed 
by Arnot and Gobas [32], and the EURAS-CEFIC database [89]. These databases were selected 
for two main reasons. Firstly, they assessed in vivo BCF data based on the quality principles 
reported in OECD TG 305 [10,31]; and secondly, they compiled data from other important 
sources including the ECOTOX (http://cfpub.epa.gov/ecotox) and the Japanese Ministry of 
Economy, Trade and Industry-National Institute of Technology and Evaluation (METI-NITE) 
database (http://www.nite.go.jp/index-e.html).  
Table 2.2 lists the general features of the different databases in terms of their availability and 
format, BCF data contained therein and the assessment score. It should be noted that 
although the databases differ in the number of criteria and scoring system to assess the 
quality of the in vivo BCF, they all agree with the recommendations for identification of high 
quality BCF data proposed by Parkerton et al. [90]: the correct analysis of test substance in 
fish and exposure medium, lack of significant toxic effects on exposed fish and achievement 
of steady state with unambiguous units.  
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Table 2.2 A summary and comparison of the features of the established BCF databases 
 Environment Canada BCF databases EURAS-CEFIC database 
Source On request from 
http://www.hc-sc.gc.ca/ 
Freely available from 
http://ambit.sourceforge.net/euras/ 
Format Microsoft excel spreadsheet Microsoft excel spreadsheet 
No.  BCF values 5317 1130 
No. chemicals 822 549 
Species Fish (82%), Invertebrates (15%), 
Autotrophs (4%) 
Only fish  
(90% for common carp) 
Score system 1 (high quality) 
2 (moderate quality) 
3 (low quality) 
Klimisch score:  
1 (reliable without restrictions)  
2 (reliable with restrictions)  
3 (not reliable) 
4 (not assignable) 
Only BCF data for rainbow trout and common carp supported by the highest quality score 
and measured under the same experimental conditions were selected for inclusion in the 
reference list. The experimental considerations were: 1) analytical determination of the test 
compounds in the whole fish (wet weight); 2) experimental tests conducted in a flow-
through system and; 3) using the steady state method for the calculation of BCF.  For 
chemicals with multiple BCF values, only those presenting coefficient of variance (100 x 
standard deviation/average value; CV %) lower than 50% were considered (Figure 2.1). Single 
BCF values for each chemical were obtained by averaging the multiple data points after the 
removal of statistically significant outliers. Outliers were identified using the boxplot graph 
representation in the SPSS software version (v.) 18 (http://www.spss.co.in). In this simple 
analysis, outliers were identified outside the T-bars (95% confidence intervals of the data). 
With regard to chemicals supported by in vivo KMET and metabolite identification data, both 
waterborne and dietary exposures were considered for the compilation of chemicals from 
the literature due to the lack of sufficient in vivo fish studies covering metabolism of 
chemicals. 
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2.2.4 Identification of Chemical Classes 
Compounds processed in Tier II were assigned to chemical classes according to the categories 
established in Tier I (Table 1.1) and the presence of other functional groups that were not 
listed in Table 1.1 (e.g. nitrile, peroxide, ketone). A further sub-classification according to 
structural properties (e.g. aliphatic vs aromatic fragments) was conducted for those chemical 
classes that contained a large number of chemicals. Industrial names were used for 
chemicals with complex chemical structures (e.g. dyes). 
2.2.5 Calculation of Descriptors and Properties 
Chemical structures of the compiled compounds were obtained from the EPI Suite version 
4.1 (http://www.epa.gov). The International Chemical Identifier (InChI) was obtained from 
the OpenBabel v. 2.3.1 software (http://openbabel.org/) and used to identify replicate 
compounds among databases and fish species. Chemical structures were recorded as SMILES 
strings for descriptor calculation and entered into different EPI Suite models to calculate: 1) 
log KOW and MW from KOWWIN v. 1.68; 2) Henry’s Law Constant (HLC) from HenryWin v. 
3.20 using the bond contribution method; and 3) KMET (HL) normalised to a 10 g fish from 
BCFBAF v. 3.01, which was based on the QSAR model developed by Arnot et al. [57]. Common 
names extracted from ChemSpider (http://www.chemspider.com/) were used for those 
chemicals presenting complex International Union of Pure and Applied Chemistry (IUPAC) 
names. 
Dmax values were calculated from the geometry optimised 3-D structures (in xyz format). The 
3-D structures were obtained from SMILES strings using a Python v 2.7.3 script. The 3D 
geometries were generated using OpenBabel v. 2.3.2 (http://openbabel.org/); accessed 
using Python via the Pybel module v. 1.8 (http://openbabel.org/wiki/Python) and locally 
optimised using the MMFF94 force-field [91]. The MOPAC input files were extracted, and 
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MOPAC v. 2012 (http://openmopac.net/) was run to optimise the chemical structures using 
the AM1 Hamiltonian. The following keywords were employed: charge=0 and PRT INT 
(setting no charge and exporting the interatomic distances, respectively). Dmax values were 
obtained from the MOPAC.out file, where Dmax was defined as the maximum interatomic 
distance between non-hydrogen atoms. The Dmax values were extracted automatically from 
the MOPAC.out file using an in-house Perl script.  
The prediction of metabolic pathway and resulting metabolites was made using the Meteor 
Nexus v.1.5.1 software (Lhasa Limited, Leeds, England (www.lhasalimited.org/meteor/). 
Meteor predicts biotransformation reactions from the structure of the parent compound by 
applying rules that were created based on knowledge on mammalian metabolism [92]. Such 
knowledge was extracted from the literature and/or confidential information from 
pharmaceutical industries. The Meteor Nexus software uses absolute and relative reasoning 
to make biotransformation predictions. Absolute reasoning describes the probability of 
biotransformation taking place (probable, plausible, equivocal, doubted and improbable), 
whereas relative reasoning allows further ordering of all possible metabolic outcomes. Levels 
of probable, plausible and equivocal, were selected for the analysis of the total number of 
resulting metabolites of the examined compounds, whereas predictions identified as 
probable and/or plausible were used to characterise the metabolic pathways of compounds 
identified in Tier II.  
2.2.6 Development of Log BCFmax Models 
The objective of the development of log BCFmax models was to identify chemicals whose BCF 
values were poorly correlated (over-predicted) with log KOW. Compounds supported by in 
vivo BCF data for rainbow trout and common carp were classified into six categories, noted 
below, depending on the difference between their reported predicted maximal BCF and 
experimental values. To provide an estimate of the maximal bioconcentration potential of 
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the examined chemicals, a model for the maximal log BCF (log BCFmax) for both fish species 
was thus required. To accomplish this, Equation 2.1 developed by Bintein et al. [93] was 
modified to accommodate a subset of in vivo BCF data, using the Minitab v. 16 statistical 
software (http://www.minitab.com).  
Log BCF = 0.91 log Kow – 1.97 log (6.8 x 10-7 Kow + 1) - 0.79      (2.1) 
n = 154, r2 = 0.950, s = 0.347, F = 464 
Where n is the number of observations; r2 is the square of the correlation coefficient; s is the 
standard error, and F is Fisher’s statistic 
As a difference of 0.5 log BCF is assumed reasonable to account for the variability resulting 
from experimental procedures [94], compounds whose residuals were between 0 and 0.5 
log units from this log BCFmax were considered well-predicted (W). In a similar manner, 
compounds whose residuals were less than 0 were considered under-predicted (U) and 
compounds whose residuals were greater than 0.5 log units were considered over-predicted 
(O) by the log BCFmax model. Under-predicted and over-predicted compounds were further 
classified into: 1) highly under-predicted compounds (U2) (residuals < -1); 2) slightly under-
predicted (U1) (residuals = -0.5 to 0); 3) slightly over-predicted (O1) (residuals > 0.5-1); 4) 
moderately over-predicted (O2) (residuals = 1 to 1.5); and 5) highly over-predicted (O3) 
(residuals > 1.5).  
2.2.7 Refinement of Chemical Domain 
The objective of Tier III was to pursue chemical diversity within the reference list in terms of 
physico-chemical, molecular and metabolic properties for each of the chemical classes 
identified in Tier II. Hydrophobicity (Log KOW) was selected amongst other physico-chemical 
properties due to its strong influence on BCF [47]; MW and Dmax were selected as they have 
been widely used to investigate the effect of molecular mass and size on chemical 
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bioaccumulation [81,82]; and finally, KMET (HL), metabolic pathway and number of 
metabolites of chemicals were selected amongst other metabolic properties. All these 
properties were calculated using the software as described above. When compounds in the 
same chemical class were identified as having the same bioconcentration potential for a 
similar range of log KOW, compound selection was then based on ensuring a broad range of 
molecular and metabolic properties. It should be noted that chemicals that were in common 
between rainbow trout and common carp and other chemicals that were supported by 
existing in vitro data were included in the reference list regardless of their physico-chemical, 
molecular and metabolic properties.  
2.3. Results and Discussion  
The present study aimed to establish a list of reference compounds for the development, 
assessment and validation of alternative methods to in vivo bioaccumulation studies in fish. 
As no official guidance is provided for conducting such a selection process, the present study 
presents a novel approach to select and evaluate such reference compounds.  
Different strategies have been developed to select representative compounds from existing 
databases depending on the number of compounds in the databases and purpose of the 
study. Particularly in drug discovery, computational techniques, such as cluster analysis and 
dissimilarity-based compound selection, have been used to ensure the selection of 
structurally diverse sets of compounds for testing [95]. In contrast, the chemical selection 
procedure is rationalised in (eco)toxicological studies by considering aspects important for 
the evaluation of alternative methods through the establishment of a list of selection criteria, 
and therefore, not necessarily employing high-throughput screening approaches. Similar to 
other chemical selection strategies in (eco)toxicology [79,96-98], the strategy followed in the 
present study was based on the establishment of a list of criteria, evaluation of available 
experimental in vivo data, and the use of in silico techniques to complement the selection 
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process. It should be noted, however, that whilst for toxicity studies there is a need to 
consider the mechanism of toxic action to ensure either consistency or diversity, chemical 
bioaccumulation is governed to a large degree by ADME processes that are more clearly 
linked to physico-chemical and molecular properties.  
The selection process performed in the present study involved three Tiers: Tier I selected 
relevant in vivo bioaccumulation endpoints, fish species and chemical classes for the 
development of a list of reference compounds; Tier II compiled and analysed chemicals 
supported by high quality in vivo data for the established endpoints and chemical classes in 
Tier I; and Tier III applied further criteria to ensure a broad chemical domain. Tier I has been 
explained in detail in Materials and Methods, and therefore, it will not be discussed again in 
this section.   
2.3.1 Compounds Supported by In Vivo BCF Data 
Data Extraction  
A total of 361 BCF values for rainbow trout and another 840 BCF values for common carp 
were obtained from the Canadian DSL and non-DSL and EURAS-CEFIC BCF databases based 
on the highest reliability score and application of the same test conditions. Initially, all BCF 
values that were extracted for common carp were assessed as having the highest reliability 
score since they were measured in compliance with Good Laboratory Practise in Japan to 
meet the Chemical Substance Control Law [33]. In contrast, for rainbow trout 331 BCF values 
failed to meet one or more of the established quality criteria of the databases [32,89], for 
example the toxic effects reported for two dioxin-like compounds, uncertain correction of 
the radiolabel analysis for some organophosphates and insufficient exposure duration to 
achieve 80% of steady state for the majority of polychlorinated compounds.  
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Multiple BCF values were obtained for the majority of compounds for rainbow trout; all 
chemicals assessed in common carp had two BCF values. Compounds containing multiple 
BCFs with a coefficient of variance (CV) that was lower than 50% were considered for the 
development of list of reference compounds. A total of 51 out of 59 compounds were 
selected for rainbow trout; a total of 224 compounds out of 420 were selected for common 
carp. Generally, rejected compounds (CV > 50%) showed a significant difference between 
their BCFs reported at different test concentration as is represented in Figure 2.2 for a 
rejected compound, pentachloronitrobenzene (CAS no. 62-68-8). This could be an indication 
of toxic effects and/or enzyme saturation in test organisms produced at high concentrations 
[32].  
 
Figure 2.2 Relationship between log BCF and uptake duration phase depending on test 
concentration for pentachloronitrobenzene.  
Single BCF values for selected compounds (CV < 50%) were obtained by averaging the 
multiple data points after the removal of two outliers that were identified for two 
compounds for rainbow trout, and thus were excluded in the calculation of the average 
values for these compounds.  
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Identification of Chemical Classes  
The selected chemicals supported by high quality in vivo BCF data for both rainbow trout and 
common carp were classified into 18 chemical classes and additional subclasses on the basis 
of their functional groups and structural properties. Table 2.3 shows the chemical classes 
identified and number of compounds in each according to fish species. As can be seen, the 
majority of compounds were found to be aliphatic and aromatic hydrocarbons (classes 1-5), 
phenols, nitrobenzenes and amines, with a relatively small number of organosulfur 
compounds, carboxylic acids, alcohols, amides and organophosphates.  
Table 2.3. Chemical classes and subclasses for compounds with in vivo BCF data 
No. Chemical classes  Subclasses Trout Carp Total 
1 Aliphatic linear 
hydrocarbons  
Alkenes, Alkanes 0 24 24 
2 Aliphatic cyclic 
hydrocarbons 
Cycloalkanes, Cycloalkenes  1 13 14 
3 Benzenes Alkylbenzenes, Benzenes 17 28 45 
4 Biphenyls Chlorobiphenyls, Bromobiphenyls  5 5 10 
5 Polycyclic aromatic 
hydrocarbons (PAHs) 
Naphthalenes, Other PAHs 3 7 10 
6 Ethers Aliphatic ethers, Aromatic ethers 2 9 11 
7 Carboxylic acids and 
esters 
Any subclassification was conducted 6 1 7 
8 Alcohols Alcohol derivatives, Alcohols 0 7 7 
9 Phenols Alkylphenols, Nitrophenols, Phenol 
derivatives 
3 35 38 
10 Ketones  No subclassification  0 4 4 
11 Quinones No subclassification  0 7 7 
12 Nitrobenzenes Alkylnitrobenzenes 12 13 25 
13 Amines Alipathic amines, Naphthalenamines, 
Benzoamines, Other amines 
0 25 25 
14 Amides and carbamates Aliphatic amides, Aromatic amides, 
Carbamates 
0 7 7 
15 Organophosphates Aliphatic organophosphates, Aromatic 
organophosphates, Thiophosphates 
1 8 9 
16 Heterocyclic compounds Saturated, Unsaturated 1 16 17 
17 Dyes (azo compounds) No subclassification 0 5 5 
18 Minority groups Nitriles, Organosulfur compounds, 
Phenyls, Hydrazobenzenes, Peroxides 
0 10 10 
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Table 2.3 covered the majority of the chemical classes that were proposed for inclusion in 
the reference list based on their known biotransformation reactions (Table 2.1) with the 
exception of aldehydes, epoxides and polyunsaturated fatty acids. Of these, only two 
epoxides were found initially within the common carp data, however they were not 
considered further due to a CV > 50%. The lack of diversity for some classes of chemicals in 
the original BCF databases, such as reactive compounds (e.g. epoxides), can be explained by 
the fact that such chemicals are likely to cause toxicity higher than the 10 % mortality validity 
limit set for OECD tests even at low exposure concentrations [10,31], and hence may not be 
good candidates for in vivo bioaccumulation assessments. This observation is supported by 
the toxic effects reported for dioxin-type compounds described above for rainbow trout. 
Nonetheless, a broad range of chemical structures and other chemical groups that were not 
initially considered in Tier I, such as ketones, carbamates, esters, nitriles and peroxides, were 
considered for the development of the list of reference compounds.  
Table S1 lists the 265 chemicals that entered into Tier III according to the chemical classes 
noted in Table 2.3. Table S1 is provided as electronic supplementary data (Appendix IV). 
Physico-chemical properties (log Kow, log HLC), molecular properties (MW, Dmax), metabolic 
properties (metabolic reactions, number of metabolites, KMET (HL)) and data related to the 
measurement of the in vivo BCF (test temperature, final wet weight and lipid content of test 
organisms, reference database) are shown in Table S1.  
Compounds in Common Between Fish Species 
Of the 265 chemicals, ten chemicals were in common between rainbow trout and common 
carp including five substituted benzenes (44, 45, 53, 64, 71) (see Table S1), 2,2',5-
trichlorobiphenyl (83), pentachlorophenol (151) and three nitrobenzenes (177, 178, 182). For 
all chemicals in common, lower values of log BCF were obtained for common carp than for 
rainbow trout. This could be caused by differences in the temperature of the test system, 
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since the temperature used to measure BCFs in common carp was 22 °C and a temperature 
of 15 °C was reported for rainbow trout (see Table S1). Temperature is considered to be one 
of the factors affecting bioconcentration kinetics since it may influence the biological 
enzymatic rates and other temperature-dependent biological processes [29]. In fact, a 
comparative study has shown that in vitro metabolite formation was 10 to 100 times faster 
in carp than trout [99], which could explain the consistently lower BCF values observed for 
common carp in the present comparison.  
2.3.2 Development of Log BCFmax Models 
The first step for the identification of compounds with lower log BCF values than expected 
from the relationship with log KOW correlation was the development of a model for maximal 
log BCF for rainbow trout and common carp (log BCFmax). Equation 2.1 was modified to 
accommodate a subset of chemicals with high BCF values for each of the fish species. The 
bilinear models built for rainbow trout and common carp are shown as a solid line in Figure 
2.3 and are described by Equations 2.2 and 2.3 respectively. These models represent the 
worse-case scenario for BCF where accumulation is driven purely by passive diffusion 
processes. 
Log BCFmax, Rt = 0.88 log KOW – 1.73 log (2.25 x 10-6 KOW + 1) - 0.08   (2.2) 
Log BCFmax, Cc = 0.89 log KOW – 1.51 log (1.41 x 10-6 KOW + 1) - 0.88   (2.3) 
It should be noted that the data used in Equations 2.2 and 2.3 were based on selecting 
chemicals with high BCF values (shown as open circles in Figure 2.3) to obtain the maximal 
BCF value and, therefore, were not subjected to any statistical treatment. 
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Figure 2.3 Relationship between log BCF and log KOW for rainbow trout and common carp 
compounds.  Solid line: log BCFmax model developed from a set of chemicals with representative 
maximal values (represented as open circles).  
Compounds supported by in vivo BCF data were then split into six different categories 
depending on their residual values from Equations 2.2 and 2.3. Following the rationale 
explained above, 6% of compounds were classified as being highly and slightly under-
predicted (U2,U1), 31% well-predicted (W), another 35% slightly over-predicted (O1) and 
finally 28% of substances were identified as being moderately and highly over-predicted 
(O2,O3). Over-predicted compounds represent groups of interest to allow for the 
Eq. 2.2 
Eq. 2.3 
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investigation of factors reducing BCF of chemicals such as high rates of metabolic reactions, 
poor bioavailability due to a high degree of ionisation and lack of undergoing uptake due to 
molecular constraints. 
Compounds that were under-predicted (U2,U1) included a set of hydrophilic heterocyclic 
compounds (234,235,237,238), aliphatic amides (218,224) and highly hydrophobic 
hydrocarbons (log KOW > 7) such as dechloran A (38), 1,3,5-tris (1,1-dimethylethyl)benzene 
(78), decabromobiphenyl (87) and tris (1-methylethyl)naphthalene (96) (see Table S1). The 
high bioconcentration potential of highly hydrophobic hydrocarbons (38,78,87) could be 
attributable to a lack of metabolic biotransformation, since halogen groups and/or alkyl 
groups at the target site of metabolic reaction, or at surrounding positions, may have the 
potential to inhibit partly or completely the metabolic biotransformation of these 
compounds [29]. 
Well-predicted and slightly over-predicted compounds (W, O1) included the majority of 
neutral compounds such as cyclic aliphatic, benzenes, biphenyls, PAHs and all compounds 
classified as ethers. This observation is supported by their relatively high values of KMET (HL) 
and lack of polar groups in the chemical structure that may make them less susceptible to a 
metabolic attack [47]. However, compounds with log KOW < 3 with polar groups and relatively 
low values of KMET (HL) such as alcohols (119), phenols (123-130), quinones (164), 
nitrobenzenes (171-180) and organophosphates (225) were also classified as W and O1 
(Table S1). This is in agreement with previous in silico predictions suggesting that high 
biotransformation rates have only a minimal impact on the BCF for compounds with log KOW 
< 3 [43,84]. High rates of chemical flux across the gills could be more important for the overall 
BCF than the biotransformation rates for such compounds. Conversely, more hydrophobic 
compounds (log KOW > 3) with polar groups such as ketones (160,161,163), quinones 
(169,170), nitrobenzenes (187,188,191), amines (212,216), amides (219-221,223) were 
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identified as being over-predicted (O2,O3) (Table S1). The lower than expected log BCF values 
may be a result of metabolism as previous modelling studies have shown that relatively low 
biotransformation rate may have a large influence on bioaccumulation for hydrophobic 
compounds (log KOW > 3) [43,84].  
As expected, the observed log BCF of the majority of ionisable compounds in the present 
study showed low bioconcentration potential, as chemical properties other than 
hydrophobicity account for the bioaccumulation of ionisable compounds. Ionisable 
compounds included organic acids such as phenols, carboxylic acids and phosphates and 
organic bases such as amines and heterocyclic compounds containing a nitrogen atom in the 
ring. Descriptors other than log KOW have been considered in recent in silico studies to 
improve the prediction of bioaccumulation for ionisable compounds [80]. Alternative 
descriptors include the logarithm of the distribution coefficient (log D), which is the ratio of 
concentration of unionised forms of a compound in octanol and the total concentration of 
unionised and ionised forms in water. It should be noted that the log KOW of ionisable 
compounds provided in the present study refers to their neutral form. The absorption of 
ionisable compounds is dependent on several factors such as the log KOW of the neutral form 
and the degree of ionisation, i.e. the negative logarithm of the equilibrium constant for 
dissociation (pKa). No significant reduction in the uptake rate is predicted for weak organic 
acids and weak bases at a pH of 7 [80]; however, a moderate reduction in the uptake is 
expected at higher pH (pH > 9) and, therefore, further analysis of the degree of ionisation for 
ionisable compounds will be required to address this in detail. 
It is worth noting that as the bioaccumulation of a compound is a complex function 
comprising diverse chemical properties and biological processes, the low bioconcentration 
of some of the examined compounds could be associated with more than one factor [83]. 
For instance, the significant low bioconcentration potential of dyes (251-255) (Table S1) could 
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be a result of several processes such as a potential fast metabolic biotransformation, 
absorption limitation due to their large molecular size (Dmax = 1.44 to 2.64) and poor 
bioavailability due to ionisation and binding to proteins. 
2.3.3 Compounds Supported by In Vivo KMET Data 
Data for 14 chemicals with measured in vivo KMET values were found for rainbow trout, which 
contrasted with the lack of information for KMET for common carp. These chemicals are listed 
in Table S2, provided as electronic supplementary data in the Appendix IV, and encompassed 
five phenyls (1-5) [100,101] and nine heterocyclic pesticides (6-14) [101,102]. Of these, 
tetrachlorobiphenyl (1) and DDT (2) were also supported by in vivo BCF data (see compounds 
85 and 261 in Table S1). Experimental details used for the assessment of KMET, such as type 
of exposure, tissue analysed and test concentration are provided in Table S2. KMET values were 
calculated by comparing the HL of test compounds with known recalcitrant PCBs in a non-
linear relationship between log KOW and HL [103]. Based on this approach, chemicals whose 
HL fall on, or near, this non-linear relationship were assumed to be recalcitrant to 
biotransformation, whereas those chemicals with data that fall below this relationship were 
suggested to be more readily biotransformed. This method allows for the quantification of 
the biotransformation rates of a number of organic chemicals that were tested under the 
same experimental conditions [103]. 
2.3.4 Compounds Supported by In Vivo Analysed Metabolites 
Data for eight chemicals whose resulting metabolites were analysed in an in vivo system using 
rainbow trout were compiled from the literature. These chemicals are provided in Table S3 
(electronic supplementary data, Appendix IV) and included four perfluoroalkylated 
compounds (1-4)[104,105], decabromodiphenyl ether (BDE) (5)[106] and three carboxylic 
acid pharmaceuticals (6-8) [107,108]. Although few metabolites were monitored for each 
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compound, the biotransformation pathway was proposed for fluorotelomer acrylate (4) and 
carboxylic acids (6-8). Experimental details used for the analysis of metabolites and 
references are provided in Table S3. Depending on the study, different routes of exposure 
(dietary, waterbone, intraperitoneal injection) as well as fish tissues for analysis (muscle, 
blood, liver bile, and kidney) were used to investigate the biotransformation pathways of 
these compounds (see Table S3). Worthy of mention is that both aspects may influence the 
formation and accumulation of resulting metabolites from the parent compound. For 
instance, a different metabolic pattern was found for BDE (5), where debromominated 
diphenyl ether metabolites (De-BDEs) were the main metabolites in liver, whereas 
methoxylated diphenyl ethers (MeO-DBEs) were found in higher concentration in blood 
[106]. With regard to common carp, the biotransformation of three PAHs [109] and four 
polybrominated diphenyl ether congeners [110] have been reported, but these data were 
not included in the present study as neither study detected any metabolites of the parent 
compounds in the tissue analysed. 
2.3.5 Refinement of Chemical Domain 
All the chemicals that were compiled in Tier II were reduced in number according to the Tier 
III criteria (Figure 2.1). A total of 144 compounds out of the 265 compounds passing Tier II 
were selected to provide in vivo BCF data (see reference compound (RC) in Table S1). Selected 
chemicals are listed in Table 2.4 with some of the properties considered most relevant for 
the selection process. Generally, fewer chemicals were selected (< 50%) for the chemical 
classes that contained a large number of chemicals and low structural diversity (e.g. aliphatic 
linear and cyclic hydrocarbons, benzenes, ethers, phenols and nitrobenzenes) than for more 
diverse chemical groups with fewer chemicals (e.g. organophosphates, amides and 
heterocyclic compounds) (Table 2.3). The selection covers chemicals used in a range of 
industrial applications such as: 1) intermediates in the production of pharmaceuticals 
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(91,123), cosmetic and fragrances (192), plastics (46,225), detergents (36); 2) pesticides 
including insecticides (35, 38, 221,227, 248,250, 261), nematocides (13,98),  fungicides (262) 
and herbicides (222); 3) dyes (251-255); 4) and industrial solvents (14,21,229,234). Of the 
selected compounds, naphthalene (88), pentachlorophenol (151) and nonyl-phenol (154) 
should be considered of high environmental relevance due to their multiple industrial 
applications.  
For compounds supported by KMET and metabolite identification, 13 compounds were 
selected on the basis of the existing in vitro data and broad coverage of chemical properties 
considered for selection (see RC in Tables S2 and S3 respectively). In terms of existing in vitro 
data, four fungicides (6,7,10,11) with in vivo KMET data were previously tested in rat and 
rainbow trout  hepatic microsomes with the aim to investigate their cross-species 
comparison [111]. A high degree of metabolic conservation was found between both species. 
The biotransformation of four compounds supported by in vivo analysed metabolites was 
also investigated from an in vitro scenario (see Table S3 for details). For instance, the 
metabolism of decabromodiphenyl ether (5) was investigated using liver microsomal 
fractions from common carp and rainbow trout [112], and 8:2 Fluorotelomer acrylate (4) was 
tested in S9 fractions isolated from rainbow trout stomach and liver [113].Table 2.5 and Table 
2.6 list the selected chemicals for in vivo data for KMET and metabolites respectively.  
The ensemble of reference compounds for in vivo BCF, KMET and metabolite data 
encompasses a broad range of bioconcentration potential, log KOW (-0.93 to 12.11), molecular 
properties (MW: 68.1 to 959 g/mol and Dmax: 0.29 to 2.64 nm), KMET (HL) (0-33100 d) and 
diverse metabolic biotransformation pathways. 
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Table 2.4 Reference compounds with in vivo BCF data and other significant properties 
ID Chemical name Log KOW 
Pred. Log 
BCFmax 
   In vivo  
  log BCF 
BP     Sp MW Dmax     KMET (HL) 
Aliphatic linear hydrocarbons 
3 Dichlorodifluoromethane 1.82 1.24 0.78 W Cc 120.91 0.29 0.619 
11 2-Methyl-1,3-butadiene 2.58 1.92 1.04 O1 Cc 68.12 0.56 0.591 
13 1,2-Dibromo-3-chloropropane 2.68 2.01 1.04 O1 Cc 236.33 0.48 0.340 
14 Tetrachloroethene 2.97 2.26 1.71 O1 Cc 165.83 0.56 3.35 
19 2,4,4-Trimethyl-1-pentene 4.08 3.25 2.76 W Cc 112.22 0.65 3.00 
20 1-Nonene 4.62 3.70 3.18 O1 Cc 126.24 0.99 2.77 
21 1,1,2,3,4,4-Hexachloro-1,3-butadiene 4.72 3.78 3.82 U1 Cc 260.76 1.19 26.8 
23 2,5,8-Trimethyl-1-nonene 6.01 4.39 3.35 O2 Cc 168.33 1.24 5.89 
24 Hexadecane 8.20 3.38 1.65 O3 Cc 226.45 2.18 19.9 
Aliphatic cyclic hydrocarbons 
26 Cyclohexane 3.18 2.45 1.87 O1 Cc 84.16 0.54 0.762 
30 4-Ethenyl-cyclohexene 3.73 2.94 2.18 O1 Cc 108.18 0.61 1.55 
33 
1,2,3,4,5-Pentabromo-6-      
Chlorocyclohexane 
4.71 3.77 2.45 O2 Cc 513.09 0.66 2.52 
35 Heptachlor 5.86 4.38 3.97 W Cc 373.32 0.68 50.1 
36 Cyclododecane 6.12 4.39 3.85 O1 Cc 168.33 0.89 11.7 
38 Dechloran A 11.27 1.48 2.03 U2 Cc 653.73 1.13 33100 
Benzenes 
39 Chlorobenzene 2.64 1.97 1.24 O1 Cc 112.56 0.47 0.532 
44 1,2-Dichlorobenzene 3.28 2.54 2.26 W Cc 147.00 0.56 3.42 
   2.80 2.58 W Rt    
45 1,3-Dichlorobenzene 3.28 2.54 2.24 W Cc 147.00 0.56 3.67 
   2.80 2.74 W Rt    
46 1-Methylethenylbenzene 3.44 2.68 1.84 O1 Cc 118.18 0.66 0.940 
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Table 2.4 Reference compounds with in vivo BCF data and other significant properties (cont.) 
  ID Chemical name Log KOW 
Pred. Log 
BCFmax 
   In vivo  
   log BCF 
BP      Sp MW Dmax     KMET (HL) 
 48 1,2,4-Trimethylbenzene 3.63 2.85 2.13 O1 Cc 120.20 0.63 0.821 
       53 1,2,3-Trichlorobenzene 3.93 3.36 3.26 W Rt 181.45 0.59 5.59 
   3.12 2.82 W Cc    
       56 Ethenylethylbenzene 3.93 3.12 2.66 W Cc 132.21 0.86 2.71 
       62 1,2-Dichloro-4-(trifluoromethyl)benzene 4.24 3.62 3.18 W Rt 215.00 0.69 9.61 
       63 1,2,4-Trichloro-5-methylbenzene 4.47 3.81 3.88 W Rt 195.48 0.59 4.93 
       64 1,2,3,4-Tetrachlorobenzene 4.57 3.66 3.03 O1 Cc 215.89 0.59 8.70 
   3.88 3.85 W Rt    
       68 1,3-Bis(1-methylethyl)benzene 4.90 3.92 3.16 O1 Cc 162.28 0.89 4.01 
       71 Pentachlorobenzene 5.22 4.14 3.55 O1 Cc 250.34 0.64 13.7 
   4.28 4.19 W Rt    
      73 1,2,4,5-Tetrachloro-3,6-dimethylbenzene 5.67 4.37 3.55 O1 Rt 243.95 0.70 6.98 
      76 Hexabromobenzene 7.33 3.44 3.02 W Rt 551.49 0.67 7.32 
      78 1,3,5-Tris(1,1-dimethylethyl)benzene 7.72 3.67 4.30 U2 Cc 246.44 0.94 77.0 
Biphenyls 
      81 3,5-Dichlorobiphenyl 5.05 4.19 3.77 W Rt 223.10 0.92 20.2 
      83 2,2',5-Trichlorobiphenyl 5.69 4.35 4.07 W Cc 257.55 0.93 94.3 
   4.37 4.23 W Rt    
      84 3,3'-Diethylbiphenyl 5.83 4.38 3.80 O1 Cc 210.32 1.11 30.8 
      85 2,2',3,3'-Tetrachlorobiphenyl 6.34 4.16 4.23 W Rt 291.99 0.93 155 
PAHs 
      88 Naphthalene 3.17 2.44 1.97 W Cc 128.18 0.59 4.53 
      91 9H-Fluorene 4.02 3.19 2.75 W Cc 166.22 0.84 1.37 
      93 Anthracene 4.35 3.48 3.30 W Cc 178.24 0.90 2.54 
      95 1,2,3,4-Tetrachloronaphthalene 5.75 4.37 3.70 O1 Rt 265.95 0.70 25.2 
      96 Tris(1-methylethyl)naphthalene 7.54 3.78 3.82 U1 Cc 254.42 1.05 22.4 
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Table 2.4 Reference compounds with in vivo BCF data and other significant properties (cont.) 
      ID Chemical name Log KOW 
   Pred. Log 
    BCFmax 
   In vivo  
   log BCF 
BP      Sp MW Dmax KMET (HL) 
      97 Octachloronaphthalene 8.33 2.61 2.58 W Rt 403.73 0.78 218 
Ethers 
      98 2,2'-Oxybis (1-chloropropane) 2.39 1.75 0.91 O1 Cc 171.07 0.56 0.437 
     101 Dibenzyl ether 3.48 2.72 2.45 W Cc 198.27 0.84 0.075 
     103 1,2,3-Trichloro-4-methoxybenzene 4.01 3.43 3.25 W Rt 211.48 0.74 18.5 
     106 2-(2-Methylpropoxy)naphthalene 4.65 3.73 2.85 O1 Cc 200.28 1.06 5.93 
     107 Pentachloroanisole 5.30 4.31 4.19 W Rt 280.37 0.83 69.0 
     108 Hexabromodiphenyl ether 8.55 3.16 3.15 W Cc 643.59 1.10 40.3 
Carboxylic acids and esters 
     109 Chlorobenzilate 3.99 3.17 2.65 O1 Cc 325.19 1.03 2.13 
     112 Abietic acid 6.46 4.09 1.84 O3 Rt 302.46 1.16 49.4 
     114 Palustric acid 7.27 3.49 1.40 O3 Rt 302.46 1.20 84.8 
     115 12,14-Dichlorodehydroabietic acid 7.81 3.05 1.97 O2 Rt 369.33 1.17 53.3 
Alcohols 
    116 1,1,1,3,3,3-Hexafluoro-2-propanol 1.11 0.60 0.20 W Cc 168.04 0.46 0.370 
    118 1,1,1-Trichloro-2-methyl-2-propanol 2.09 1.48 0.26 O2 Cc 177.46 0.49 0.405 
    120 2,6-Dichloro-benzenemethanol 2.36 1.72 0.32 O2 Cc 177.03 0.63 0.228 
    121 4-Chlorobenzhydrol  3.35 2.60 1.77 O3 Cc 218.68 0.98 0.636 
Phenols 
    123 4-Nitrophenol 1.91 1.32 0.65 O1 Cc 139.11 0.63 0.073 
    129 3-Nitro-p-cresol 2.46 1.81 0.95 O1 Cc 153.14 0.68 0.051 
    134 2-Chloro-5-methylphenol 2.70 2.02 0.50 O3 Cc 142.59 0.59 0.227 
    135 4-Chloro-2-methylphenol 2.70 2.02 1.14 O1 Cc 142.59 0.61 0.209 
    136 2,6-Dichlorophenol 2.80 2.11 1.06 O2 Cc 163.00 0.56 0.350 
    137 3,4-Dichlorophenol 2.80 2.11 1.70 W Cc 163.00 0.56 0.528 
    140 2,5-Dichlorophenol 2.80 2.11 1.15 O1 Cc 163.00 0.56 0.436 
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Table 2.4 Reference compounds with in vivo BCF data and other significant properties (cont.) 
       ID Chemical name Log KOW 
   Pred. Log 
    BCFmax 
    In vivo  
   log BCF 
BP      Sp MW Dmax   KMET (HL) 
      143 2,4-Dichloro-6-nitrophenol 3.20 2.47 1.28 O2 Cc 208.00 0.62 0.190 
144 1,1'-Biphenyl-4-ol 3.28 2.54 1.64 O1 Cc 170.21 0.93 0.630 
145 2,4,5-Trichlorophenol 3.45 2.69 2.60 W Cc 197.45 0.62 0.734 
147 4-(Phenylmethyl)phenol 3.54 2.77 1.39 O2 Cc 184.24 0.92 0.231 
148 2-Methoxytetrachlorophenol 3.92 3.36 2.26 O2 Rt 261.92 0.78 5.91 
151 Pentachlorophenol 4.74 3.80 2.10 O3 Cc 266.34 0.62 2.20 
   4.00 2.65 O2 Rt    
153 2,6-Bis(1,1-dimethylethyl)-4-ethyl-phenol 5.52 4.29 3.49 O1 Cc 234.38 0.93 1.42 
154 Nonyl-phenol 5.99 4.39 0.33 O3 Cc 220.36 1.57 1.33 
156 2,6-Dicyclohexylphenol 6.30 4.36 2.95 O2 Cc 258.41 1.01 1.06 
158 Hexachlorophene  6.92 4.12 2.07 O3 Cc 406.91 1.01 3.78 
Ketones 
160 Diphenylmethanone 3.15 2.43 0.84 O3 Cc 182.22 0.97 0.248 
161 Michler's ketone 3.50 2.74 1.52 O2 Cc 268.36 1.44 0.298 
162 Oxybenzone 3.52 2.75 1.98 O1 Cc 228.25 1.21 0.173 
163 2-(1-Cyclohexenyl)cyclohexanone 3.73 2.94 0.49 O3 Cc 178.28 0.85 0.480 
Quinones 
165 1-Amino-9,10-anthracenedione 3.53 2.76 1.99 O1 Cc 223.23 0.96 0.126 
166 1-Hydroxy-9,10-anthracenedione 3.64 2.86 2.26 O1 Cc 224.22 0.96 0.070 
169 2-Ethyl-9,10-anthracenedione 4.38 3.50 0.99 O3 Cc 236.27 1.15 0.432 
170 7-Oxobenz[de]anthracene 4.73 3.79 2.07 O3 Cc 230.27 0.96 0.387 
Nitrobenzenes 
171 Nitrobenzene 1.81 1.23 0.63 O1 Cc 123.11 0.61 0.099 
175 1-Methyl-3-nitrobenzene 2.36 1.72 0.76 O1 Cc 137.14 0.71 0.335 
177 1-Chloro-4-nitrobenzene 2.46 2.08 2.00 W Rt 157.56 0.61 0.644 
   1.81 1.12 O1 Cc    
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Table 2.4 Reference compounds with in vivo BCF data and other significant properties (cont.) 
ID Chemical name Log KOW 
  Pred. Log   
   BCFmax 
  In vivo             
 log BCF 
BP      Sp   MW Dmax  KMET (HL) 
178 1-Chloro-2-nitrobenzene 2.46 2.08 2.09 U1 Rt 157.56 0.61 0.644 
   1.81 1.16 O1 Cc    
181 2-Ethylnitrobenzene 2.85 2.16 1.06 O2 Cc 151.17 0.77 0.372 
182 1,2-Dichloro-4-nitrobenzene 3.10 2.65 2.07 O1 Rt 192.00 0.60 1.03 
   2.38 1.67 O1 Cc    
188 1,2,3-Trichloro-4-nitrobenzene 3.74 3.20 2.19 O2 Rt 226.45 0.61 1.62 
189 1,3,5-Trichloro-2-nitrobenzene 3.74 2.95 2.44 O1 Cc 226.45 0.69 1.71 
191 1,2,3,4-Tetrachloro-5-nitrobenzene 4.39 3.74 1.85 O3 Rt 260.89 0.68 2.14 
192 Musk xylol 4.45 3.56 3.56 W Cc 297.27 0.92 0.070 
Amines 
193 1,8-Naphthalenediamine 1.34 0.81 0.70 W Cc 158.20 0.63 0.042 
194 N-Ethyl-benzenamine 2.11 1.50 0.91 O1 Cc 121.18 0.90 0.125 
195 2,5-Dimethylbenzenamine 2.17 1.55 0.48 O2 Cc 121.18 0.69 0.095 
197 N,2-Dimethylbenzenamine 2.17 1.55 0.72 O1 Cc 121.18 0.76 0.317 
204 Triallylamine 2.58 1.92 0.47 O2 Cc 137.23 0.99 0.122 
206 1,1'-Biphenyl-2-amine 2.84 2.15 1.36 O1 Cc 169.23 0.93 0.750 
207 2,4,6-Trichlorobenzenamine 3.01 2.30 1.92 W Cc 196.46 0.67 0.979 
208 N,N-Diethyl-benzenamine 3.15 2.43 1.93 W Cc 149.24 0.81 0.143 
212 N-Nitroso-N-phenylbenzenamine  3.16 2.43 1.36 O2 Cc 198.23 0.91 0.123 
213 4,4'-Methylenebis (2-chlorobenzenamine) 3.47 2.71 2.33 W Cc 267.16 1.11 0.552 
215 N-Phenyl-1-naphthalenamine 4.47 3.58 3.22 W Cc 219.29 1.08 2.21 
216 N-Phenyl-2-naphthalenamine 4.47 3.58 2.32 O2 Cc 219.29 1.26 2.51 
217 N,N-Dioctyl-1-octanamine 10.35 2.05 1.86 W Cc 353.68 2.30 20.0 
Amides and carbamates 
218 N,N-Dimethylformamide -0.93 -1.22 -0.19 U2 Cc 73.10 0.42 0.007 
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Table 2.4 Reference compounds with in vivo BCF data and other significant properties (cont.) 
ID Chemical name Log KOW 
   Pred. Log   
   BCFmax 
   In vivo           
   log BCF 
BP     Sp MW Dmax  KMET (HL) 
219 N,N-Diethyl-3-methylbenzamide 2.26 1.63 0.29 O2 Cc 191.28 1.01 0.206 
220 3,5-Dimethylphenyl methylcarbamate 2.27 1.64 0.25 O2 Cc 179.22 1.06 0.051 
221 Fenocarb 2.86 2.17 0.36 O3 Cc 207.27 0.81 0.132 
222 Linuron 2.91 2.21 1.25 O1 Cc 249.10 0.92 0.148 
223 
3-Hydroxy-N-phenyl-2-
naphthalenecarboxamide 
4.47 3.58 0.66 O3 Cc 263.30 1.36 0.186 
Organophosphates 
225 Triethyl phosphate 0.87 0.39 -0.04 W Cc 182.16 0.88 0.028 
226 Tris(1-chloro-2-propanyl) phosphate 2.89 2.19 0.39 O3 Cc 327.57 0.87 0.136 
227 Fenitrothion 3.30 2.56 1.60 O1 Cc 277.23 1.11 0.785 
228 Gardcide 3.81 3.01 1.65 O2 Cc 365.97 1.08 1.57 
229 Tributyl phosphate 3.82 3.02 1.01 O3 Cc 266.32 1.32 0.289 
230 Foxim 4.39 3.51 3.00 O1 Cc 298.30 1.25 1.10 
231 2-Methylphenyl diphenyl phosphate 5.25 4.16 2.51 O3 Cc 340.32 1.12 0.506 
232 2-Ethylhexyldiphenyl phosphate 6.30 4.36 2.63 O3 Cc 362.41 1.38 0.559 
233 Triphenyl phosphite 6.62 3.99 2.39 O3 Rt 310.29 1.12 4.04 
Heterocyclic compounds 
234 1,4-Dioxane -0.32 -0.67 -0.35 U1 Cc 88.11 0.41 0.031 
237 N,N-Dimethyl-1,2-dithiolan-4-amine 1.38 0.84 1.68 U2 Cc 149.27 0.66 0.026 
238 4-Ethenyl-pyridine 1.71 1.14 1.87 U2 Cc 105.14 0.68 0.151 
241 Benzothiazole 2.17 1.55 0.66 O1 Cc 135.18 0.66 0.112 
243 3-Methyl-thiophene 2.36 1.72 0.61 O2 Cc 98.16 0.51 0.291 
244 
2-(3-Oxo-1H-indol-2-ylidene)-1H-indol-3-  
one 
3.11 2.39 0.39 O3 Cc 262.27 1.27 1.85 
245 9H-Carbazole 3.23 2.50 2.13 W Cc 167.21 0.93 1.42 
246 Dibenzofuran 3.71 2.92 3.17 U1 Cc 168.20 0.85 0.824 
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Table 2.4 Reference compounds with in vivo BCF data and other significant properties (cont.) 
ID Chemical name Log KOW 
   Pred. Log   
    BCFmax 
    In vivo                   
   log BCF 
BP      Sp MW Dmax KMET (HL) 
247 10H-Phenothiazine 3.82 3.02 2.57 W Cc 199.27 0.99 0.820 
248 Dibenzothiophene 4.17 3.32 3.16 W Cc 184.26 0.85 0.901 
249 N,N'-dicyclohexyl-thiourea 4.16 3.32 0.60 O3 Cc 240.41 1.05 0.236 
250 Synepirin 500 6.07 4.39 3.06 O2 Cc 345.53 1.39 7.46 
Dyes 
251 Disperse Blue 143 2.20 1.58 0.50 O2 Cc 408.46 1.84 0.001 
252 Disperse Yellow 42 4.33 3.46 1.49 O3 Cc 369.40 1.44 0.391 
253 Disperse Yellow 163 5.00 3.99 1.58 O3 Cc 417.26 1.65 1.07 
254 Pigment Yellow 12 7.05 4.05 0.62 O3 Cc 629.51 2.34 0.139 
255 Pigment Orange 13 9.55 2.54 0.60 O3 Cc 623.51 2.64 78.7 
Others 
256 1,4-Benzenedicarbonitrile 1.09 0.59 0.12 W Cc 128.13 0.68 0.232 
257 4-Cyano-4'-hexylbiphenyl 6.31 4.36 3.55 O1 Cc 263.39 1.65 49.7 
258 Diphenylmethane 4.02 3.19 2.92 W Cc 168.24 0.95 0.559 
259 Phenyl xylylmethane 5.11 4.07 3.20 O1 Cc 196.29 1.08 2.46 
260 Triphenylchloromethane 5.58 4.32 2.55 O3 Cc 278.78 0.94 2.12 
261 DDT 6.79 4.18 4.19 W Cc 354.49 1.04 161 
262 Thiram 1.70 1.13 0.48 O1 Cc 240.42 1.17 0.228 
263 2-Naphthyl disulfide 6.66 4.24 0.39 O3 Cc 318.45 1.34 94.3 
264 2,2'-Dichlorohydrazobenzene 4.34 3.47 3.64 U1 Cc 253.13 1.17 15.2 
265 Dicumyl peroxide 5.88 4.39 2.77 O3 Cc 270.37 1.06 2.79 
BP = bioconcentration prediction (O1 = slightly over-predicted; O2 = moderately over-predicted; O3 = significantly over-predicted; U1 = slightly under-predicted; U2 = highly under-
predicted; W = well predicted); Dmax = maximum interatomic distance between two atoms in the chemical structure (nanometers); ID = identification number in Table S1; KMET(HL) 
= Whole body biotransformation half-lives (days); Log BCF = logarithm of bioconcentration factor (Litres per kilogram wet weight fish); Log KOW = logarithm of octanol–water partition 
coefficient calculated from KOWWIN v. 1.68; MW= molecular weight (grams per mole) calculated from KOWWIN v. 1.68; PAH = polycyclic aromatic hydrocarbon; Sp = species (Cc = 
common carp; Rt = rainbow trout); Pred. log BCFmax= predicted maximal log BCF using equations 2.2 and 3.2 according to fish species. 
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Table 2.5 Reference compounds with in vivo whole body biotransformation rate (KMET) data 
ID  Chemical name 
Log 
KOW 
KMET Sp Dmax  MW  
KMET 
(HL) 
Phenyls 
      1 2,2',3,3'-Tetrachlorobiphenyl 6.34 0.00 Rt 0.93 292 155 
      2 DDT 6.79 0.01 Rt 1.04 354 161 
      4 2,2',3,3',5,6'-
Hexachlorobiphenyl 
7.62 0.01 Rt 0.93 361 343 
Heterocyclic compounds 
     6 Myclobutanil 3.5 0.20 Rt 1.1 289 5.35 
     7 Propiconazole 4.13 0.57 Rt 1.18 342 6.20 
   10 Metconazole 4.19 0.58 Rt 1.05 320 4.58 
   11 Triadimefon 2.94 0.54 Rt 1.14 294 2.68 
   14 Fipronil 6.64 1.01 Rt 1.21 437 3.77 
Dmax: Maximum inter-atomic distance between two atoms in the chemical structure (nm); ID: Identification 
number in Table S2; KMET: In vivo whole body biotransformation rate (1/d); KMET (HL): Whole body 
biotransformation half-lives (days); Log KOW: Logarithm of octanol-water partition coefficient calculated from 
KOWWIN v. 1.68; MW: Molecular weight (g/mol) calculated from KOWWIN v. 1.68; Sp: Species (Rt: Rainbow 
trout). 
Table 2.6. Reference compounds with in vivo metabolite data 
 
Dmax: Maximum inter-atomic distance between two atoms in the chemical structure (nm); ID: Identification 
number in Table S3; KMET: Whole body biotransformation half-lives (days); Log KOW: Logarithm of octanol-water 
partition coefficient calculated from KOWWIN v. 1.68; MW: Molecular weight (g/mol) calculated from KOWWIN 
v. 1.68; Sp: Species (Rt: Rainbow trout); Metabolites: FTCA: Fluorotelomer saturated acid; FTUCA: Fluorotelomer 
unsaturated acid; FTOH: Fluorotelomer alcohol; FTOH-Glu: Fluorotelomer glucuronide conjugate; PFOA: 
perfluorooctanoate; De-BDEs: Debrominated diphenyl ethers; MeO-BDEs: Methoxylated brominates diphenyl 
ID  Chemical name 
Log 
KOW 
Metabolites Sp Dmax MW 
KMET 
(HL) 
Perflouroalkylated hydrocarbons    
    3 8:2 Fluorotelomer 
alcohol 
5.75 8:2 FTCA; 8:2 FTUCA Rt 1.34  464 24.4 
    4 8:2 Fluorotelomer 
acrylate 
7.11 8:2 FTOH; 8:2 FTUCA; 7:3 
FTCA;  8:2 FTCA; PFOA; 
8:2 FTOH-Glu 
Rt 1.7 
 
518 20.7 
Phenyls 
    5 Decabromodiphenyl 
ether 
12.11 De-DBEs; MeO-BDEs Rt 1.08 
 
959 581 
Carboxylic acids        
    6 Diclofenac 4.02 4'-OH-DCF; 5-OH-DCF; 
DCF- A.Glu; 4'-OH-DCF-
Sul; 5-OH-DCF-Sul; 4'-
OH-DCF-A.Glu; 5-OH-
DCF- A.Glu; 3'-OH-DCF-
A.Glu; 4'-OH-DCF-E.Glu 
Rt 0.96 
 
296 6.13 
    8 Ibuprofen  3.79 Carboxyl-IBF; 2-OH-IBF; 
IBF-A.Glu; OH-IBF-A.Glu; 
3-OH-IBF; IBF-Tau 
Rt 1.03 
 
206 1.87 
  
51 
 
ethers; OH-DCF: Hydroxylated diclofenac; OH-DCF-Sul: Sulfate conjugate of hydroxylated diclofenac; DCF-A.Glu: 
Acyl glucuronide of diclofenac; DCF-E.Glu: Ether glucuronide of hydroxylated diclofenac; Carboxyl-IBF: Carboxyl 
ibuprofen; OH-IBF: Hydroxylated ibuprofen; IBF-A.Glu: Acyl glucuronide of ibuprofen; OH-IBF-A.Glu: Acyl 
glucuronide of hydroxylated ibuprofen; IBF-Tau: Taurine conjugate of ibuprofen. 
 
2.3.6 Lists of Reference Compounds: Further Considerations and Implications 
The successful development and validation of non-animal methods to in vivo 
bioaccumulation studies in fish are dependent on the rational selection of key chemical 
classes supported by a broad chemical domain and high quality in vivo data. However, further 
refinement of the reference list to accommodate project-specific requirements and specific 
purposes of the studies to be conducted is likely to be warranted. For instance, chemical 
purity, commercial availability, and availability of reliable quantitative analytical methods 
(e.g. analytical sensitivity, accuracy and reproducibility) are likely to represent practical 
selection criteria for such refinements. Chemical properties crucial for the performance of 
experimental approaches such as high volatility in solution (log HLC > 3 [114]), a high degree 
of adsorption to the test vessels (log KOW > 6 [47]) and rapid hydrolysis in water (HL < 12 
hours [115]) should also be considered to ensure the stability of the chemical in any assay 
performed. It should be noted that these additional criteria are likely to depend on the assay 
format, and no measures were taken to exclude those from the reference list. Moreover, 
additional compounds could be added to the reference list to expand the chemical domain 
for those chemical classes that were not represented in the original databases (aldehydes, 
epoxides and polyunsaturated fatty acids).  
It is anticipated that the present list of reference chemicals may benefit the development 
and validation of alternative methods. Various in vitro test systems such as microsomes, 
subcellular fractions and isolated hepatocytes are currently deployed in different studies 
worldwide, and harmonisation of experimental efforts aided by the use of common 
reference compounds may facilitate a more rapid standardisation of alternative methods for 
future regulatory use. The present reference list also aims to provide a better foundation for 
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future in vitro to in vivo BCF extrapolations, as well as identifying compounds that may be 
particularly challenging for in silico predictions. For instance, reference compounds identified 
as over-predicted by log KOW and susceptible to metabolic biotransformation may be 
particularly relevant for such studies. Additionally, in vitro derived data could enhance the 
knowledge of in vivo absorption and metabolism processes, allowing a better understanding 
of how both processes can influence in vivo assessment of chemical bioaccumulation in fish. 
Moreover, in vitro biotransformation data could be incorporated into the log BCFmax models 
developed for rainbow trout and common carp to correct for the effect of metabolism on 
BCF and to refine the knowledge of metabolic pathways in fish.  Finally, greater acceptance 
of alternative methods in regulatory frameworks may accommodate implementation of both 
testing (e.g. in vitro assays) and non-testing (e.g. in silico methods) in Integrated Testing 
strategies (ITS) to prioritise chemicals for in vivo testing and aid hazard assessment in general 
[30,75]. 
2.4 Conclusion  
In order to reduce the number of fish required for experimentation, there is a need to 
develop and validate non-animal methods to assess bioaccumulation of chemicals. 
Successful development of alternative test systems to in vivo testing could provide not only 
accurate information on ADME processes for a given compound, but also be used in 
regulatory processes and thus reducing animal use.  
The present work provides a transparent description of the selection of reference chemicals 
for future development and evaluation of alternative testing approaches using a three-tiered 
approach. This approach was based on: Tier I) selection of relevant in vivo bioaccumulation 
properties, fish species and chemical classes; Tier II) data collection, evaluation and analysis 
of the chemicals supported by high quality in vivo BCF data ; and Tier III) a refinement process 
to ensure a representation of a large chemical domain in terms of physico-chemical, 
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molecular and metabolic properties. As a consequence of this work, a reference list of 144 
chemicals with high quality BCF data, eight chemicals with KMET data and five compounds 
with metabolite data have been proposed. It is envisioned that this list may facilitate the 
development of alternative approaches to regulatory in vivo testing, enhance the 
understanding of the relationship between in vivo and in vitro data, refine in silico prediction 
of BCF and metabolic properties of chemicals and facilitate larger implementation of 
alternative testing and non-testing approaches within regulatory frameworks. 
Chapter 2 has focused on the establishment of a list of reference compounds to enable the 
development and evaluation of non-animal methods to assess chemical bioaccumulation. 
Once such a list was established, a set of compounds supported by high quality in vivo BCF 
data was selected to investigate the reliability of the most common alternative methods used 
for the estimation of the whole body biotransformation rate and BCF. This work is explained 
in more detail in Chapter 3.    
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Chapter 3. A Review and Comparison of Alternative 
Methods to In Vivo Bioaccumulation Studies in Fish 
3.1 Introduction 
The bioaccumulation of a compound is the result of Absorption, Metabolism, Distribution 
and Excretion (ADME) processes [30]. The potential bioaccumulation of chemicals directly 
from water is usually expressed by the bioconcentration factor (BCF), which may be 
measured in the whole fish, for instance according to the Organisation for Economic 
Cooperation and Development (OECD) Guideline 305 [10]. In order to reduce the cost and 
the number of fish used in in vivo testing studies, non-animal methods including in silico and 
in vitro methods have been proposed to assess the BCF of chemicals [116]. 
Early in silico models were built on the relationship between the experimental log BCF and 
hydrophobicity, expressed by the logarithm of octanol-water partition coefficient (log KOW), 
as a surrogate for biological lipids [47].  However, compounds which are ionised and others 
prone to metabolism and highly hydrophobic chemicals (log KOW > 6) show a poor correlation 
with log KOW [48]. To deal with some of these uncertainties, Meylan al [50] used an innovative 
approach based on the development of linear regression models for non-ionisable (neutral) 
and ionisable compounds applying different log KOW ranges (e.g. 1 to 7 and > 7). To account 
for the ADME processes of chemical bioaccumulation, other in silico studies have been 
focused on building kinetic mass balance models, such as the model developed by Arnot and 
Gobas [53,54] normalised for fish of a weight of 1 Kg. Such mass balance models were 
improved recently by Nichols et al. [117] through the incorporation of new experimental data 
for the calculation of extrapolating parameters such as the fraction that is bioavailable to the 
fish in water (ф). In addition, Nichols et al. [117] proposed designing the mass balance model 
for a 10 g fish based on the rationale that the majority of in vivo BCF data have been 
measured in small fish. Although some of these models are available within the EPI Suite 
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software (http://www.epa.gov) to enable their use, a comparison between log KOW-based 
and kinetic mass balance models in terms of their ability to predict BCF of chemicals is still to 
be conducted. 
Of the ADME processes of chemicals, metabolism has been identified as the main uncertainty 
in predictive studies due to the lack of in vivo metabolic data for fish to be used for modelling 
[30]. Nonetheless, Arnot et al. [84] predicted the whole body biotransformation rate (KMET) 
in fish based on in vivo data available for bioaccumulation by re-arranging the mass balance 
BCF model equation (see Equation 1.1). In doing this, a database of predicted KMET in fish was 
created [85] and used for the development of a Quantitative Structure-Activity Relationship 
(QSAR) [57] model to predict whole body biotransformation rates in fish based on half-lives 
(HL). KMET data for chemicals can also be predicted by the incorporation of their in vitro 
intrinsic clearance rate (CLINT) into established Physiologically-Based ToxicoKinetic (PBTK) 
models designed for a 1 Kg rainbow trout [42,43] (see Figure 1.1 for more details). CLINT data 
were calculated using in vitro test systems including S9 subcellular fractions and isolated 
hepatocytes, both derived from the livers of fish donors [37,38]. Hans et al. [37] and Cowas-
Ellsberry et al. [38] were the first authors to perform in vitro-in vivo data extrapolations to 
calculate KMET from in vitro intrinsic clearance; however, they used different values for key 
extrapolation factors such as the weight of fish liver. Consequently, Nichols et al. [117] have 
recently proposed a standardised PBTK calculation model defined for rainbow trout, to 
enable future in vitro-in vivo extrapolations.    
The applicability of in vitro methods for metabolism is currently limited due to data variability 
and technical challenges [44]. In particular, the question remains whether the biological 
features of the fish donors could be partly responsible for a high data variability reported for 
in vitro clearance using rainbow trout hepatocytes [37,39,40]. As a result of better analytical 
technologies not yet being developed, only a limited number of chemicals have been tested 
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in such bioassays [37,39,40]. Therefore, there is a need to develop and improve in vitro 
metabolic assays to enable their validation and utility for risk assessment procedures. The 
benefits of the validation of in vitro test systems using fish cells can be enormous. For 
example, accurate in vitro metabolic data not only could unravel the impact of 
biotransformation processes on the maximal BCF of chemicals expected by their passive 
diffusion processes, but also they could refine BCF estimates by incorporating in vitro KMET 
data into mass balance BCF models [37,38]. 
The aim of this study was to review and compare the non-animal methods described above 
which have been proposed as alternatives to in vivo bioaccumulation studies in fish. The 
specific aims included: 1) to investigate the metabolic biotransformation fora set of 
compounds supported by in vivo BCF data in a clearance assay using freshly isolated trout 
hepatocytes, along with providing an explanation of the potential factors affecting data 
variability; 2) to compare the QSAR model of Arnot [57] with different PBTK calculation 
models in terms to their ability to estimate KMET. The intrinsic clearance rates of test 
compounds were integrated into the  PBTK models provided by Hans et al. [37], Cowas-
Ellsberry et al. [38] and Nichols et al. [117] for KMET  estimation; and 3) to compare EPI-log 
KOW-based and mass balance BCF models using the goodness of fit between in vivo and 
predicted BCF data for the chemicals examined. Fish weights of 10 g and 1 Kg using the in 
vitro KMET calculated by Nichols et al. [117] model were employed to investigate their impact 
on the predicted BCF. This study also provided an insight into the challenges and future 
perspectives for each of the alternatives examined. 
 
 
 
  
57 
 
3.2 Materials and Methods 
It should be noted that this work was undertaken as part of the PhD programme at the 
Norwegian Institute for Water Research (NIVA) in Oslo, Norway, from January to June in 
2013. 
3.2.1 Test Compounds  
A total of ten compounds including diverse halogenated benzenes, two polycyclic aromatic 
hydrocarbons (PAHs), one heterocyclic compound (dibenzofuran) and one polychlorinated 
biphenyl (PCB14) were tested in the trout clearance assay (see Table 3.1). All test chemicals 
were obtained from Sigma-Aldrich Norway (www.sigmaaldrich.com/norway) with purities 
between 94 and 99% and, therefore, they were not purified prior to testing. The majority of 
these chemicals were selected from the reference list developed for the evaluation of 
alternatives to bioaccumulation in fish (Chapter 2) [118]. Chemicals that were not included 
in the reference list, such as benzo(a)pyrene (BaP) and pentachloronitrobenzene (PCNB), 
were also considered for in vitro testing. BaP was considered as a benchmark compound in 
this study based on the widely reported in vitro data for this compound [35,37,40]; PCNB 
was selected to enable metabolic data comparison with the other two hydrophilic 
chloronitrobenzenes (see Table 3.1). Whilst any in vivo BCF data were found for BaP from 
the established databases (see Table 2.2), data measured at three different concentrations 
were found for PCNB (see Figure 2.2), from which only values obtained at the lowest 
concentration (0.0014 µg/L) were considered for the average of the BCF. A set of key 
properties such as the predicted metabolic pathway, the bioconcentration prediction (BP) 
and molecular properties of the test compounds were considered prior to testing (Table 3.1).  
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Table 3.1 Test compounds considered for in vitro testing with relevant properties and chemical analysis parameters  
CAS NR 
Chemical name and 
abbreviation 
Log 
Kowa 
In vivo BCF 
(Fs)  
Predicted metabolic pathway  
(Enzyme) b 
BP 
m/z 
quant. 
m/z 
Qualifier 
ion 
Internal standard 
88-73-3 1-Chloro-2-nitrobenzene  
(CNB) 
2.46 123 (Rt) 
14 (Cc) 
1) 4-Hydroxylation (CYP) > O-Sulphation (SULT), 
Glucuronidation (UGT) ; 2) Reduction of Nitro Group (CYP450 
reductase/XO/AO) 
U1 (Rt) 
O1 (Cc) 
 
157 159 d10- biphenyl 
618-62-2 1,3-Dichloro-5- 
nitrobenzene (DCNB) 
3.10 170 (Rt) Reduction of Nitro Group (CYP450 reductase/XO/AO) W 145 191 d8-acenaphthylene 
132-64-9 Dibenzofuran (DBF) 3.71 1490 (Cc) 1) Hydroxylation of Fused Benzenes (CYP) > O-Sulphation 
(SULT), Glucuronidation (UGT); 2) Hydroxylation of Fused 
Benzenes (CYP) 
U1 168 Not used d8-acenaphthylene 
54135-
80-7 
2,3,4-Trichloroanisole (TCA) 4.01 1778 (Rt) 1) Oxidative O-Demethylation (CYP);  2) 5-Hydroxylation 
(CYP) > Glucuronidation (UGT), O-Sulphation (SULT), 
Oxidative O-Demethylation (CYP) 
W 212 210 d8-acenaphthylene 
120-12-7 Anthracene (AT) 4.35 2012 (Cc) 1) Hydroxylation of Fused Benzenes (CYP) > Glucuronidation 
(UGT), O-Sulphation (SULT);  2) Dihydrodiols (CYP, EH)  
W 178 Not used d8-dibenzothiophene 
87-86-5 Pentachlorophenol (PCP) 4.74 447 (Rt)     
126 (Cc) 
Nd O2 (Rt) 
O3 (Cc) 
266 264 d8-dibenzothiophene 
82-68-8 Pentachloronitrobenzene 
(PCNB)                     
5.03 590 (Rt)    Reduction of Nitro Group (NTR)>  Glucuronidation (UGT), O-
Sulphation (SULT) 
O2 295 212 d8-dibenzothiophene 
34883-
41-5 
3,5-Dichlorobiphenyl 
(PCB14) 
5.05 5888  (Rt) 4-Hydroxylation (CYP) > Glucuronidation (UGT), O-Sulphation 
(SULT) 
W 222 224 d8-dibenzothiophene 
636-28-2 1,2,4,5-
Tetrabromobenzene (TBB)c 
5.55 4677 (Rt) Nd O1 394 393 d8-dibenzothiophene 
50-32-8 Benzo(a)pyrene (BaP)  6.11 Nd 1) Hydroxylation (CYP); 2) Dihydrodiols formation (CYP,EH) Nd  252 132 d12-perylene 
BP: Bioconcentration predictions based on log BCFmax model predictions using Equations 2.2 and 2.3 (U1: Under-predicted (residuals = -0.5 to 0), W: Well-predicted (residuals = 0 to 0.5), O1: Over-
predicted (residuals = 0.5 to 1); O2: Over-predicted (residuals = 1 to 1.5); O3: Over-predicted(residuals > 1.5); CAS NR: Chemical Abstracts Service Registry Number; Enzymes (AO: Aldehyde oxidase, CYP: 
Cytochrome P450, EH: Epoxide hydrolase, GST: Glutathione S-transferase, SULT: Sulfotransferase, UGT: UDP-glucuronosyl transferase, XO: Xanthine oxidase); Fs: Fish species (Rt: Rainbow trout, Cc: 
Common carp); Log KOW: Predicted logarithm of octanol-water coefficient, m/z quant: m/z used for quantification; Nd: No data predicted for metabolic pathways. a KOWWIN v.1.68 (EpiSuite); b Meteor 
NEXUS v.1.5.1 software;  c Compound tested only in preliminary experiments. 
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3.2.2 Fish Culture  
Juvenile rainbow trout of approximately 200 to 500 g obtained from the Valdres Rakfisk BA 
hatchery (Valdres, Norway) were kept at the Department of Biology, University of Oslo 
(Norway), in the following culture conditions:  6 ± 2 o C, pH 6.6, 100% oxygen saturation and 
under a 12h light/12h dark photo cycle. The fish were fed daily with commercial pellets 
(Skretting, Stavanger, Norway) that corresponded to approximately 0.5% of total body 
weight. 
3.2.3 Hepatocyte Isolation  
The procedure for the isolation of hepatocytes from rainbow trout is described by Tollefsen 
et al. [119]. In brief, juvenile rainbow trout were killed by a blow to the head, then fish liver 
and intestines were exposed by dissection and finally liver cells were isolated by a two-step 
liver perfusion procedure. The resulting single cell suspension was checked for cell viability 
(criteria > 85% viable) using the trypan blue method. The cell concentration was determined 
using Coulter counter. Cells were diluted to 2 x 106 cells/mL in Leibovitz media (L-15).  
3.2.4 Hepatocyte Incubation 
A detailed protocol for this technique is provided as Supplementary Data in the Appendix I. 
The hepatocyte incubation was performed in 1 mL of a 2 x 106 cells/mL suspension in 5 mL 
sample vials with orbital shaking (100 rpm) at 11 °C. A volume of 5 µL of test chemical 
dissolved in dimethyl sulfoxide (DMSO) were added to each of the incubation glass vials that 
were swirled gently to ensure sample homogeneity. The incubation was terminated at 0, 1, 
2, 3, 4, 5 h into Eppendorf tubes containing 400 µL of dichloromethane with internal standard 
added to correct for the loss of analyte during sample tubes. Sample tubes were mixed briefly 
by vortexing and centrifuged at 20800 centrifugal force (xg) for 10 minutes at 4 °C. The 
supernatant was transferred to Gas Chromatography Mass Spectrometry (GC-MS) vials and 
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stored until chemical analysis at 4 °C. The control (dead) cells were obtained by heating at 
100 °C for 15 minutes to inactivate cells and then were treated in the same way as fresh 
hepatocytes.  
3.2.5 Analytical Methods 
The target analytes were determined on an Agilent 7890A gas chromatograph (GC Agilent 
JW Scientific, Santa Clara, CA) linked to an Agilent 5975c inert XL EI/CI mass spectrometer, 
MS (Agilent JW Scientific) operated in single-ion monitoring mode (SIM) with electron impact 
ionisation (70 keV). Separation was on a DB-5MS column (30 m, -0.25 mm i.d. and 0.25 μm 
film thickness, Agilent JW Scientific) following a pulsed splitless injection (1 μL injection, pulse 
pressure 20 psi for 1.2 min, injector temperature of 300 oC). The helium carrier gas flow was 
set to 1.0 mL min-1. The GC oven temperature programme started with a step at 60 oC (held 
for 2 min) before an increase to 200 oC (at the rate 20 oC min-1), followed by an increase to 
225 o C (at the rate of 4 o C min-1) and then again increased to 315 o C (at the rate of 30 oC min-
1) with this temperature held constant for a further 2 min. The temperatures for the ion 
source, quadrupole and transfer line were set to 230, 150 and 280 oC, respectively. The 
relative response of surrogate internal standards and 8-point calibration curves were used 
for the quantification. The retention time and the m/z compared to the external standard 
was used for identification. The internal standards, m/z qualifier ion and m/z used for the 
quantification of the chemicals examined are shown in Table 3.1. The chemical analysis of 
the compounds tested in this study was conducted at NIVA by Andreas S Hogfeldt. 
3.2.6 Intra and Inter Assay Variability 
Variability within and between assays were reported as a percent Coefficient of Variation 
(100 x standard deviation/average value; % CV), which were calculated using Microsoft Excel 
v.2010. 
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3.2.7 Predicting KMET and BCF from the Intrinsic Clearance  
Figure 3.1 shows the key equations required for the calculation of KMET from the in vitro data 
generated in the clearance assay. Definitions of all parameters and their units are listed in 
Table 3.2.  To calculate KMET and BCF, the first step was the calculation of the first-order 
elimination rate constant (k) (h-1) using the following equation:  
Log Ct = Log CO – k/2.3 t          (3.1) 
Where CO and Ct are the concentration of test chemicals (µM) at time 0 and t, respectively. 
The intrinsic clearance rate (CLINT) was normalised to the hepatocytes concentration (CHEP) (2 
x 106 cells/mL) and loss of the chemical in control samples according to Equation 3.2: 
CLINT = CLINT, ACTIVE HEPATOCYTES - CLINT, CONTROL         (3.2) 
As can be seen in Figure 3.1, the intrinsic clearance in liver (CLINT LIVER), hepatic clearance (CLH) 
and finally KMET were calculated from the input of other physiological parameters. These 
were the liver weight (LW), the total number of hepatocytes in the fish liver (LHEP), the hepatic 
blood flow (QH), the hepatic clearance binding term (fU) and the apparent volume of 
distribution (VD,BL). The term fU is the ratio of the unbound (free) fraction of test compound 
in blood (fU,b) between the unbound fraction in the in vitro clearance assay (fU,h). Vd relates 
the amount of test compound in the body to the concentration in the blood at steady state. 
Data for LW, LHEP, QH, fU, and VD,BL were calculated from the parameters used by Has et al. 
[37], Cowas-Ellsberry et al. [38] and Nichols et al. [117]. These are shown in Table 3.3 to allow 
comparison. It should be noted that same variable could differ in nomenclature depending 
on the calculation model (e.g. VD,BL also termed Vd). 
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Figure 3.1 In vitro-in vivo data extrapolation process to calculate Kmet and BCF. 
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Table 3.2 Parameters used in the in vitro-in vivo data extrapolation 
Definition Symbol Units 
      Fraction of a chemical that is bioavailable to the fish in water  ф; FD Unitless 
Gill uptake rate constant  K1 L/Kg x d 
Gill chemical uptake efficiency  EW Unitless 
Ventilation rate  GV L/d 
DOC content CDOC Kg/L 
POC content CPOC Kg/L 
Disequilibrium factor for DOC DDOC Unitless 
Disequilibrium factor for POC DPOC Unitless 
DOC content binding constant αDOC  Unitless 
POC content binding constant αPOC  Unitless 
Elimination rate constant  K2 1/d 
Lipid content in trout νLT Kg/Kg 
Non-lipid content in trout  νNT Kg/Kg 
Water content in trout  νWT Kg/Kg 
Non-lipid organic matter-octanol proportionality constant β Unitless 
Lipid content of the organism LB Unitless 
Faecal egestion rate constant  KE 1/d 
Dietary chemical transfer efficiency ED Unitless 
Feeding rate  GD Kg/d 
Temperature T °C 
Growth dilution rate constant KG 1/d 
Octanol-water partition coefficient Kow Unitless 
Wet weight of the organism WB Kg 
Whole body transformation rate KMET 1/d 
Metabolic clearance of all organs CLT L/d/Kg 
Metabolic hepatic clearance  CLH L/d/Kg 
Apparent volume of distribution  VD,BL ; Vd L/kg 
Total number of hepatocytes in the fish liver      LHEP  106 cells/g liver 
Organism-water partition coefficient BCFp Unitless 
Blood: water partition coefficient Pb:w Unitless 
Fractional whole-body lipid content νLWB Unitless 
Depletion rate constant k 1/h 
Concentration of hepatocytes  CHEP 106 cells/mL 
In vitro intrinsic clearance CLINT    mL/h/106 cells 
Intrinsic clearance in liver CLINT LIVER L/d/Kg fish 
Liver weight LW g/kg 
Hepatic blood flow QH L/d/Kg 
Liver blood flow as fraction of cardiac output QHFRAC Unitless 
Cardiac output (with temperature adjusted) QC L/d/Kg 
Fraction of blood flow through liver LF Unitless 
Cardiac output  CO mL/min/Kg 
Hepatic clearance binding term  fU Unitless 
Unbound fraction of test compound in blood plasma fU,P ; fu,b Unitless 
Unbound fraction of test compound in the clearance assay fU,HEP ;fu,h Unitless 
   DOC: dissolved organic carbon; POC: Particulate organic carbon 
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Table 3.3 Parameters used by each of the PBTK calculation models considered 
As Figure 3.1 shows, KMET calculated from the in vitro clearance rate was then incorporated 
into the mass balance BCF model provided by Nichols et al. [117], which was compared with 
the model of Arnot and Gobas [53,54] that is referred to as EPI-mass balance model in this 
study. Parameters for each of the mass balance models are shown in Table 3.4 to allow 
comparison. The BCF values of test compounds were estimated as a result of other 
physiological processes including the chemical uptake from the water via gills (K1), 
elimination processes through gills (K2), faecal egestion (KE) and growth dilution (KG). The 
mass balance BCF equation also takes into account the fraction of chemicals that are 
bioavailable to the fish in water (ф or FD). 
 
Parameter 
 (Units) 
                                             Calculation models 
Hans [37] Cowas-Ellsberry [38] Nichols [117] 
LW (g/Kg)                    12.7 8.5   15 
LHEP (106 
cells/mL) 
510 255 500 
QH (L/d/Kg) 
                     QH = LF CO 
               CO = 34.5 ml/min/kg  
 
LFHans = 0.259 
LF Cowas-Ellsberry  = 0.20 
QH = QHFRAC QC 
 
QHFRAC = 0.259 
QC = ((0.23T)-0.78) (WB /500)^-0.1)24 
T= 15 °C 
fU  
                      fU = fu,b/ fu,h 
 
fu,b-Hans = 1/ (10-0.613logkow-0.569  + 1) 
fu,h-Hans  = 1/ (10-0.676logkow-2.215 + 1) 
 
fu,b-Cowas-Ellsberry = 1/ (10-0.605logkow-0.558 + 1) 
fu,h-Cowas-Ellsberry = 1/ (10-0.685logkow-2.237 + 1) 
fu = fU,P / fU,HEP 
 
fu,p =  νWBL / PBW 
fu,HEP = 1/((CHEP / 2) x 100.676logKow-2.215+1) 
PBW = (100.73logKow x 0.16) + νWBL 
νWBL = 0.839 
 
Vd  (L/Kg)                                  
                      Vd =  BCFp/Pb:w 
 
 BCFp = νLT Kow + νNTβKow+ νWT 
β = 0.035; νLT = 0.1; νNT = 0.2; νWT = 0.7 
       Pb:w = νLBKow + νNBβKow+ νWB 
β = 0.035; νLB = 0.014; νNB = 0.147; νWB = 
0.839 
VD,BL = BCFp/PBW 
 
BCFp = νLWB Kow 
νLWB = 0.05 
PBW = (100.73logKow 0.16) + νWBL 
νWBL= 0.839 
 
  
65 
 
Table 3.4 Parameters used by each of the mass balance models considered 
Parameter  
(Units) 
EPI-mass balance model [53,54] Nichols  mass balance model [117] 
Ф; FD 
ф = 1/(1+αPOC DPOC CPOC Kow + αDOC DDOC CDOC 
Kow)  
 
αPOC = 0.35; αDOC = 0.08;  
DPOC = 1; DDOC = 1 
CPOC = 5 x 10-7 ; CDOC = 5 x 10-7  
FD  = 1/(1+αPOC CPOC Kow + αDOC CDOC Kow) 
 
αPOC = 0.35; αDOC = 0.08 
CPOC = 4.6 x 10-6; CDOC = 1 x 10-6  
 
 
 
K1  (L/Kg d)                
 
 
K1 = EW GV/ WB  
 
EW = (1.85+ (155/Kow))-1 
GV = 254.4  
K1 = 1/((0.01+1/Kow)WB0.4)  
 
 
K2  (1/d) 
K2 = K1/ BCFpb        
 
BCFp = νLT Kow + νNTβKow+ νWT 
β = 0.035; νLT = 0.1; νNT = 0.2; νWT = 0.7 
K2 = K1/ LBKOW   
 
LB = 0.05 
KE  (1/d)               
 
KE = 0.125 GD / ED WB 
 
ED = 3 x 10-7 KOW + 2 
GD = 0.022 WB0.85e(0.06T) 
T=10 °C 
 
KE = 0.125 GD / ED WB 
 
ED = 5.1 x 10-8 KOW + 2 
GD = 0.022 WB-0.15 e(0.06T) 
T=15°C 
KG   (1/d) 
 
KG = 0.0005 WB -0.2 KG = 0.0005 WB -0.2 
3.2.8 Predicting KMET and BCF from EPI Suite v.4.1 
Chemical structures of test compounds were recorded as SMILES strings and entered into 
the BCFBAF software v.3.01 (http://www.epa.gov) to calculate: 1) KMET normalised to 1 Kg 
fish, which was based on the QSAR model developed by Arnot et al. [57]; and 2) BCF 
predicted from the mass balance model created by Arnot and Gobas [53,54] assuming no 
biotransformation and incorporating biotransformation rates calculated from biological HL; 
and 3) BCF predicted form the EPI-log KOW-based model built by Meylan et al. [50]. 
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3.3. Results and Discussion  
There is an urgent need to develop, improve and validate non-animal methods to assess the 
bioaccumulation potential of chemicals in fish.  Validated alternatives to in vivo studies are 
likely to be implemented into tiered strategies to reduce the number of fish required to 
assess chemical bioconcentration [30,75]. The integration of in vivo, in vitro and in silico 
methods is likely to allow for the successful development and standardisation of alternatives 
to in vivo bioaccumulation tests. Based on the integration of in vivo-in vitro-in silico data, this 
Chapter reviewed and compared the current alternatives to in vivo bioaccumulation in fish. 
3.3.1 In Vitro Clearance Assay: Development of an Experimental Protocol 
The first aim of this Chapter was to investigate the ability of the in vitro clearance assays 
using freshly isolated rainbow trout hepatocytes to generate clearance data for a set of 
reference compounds. As a standardised protocol is still to be developed, the experimental 
procedure taken in this study was based on the methodology carried out by Fay and 
colleagues [40]. A similar protocol was also learnt in a course undertaken in the 6th Society 
for Environmental Toxicology and Chemistry (SETAC) World congress held in 2012 in Berlin.  
Before performing definitive assays, preliminary experiments were undertaken to develop 
an experimental protocol. One of the objectives of the preliminary experiments was the 
selection of appropriate test concentrations based on their first-order kinetics [35]. It should 
be stressed that there is a lack of consensus in the literature for the selection of test 
concentration. For example, the benchmark compound, BaP, has been tested at different 
concentrations including 4 µM [39], 2 µM [37], and 0.5 µM [40] using a cell concentration of 
2 x 106 cells/mL. Therefore, the first experiment consisted of testing BaP at 4, 2, 1 and 0.5 
µM in order to investigate its first order kinetics. Figure 3.2 shows the depletion curves for 
each of these test concentrations.  
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Figure 3.2. Depletion of BaP at 4, 2, 1 and 0.5 µM in freshly isolated hepatocytes. Log C: Logarithm 
of test concentration; BaP: benzo(a)pyrene. 
Apparent higher depletion rates were obtained at lower concentrations, suggesting poor 
bioavailability of BaP and/or enzyme saturation at higher concentrations. Based on the same 
rationale, the other test chemicals listed in Table 3.1 were tested at 2, 1 and 0.5 µM to 
investigate their first order kinetics. A concentration of 4 µM was not considered further to 
reduce the final number of samples per test substance and to avoid possible toxic effects at 
this concentration. When testing chemicals with unknown metabolic biotransformation, a 
sample of BaP at 0.5 µM was considered as an additional control to ensure that the metabolic 
clearance occurred. Table 3.5 shows the CLINT data at each of these test concentrations for 
the compounds examined. Attempts at measuring DBF, AT, PCN, PCB14 at some 
concentrations failed. As higher CLINT values were obtained at the lowest concentration for 
the majority of chemicals, a concentration of 0.5 µM was selected. Additionally, by testing 
chemicals at 0.5 µM, concentrations above the aqueous solubility for hydrophobic chemicals 
were avoided.  
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Table 3.5 CLINT data for test chemicals at 2, 1 and 0.5 µM 
Chemicals (AT: anthracene; BaP: benzo(a)pyrene; CNB: 1-chloro-2-nitrobenzene; DBF: dibenzofuran; DCNB: 1,3-
dichloro-5-nitrobenzene; PCN: pentachloronitrobenzene; PCB14: 3,5-dichlorobiphenyl; PCP: pentachlorophenol; 
TBB: 1,2,4,5-tetrabromobenzene; TCA: 2,3,4-trichloroanisole); C: Nominal test concentration (µM); CLINT = In vitro 
clearance rate; Nd: No data available. 
Another crucial question to be determined for experimental testing was whether the 
depletion rates should be normalised to the loss of the examined chemicals in control 
samples or not. In vitro clearance rates are usually determined with no control normalisation, 
although some chemical losses over time have been reported in control samples, being 
attributed to the method used to boil hepatocytes [40]. According to the preliminary results, 
the depletion of the parent compound in denatured samples could be related to the intrinsic 
properties of test chemicals rather than the method used to boil hepatocytes [40]. For 
instance, Figure 3.3 shows the depletion curves in control (open circles) and treated (solid 
circles) samples for BaP and TBB determined at 0.5 µM. As can be seen, whilst the 
concentration of BaP in control samples was constant over time, a steady loss was observed 
for TBB. Such loss of TBB in denatured samples was also found at 1 and 2 µM, and therefore 
this compound was rejected for further experimentation. Consequently, CLINT values were 
normalised with respect to controls based on Equation 3.2 to avoid the over-estimation of 
metabolic biotransformation for certain types of chemicals and also to take into account 
chemical losses due to abiotic degradation processes (e.g. volatilisation) and the adsorption 
of the test chemicals to plastic materials. 
 
 
  C  
CLINT (mL/h/106 cells)  
CNB DCNB DBF TCA AT PCP PCNB PCB14 BaP TBB 
2 0 0.017 Nd 0.049 0.096 0.063 Nd 0.037 0.064 0 
1 0 0.000 0.086 0.068 0.131 0.046 Nd 0.012 0.048 0 
0.5 0 0.015 0.040 0.093 Nd 0.053 Nd Nd 0.182 0 
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Figure 3.3 Depletion of BaP and TBB at 0.5 µM. Log C: Logarithm of test concentration (0.5 µM); BaP: 
benzo(a)pyrene; TBB: tetrabromobenzene; Solid circles: treated samples; Open circles: control 
samples. 
Finally, to avoid the high rate of CV (50-70%) reported in the literature [37,39,40], the 
intrinsic clearance rates of test chemicals were calculated using cells from the same fish 
donor. This involved, however, the use of two replicates in order to test all chemicals at the 
same time.  
3.3.2 In Vitro Clearance Assay: Results and Data Variability 
Table 3.6 shows the average of the metabolic clearance (CLINT) values for test compounds 
from two individual experiments. These results were in a good agreement with the CLINT data 
determined at 0.5 µM in the preliminary experiments, with the exception of TCA (Table 3.5). 
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Table 3.6 CLINT data measured from two experiments using freshly isolated hepatocytes 
Chemicals (AT: anthracene; BaP: benzo(a)pyrene; CNB: 1-chloro-2-nitrobenzene; DBF: dibenzofuran; DCNB: 1,3-
dichloro-5-nitrobenzene; PCN: pentachloronitrobenzene; PCB14: 3,5-dichlorobiphenyl; PCP: pentachlorophenol; 
TCA: 2,3,4-trichloroanisole); CLINT = In vitro clearance rate; Exp: Experiment; Nd: No data available; CV: Coefficient 
of variation; SD: Standard deviation. Duplicates were used in each assay. 
Only anthracene (AT), pentachloronitrobenzene (PCNB) and benzo(a)pyrene (BaP) showed 
significant metabolism (CLINT > 0.15) contrasting with the low and negligible clearance rates 
obtained for the majority of the compounds. The low intrinsic clearance for 3,5,-
dichlorobiphenyl (PCB14) supports the low in vivo values of KMET reported for PCBs [100] as 
well as its good correlation with log KOW (Table 3.1). In contrast, higher clearance rates were 
expected for pentachlorophenol (PCP) based on its reported in vivo metabolic data [120] and 
poor correlation with log KOW (over-prediction) (Table 3.1). Whilst similar CLINT data were 
determined for polycyclic aromatic hydrocarbons (see AT and BaP, Table 3.6), different 
intrinsic clearance rates were obtained for nitrochlorobenzenes, of which only PCNB was 
cleared at a high rate (Table 3.6). This may be attributable to a lack of passive diffusion for 
the hydrophilic nitrochlorobenzenes through the cell membrane [121]. The highest rate of 
clearance detected for PCNB supports the significant role of nitroreductases in the 
biotransformation of nitroaromatic compounds [88]. 
CLINT (mL/h/106 cells) mean, ±SD, CV 
Exp CNB DCNB DBF TCA AT PCP PCNB PCB14 BaP 
 
1 
 
0.001 
±0.001 
141% 
 
0.021 
±0.030 
141% 
 
0.015 
±0.001 
2% 
 
0.018 
±0.002 
12% 
 
0.061 
±0.009 
14% 
 
0.046 
±0.003 
6% 
 
0.848 
±0.086 
10% 
 
0.015 
±0.005 
40% 
0.104 
±0.00
76% 
 
2 
 
0.004 
Nd 
 
0.000 
±0.000 
 
0.064 
±0.014 
21% 
 
0.041 
±0.013 
31% 
 
0.268 
±0.003 
1% 
 
0.038 
±0.021 
55% 
 
1.008 
±0.001 
0.1% 
 
0.011 
±0.015 
141% 
 
0.197 
±0.07 
4% 
 
Mean 
 
0.002 
±0.002 
110% 
 
0.011 
±0.015 
141% 
 
0.039  
±0.035 
88% 
 
0.029 
 ±0.016 
56% 
 
0.164 
± 0.146 
89% 
 
0.042 
± 0.006 
14% 
 
0.928 
±0.113 
12% 
 
0.013 
± 0.003 
22% 
 
0.151 
±0.06
6 
44% 
SD 
CV 
  
71 
 
Coefficient of variation (CV) values for intra and inter assays are shown in Table 3.6. The CV 
values for non- and or poorly metabolised compounds such as CNB, DCNB and DBF should 
be treated with caution, as their mean and standard deviation (SD) values were similar to 
each other resulting in CVs > 100%.  The CVs of inter-assays in this study ranged from 12 to 
89%, slightly higher than those reported in recent studies [40]. Various factors could 
influence the experimental variability obtained such as differences in testing procedures, 
chemical analysis and enzymatic activities of the fish donors. The latter could be influenced 
by gender, age and diet [29]. The gender of fish donor was unlikely to contribute to the data 
variability since non-sexually mature fish donors were used. In addition, no metabolic gender 
differences from in vitro conditions have been reported for rainbow trout [122].  
The age of the animal (expressed by differences in body weight) is likely to be a potential 
factor affecting CLINT variability, as a good correlation (r2 = 0.72) was found between the CLINT 
values for BaP determined at 0.5 µM and the weight of the fish donors (see Figure 3.4). 
Remarkably, such linear regression could be improved (r2 = 0.99) when an apparent outlier 
was removed. It should be noted that CLINT data for BaP were taken from both preliminary 
and definitive experiments. This finding agrees with the higher metabolic rates reported in 
fat cells isolated from young rats compared to those determined in old donors [123]. 
Although the relationship between whole body metabolic rates and body mass has been 
investigated widely in the literature [124], little is known concerning such relationships at 
the cellular level, thus representing a topic of future research.  
It should be added that season could also influence the metabolic capabilities of the fish 
donors [125,126]. The potential influence of season on CLINT data variability was not explored 
in this study due to the fact experiments were conducted within the same period (April to 
June in 2013). 
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Figure 3.4 CLINT data versus the fish donor weight for BaP at 0.5 µM 
3.3.3 In Vitro Clearance Assay: Challenges and Future Perspectives 
Table 3.7 lists the two main challenges found for the in vitro clearance assay using freshly 
isolated rainbow trout hepatocytes. 
Table 3.7 Challenges of the clearance assay using rainbow trout hepatocytes  
Challenges and proposed solutions Drawbacks 
1. Low sensitivity to poorly metabolised chemicals 
 
- Use young donor animals ( < 200 g) 
 
   - Difficulties in cell isolation procedure 
   - More fish will be needed 
- Increase cell concentration  
    (> 2 x 106 cells/mL) 
   - More fish will be needed 
 - Increase temperature ( > 11 °C)   -  Decrease of cell viability 
   - No representative for in vivo conditions 
2. Time consuming procedure and low reproducibility  
 
- Use multi-channel pipettes, well-plates, 
LCMS analysis 
   - Establishment of a new protocol   
The difficulty in measuring low biotransformation rates could be explained partly due to the 
fact that in vitro biotransformation rates in fish have been determined to be much slower 
than those reported for rat hepatocytes (between 8.3 to 315 fold of difference) [37]. It is 
likely that for this reason, low or non-clearance rates were obtained for the majority of the 
test chemicals in this study supporting similar results obtained with liver S9 fractions [127]. 
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Nonetheless, future clearance assays based on isolated hepatocytes using young fish donor 
(< 200 g) and/or using cell concentrations higher than 2 x 106 cells/mL may represent 
alternatives to increase the sensitivity of measuring the depletion rates of poorly 
metabolised compounds.  
Another challenge for the clearance in vitro assay was the use of a time consuming 
experimental procedure due to the several steps involved. For example, the incubation was 
conducted in borosilicate glass tubes, then the reaction was terminated in Eppendorf tubes 
and eventually subsamples were transferred to glass vials for chemical analysis. It is expected 
that future technological improvements such as the integration of the incubation with the 
chemical analysis in the same support will allow for testing a greater number of compounds.  
Despite these drawbacks, in vitro clearance assays using fish hepatocytes may represent a 
promising alternative for fish ecotoxicology. For instance, the CLINT value for BaP in this 
investigation (CLINT = 0.151, Table 3.6) was comparable to those reported using 
cryopreserved trout hepatocytes (CLINT = 0.214) determined at the same concentration [40], 
suggesting the reliability of such assays to study xenobiotic biotransformation. Moreover, 
compared with subcellular assays (e.g. S9 and microsomes), isolated hepatocytes have 
showed higher values for CLINT [36] and metabolic activity [128], making them better 
candidates for routine screening in risk assessment. In addition, a promising benefit of the 
standardisation and validation of the clearance assay with hepatocytes would be the 
investigation of the differences between metabolic activities reported within and among fish 
species in the literature [129].  
A step-wise selection of test chemicals is the key to study the biotransformation of chemicals. 
In order to investigate the impact of metabolic biotransformation on chemical 
bioconcentration, the selection of test chemicals should be based on the relationship 
between their predicted maximal log BCF and experimental values. It was expected in this 
  
74 
 
study that compounds with high bioconcentration potential (W,U1), i.e. similar values to 
their predicted maximal log BCF values, would show low values for CLINT  values and vice 
versa. This was observed for the majority of chemicals with the exception of 
pentachlorophenol (PCP) and 1,2,4,5-tetrabromobenzene (TBB), whose other chemicals 
properties could play a role in their limited BCF.  
Amongst all chemical properties that could affect the accumulation of a compound, the 
effect of molecular properties on BCF has been extensity investigated [81,82,130,131]. As a 
consequence, a list of cut-off values for molecular weight (MW) and maximum molecular 
diameter (Dmax) have been proposed as indicators of low bioaccumulation. In particular, 
values of 700 g/mol and 1.7 nm have been proposed as cut-off values for MW and Dmax 
respectively in bioaccumulation assessment [132]. These molecular properties are unlikely 
to contribute to the low in vivo bioaccumulation reported for PCP and TBB based on these 
cut-off values. A high volatility in solution, expressed by a logarithm of Henry’s Law Constant 
(log HLC), is also unlikely to contribute to the limited in vivo bioconcentration for PCP and 
TBB, as their log HLC are lower than the cut-off value proposed as indicator of high volatility 
in solution, log HLC > 3 (see Table S1)[114]. An exposure pH higher than 8.5 used for in vivo 
testing could explain the low in vivo BCF value for PCP [133,134]. It should be emphasised 
here that molecular properties, log HLC, and the prediction of metabolic pathways should be 
taken into account when selecting potential metabolised compounds whose in vivo BCF 
values were over-predicted by log KOW. For example, no probable biotransformation 
pathways were predicted for PCP and TBB (see Table 3.1), suggesting that this piece of 
information should be considered to provide a high confidence to select well-metabolised 
compounds.  
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3.3.4 Comparison of Alternatives to Predict KMET 
The second aim of this study was to investigate current alternative methods in terms of their 
ability to predict whole body biotransformation rate (KMET) in 1 Kg fish. The KMET values for 
test compounds were calculated using the following approaches: 1) the QSAR model built by 
Arnot et al [57], which is referred to as EPI-QSAR in this study; and 2) Physiologically-Based 
ToxicoKinetic (PBTK) models that involved the extrapolation of the generated in vitro 
clearance data (Table 3.6) to an estimated whole body metabolism in liver. In such models, 
KMET is defined by the ratio between the hepatic clearance (CLH) and the apparent volume of 
distribution (VD,BL) (Figure 3.1). A comparison of different PBTK calculation models that have 
been used for fish [37,38,117] was also conducted in this study to investigate the 
physiological parameters affecting KMET. Table 3.8 shows the KMET data predicted according 
to each of these non-animal methods. Figure 3.5 shows the plot of predicted KMET data versus 
test compound according to the model employed.   
Table 3.8 Comparison of predicted KMET values for test chemicals 
Chemical 
name 
 
Log 
Kow 
KMET (d-1) (1 Kg) 
PBTK      
Nichols 
[117] 
PBTK      
Hans 
[37] 
PBTK  
Cowan-
Ellsberry [38]      
EPI-QSAR [57] 
CNB 2.46 0.027 0.008 0.002 0.398 
DCNB 3.10 0.047 0.024 0.008 0.206 
DBF 3.71 0.068 0.060 0.028 0.266 
TCA 4.01 0.035 0.041 0.021 0.012 
AT 4.35 0.136 0.208 0.115 0.086 
PCP 4.74 0.025 0.056 0.030 0.099 
PCNB 5.03 0.380 0.825 0.523 0.059 
PCB14 5.05 0.006 0.018 0.009 0.010 
BaP 6.11 0.030 0.211 0.106 0.243 
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AT: Anthracene; BaP: Benzo(a)pyrene; CNB: 1-Chloro-2-nitrobenzene; DBF: Dibenzofuran; DCNB: 1,3-Dichloro-
5-nitrobenzene; PCN: Pentachloronitrobenzene; PCB14: 3,5-Dichlorobiphenyl; PCP: Pentachlorophenol; TCA: 
2,3,4-Trichloroanisole; KMET : Whole body biotransformation rate (d-1). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 Predicted KMET data vs test chemical. AT: Anthracene; BaP: Benzo(a)pyrene; CNB: 1-
Chloro-2-nitrobenzene; DBF: Dibenzofuran; DCNB: 1,3-Dichloro-5-nitrobenzene; PCN: 
Pentachloronitrobenzene; PCB14: 3,5-Dichlorobiphenyl; PCP: Pentachlorophenol; TCA: 2,3,4-
Trichloroanisole, KMET: Whole body biotransformation rate (d-1). 
From the comparison of KMET data, a number of observations are apparent.  The first is that 
for relatively hydrophilic compounds (log KOW < 3), significantly higher KMET values were 
predicted using the EPI-QSAR model than those predicted from PBTK models that showed 
good similarities in predictions (see Figure 3.5). This could be attributable to the data that 
were used for the development of the EPI-QSAR model. In particular, due to the lack of 
reported measured metabolic rates in fish, the EPI-QSAR model was built from a database of 
fish biotransformation rates that were estimated from available bioaccumulation data by re-
arranging Equation 3.3 [84].   
Bioconcentration factor (BCF) = K1 ф/ (K2 + KE + KG + KMET) (L/Kg)          (3.3) 
In particular, when whole body BCF values were available, the KMET was calculated as: 
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KMET = (K1 ф/BCF) – (K2 + KE + KG)        (3.4) 
And if the total elimination rate constant (KT) was reported, KMET was calculated as follows: 
KMET = KT - (K2 + KE + KG)        (3.5) 
Whole body biological HL(d) was also converted to a total elimination rate constant as 
follows:  
KT = ln(2)/HL            (3.6) 
In Equations 3.4 and 3.5, data for K1, ф, K2 , KE , KG  were based on predictions [84]. However, 
this approach did not correct for the effect of hydrophobicity on measured BCF and KT, both 
being log KOW-dependent. For example, it is well-known that the most important route of 
elimination for hydrophilic chemicals is across the gill [121]. As a consequence, greater rates 
of elimination have been reported for such chemicals than for more hydrophobic chemicals 
(log KOW > 3), as illustrated in Figure 3.6 for various neutral (non-ionisable) aromatic 
compounds [135]. Therefore, when using Equations 3.4 and 3.5, high KMET values are 
estimated for chemicals with log KOW < 3 by the EPI-QSAR model as a result of their high 
measured elimination rates and low BCF values, and not as a consequence of significant 
metabolism. 
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Figure 3.6 Dependence of elimination and branchial uptake rate constants on log KOW for neutral 
compounds adapted from Erickson and McKim study [135]. Solid squares: chlorinated benzenes; 
solid circles: chlorinated benzenes/biphenyls; open squares: chlorinated benzenes/napthalenes; 
open circles: brominated benzenes/biphenyls and chlorinated biphenyls. 
The second observation from the comparison of KMET data is the low metabolic rates 
predicted for hydrophobic chemicals by the Nichols PBTK approach with respect to the other 
calculation approaches (Table 3.8). Conversely, higher metabolic rates are predicted by the 
Nichols model for chemicals with log KOW < 3 than by the other models. It is noted that 
benzo(a)pyene (BaP) and 1-chloro-2-nitrobenzene (CNB), whose reported CLINT data were 
0.151 and 0.002 respectively, showed similar KMET values (Table 3.8). In order to investigate 
this more thoroughly, physiological parameters calculated using each of the PBTK models 
were compared for BaP and CNB (Table 3.9).  
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Table 3.9 Parameter comparison for 1-chloro-2-nitrobenzene (CNB) and benzo(a)pyrene (BaP) for 
each of the calculation models 
Parameter Chemical 
 
Nichols  
model  [117] 
Hans  
model [37] 
Cowan-
Ellsberry 
model [38] 
fu CNB  0.099 0.132 0.132 
BaP  0.015 0.055 0.055 
CLINT LIVER  
(L/d/Kg fish) 
 
CNB  0.360 0.311 0.104 
BaP  27 23.473 7.85 
QH  (L/d/Kg) CNB  24.542 12.680 9.792 
BaP  24.542 12.680 9.792 
CLH (L/d/Kg) CNB  0.035 0.041 0.0082 
BaP  0.402 1.182 0.592 
Vd (L/Kg) CNB  1.33 4.9617 4.9617 
BaP  13.95 5.588 5.588 
As can be seen, different values for the hepatic clearance binding term (fu), intrinsic clearance 
in liver (CLINT LIVER ), hepatic clearance (CLH) and apparent volume of distribution (VD,BL) were 
calculated for CNB and BaP. This is due to the dependence of these variables on log KOW (see 
equations listed in Table 3.3). Of these, PBTK models are highly sensitive to changes in VD,BL , 
as it appears in the denominator of KMET. The value of VD,BL is calculated as the ratio of 
BCFp/PBW. PBW is termed as the fractional water content of blood; BCFp is the organism-water 
partition coefficient. It should be noted that whilst Hans et al. [37] and Cowan-Ellsberry et 
al. [38] used the same equations to calculate BCFp and PBW (see Table 3.3), Nichols et al. [117] 
employed the equation given by Fitzsimmons et al. [136] to calculate PBW, and a simplified 
equation for BCFp. The analysis of the data revealed that by using the Nichols model, much 
lower and higher VD,BL values were obtained for BaP and CNB respectively than the other 
approaches (see Table 3.9), which resulted in similar KMET values for both compounds (Table 
3.8). The parameter fu also has a strong influence on KMET [117,37]. fu is the ratio between the 
unbound fraction of test compound in blood plasma (fu,h o fU,P) and the unbound fraction of 
test compound in the in vitro clearance assay (fU,P o fU,HEP) (Table 3.3). To correct for the cell 
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concentration in the in vitro clearance assay, Nichols et al. [117] incorporated the cell 
concentration (CHEP) into the fu,h equation given by Hans et al. [37] (see Table 3.3.). Nichols 
also proposed the use of the equation for PBW given by Fitzsimmons et al. [136] to calculate 
fU,P. By using such equations, however, a lower value of fu was determined for BaP than the 
values predicted by Hans and Cowan-Ellsberry models (see Table 3.9), contributing to its low 
KMET. 
The final observation is related to the good concordance of predictions for 2,3,4-
trichloroanisole (TCA) and 3,5-dichlorobiphenyl (PCB14) (Figure 3.5) made by all alternative 
models. This finding suggests a high level of confidence to identify low and non-metabolised 
chemicals with log KOW > 4 by using either the EPI-QSAR or any of the PBTK models.  
3.3.5 Comparison of Alternatives to Predict BCF 
The final aim of this Chapter was the comparison of the most common non-animal models 
used in risk assessment to predict BCF of chemicals. Values of BCF for test chemicals were 
calculated according to the following methods: 1) the log KOW-based model developed by 
Meylan et al. [50] that is referred to as the EPI-log KOW-based model in this study; 2) the 
kinetic mass balance of Arnot and Gobas [53,54] (Table 3.4), assuming no biotransformation 
and incorporating biotransformation rates calculated from biological half-lives and referred 
to as the EPI-mass balance with KMET = 0 and KMET (HL) respectively; and 3) the recent mass 
balance provided by Nichols et al. [117] (Table 3.4), referred to as the Nichols mass balance 
model, using two different fish masses: 10 g and 1 Kg (Table 3.4). Nichols et al. [117] 
accounted for the effect of metabolism by incorporating the KMET data estimated from the in 
vitro clearance assay. Table 3.10 shows the predicted BCF values for test compounds 
according to each of these predictive BCF models. 
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Table 3.10 Comparison of the predicted BCF values for the examined chemicals using different 
methods 
Chemical 
name 
(log KOW) 
                               Predicted BCF (L/kg) 
In vivo  
BCF 
(L/Kg) 
Nichols mass balance 
model 
 EpiSuite (BCFBAF v.3.01) 
10 g      
(in vitro 
KMET) 
1 kg 
(in vitro 
KMET) 
 
EPI-
mass 
balance  
with KMET 
(HL) 
EPI-
mass 
balance  
KMET (HL) =0 
EPI-
Kow- based 
model 
CNB (2.46)       68 
14 
(0.027) 
14    
(0.027) 
 
15 
(2.629) 
19 14 
DCNB 
(3.10)         
170 
62 
(0.047) 
61     
(0.047) 
 
121        
(0.186) 
132 51 
DBF (3.71) 1490 
248 
(0.068) 
216   
(0.068) 
 
1179     
(0.031) 
1348 243 
TCA (4.01)        1778 
491 
(0.035) 
424  
(0.035) 
 
547      
(0.028) 
578 136 
AT (4.35)          2012 
879 
(0.136) 
433   
(0.136) 
 
1121        
(0.155) 
2743 401 
PCP (4.74) 286 
2330 
(0.025) 
1500  
(0.025) 
 
254          
(1.109) 
9569 1110 
PCNB  
(5.03)     
590 
1161 
(0.380) 
245  
(0.380) 
 
270        
(1.018) 
4046 535 
PCB14 
(5.05) 
5888 
4691 
(0.006) 
3457 
(0.006) 
 
3790    
(0.054) 
14140 6645 
BaP (6.11)        Nd 
7321 
(0.030) 
1560 
(0.030) 
 
364       
(0.622) 
21010 5147 
AT: anthracene; BaP: benzo(a)pyrene; BCF: Bioconcentration Factor (Litres/ Kg fish); CNB: 1-chloro-2-
nitrobenzene; DBF: dibenzofuran; DCNB: 1,3-dichloro-5-nitrobenzene; HL: Half-lives; KMET: Whole body metabolic 
biotransformation rate (d-1) in parenthesis; PCN: pentachloronitrobenzene; PCB14: 3,5-dichlorobiphenyl; PCP: 
pentachlorophenol; TCA: 2,3,4-trichloroanisole.  
It should be noted that the first kinetic mass balance model for aquatic chemical 
bioaccumulation was developed by Arnot and Gobas [52,53]. This was normalised for a fish 
of 1 Kg and integrated into the EPI Suite software (http://www.epa.gov). Recently, Nichols 
et al. [117] defined such a mass balance BCF model for 10 g fish based on the rationale that 
the majority of the in vivo BCF data have been determined in small fish or juveniles of large 
species. However, such a model assumed that the biotransformation rates do not change 
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with fish mass, which means that the in vitro KMET data predicted for 1 Kg fish are incorporated 
into a BCF model normalised for 10 g fish. To investigate the effect of KMET on chemical 
bioconcentration according to the fish weight, both 10 g and 1 Kg were used as inputs for 
modelling using the same KMET value determined by the Nichols PBTK model (Table 3.8).  
Results show that for chemicals with log KOW < 4, similar BCF values were predicted regardless 
of the fish mass used (Table 3.10). This finding is in good agreement with previous predictions 
that showed high metabolic rates have little impact on the bioconcentration for hydrophilic 
compounds [30,84]. In contrast, for more hydrophobic compounds, higher BCF values were 
predicted for a 10 g fish than 1 Kg (Table 3.10), supporting the concept of strong influence of 
metabolic rates on the BCF for hydrophobic chemicals [30,84]. As there is empirical evidence 
that the metabolic rates scale with the body mass of the organism [57,124], such differences 
in predicted BCF values depending on the fish weight were a result of the lack of KMET 
transformation used for a 10 g BCF. Therefore, in vitro KMET data should be normalised to the 
same fish mass used in the Nichols mass balance model to correct for the effect of 
metabolism on BCF. For instance, this can be performed by using the following equation 
provided by Arnot et al. [57]: 
KMET,0.10 = KMET,1 (WX/WN) - 0.25      (3.7) 
Where WN and WX refers to 1 and 0.01 Kg respectively according to this example. KMET is the 
whole body metabolic rate (1/d). The term KMET,1 is the KMET predicted for a 1 Kg fish 
calculated from the Nichols PBTK calculation model. The term KMET,0.10 is the KMET predicted 
for a fish of 0.01 Kg weight. 
Nichols and colleagues [117] also employed different factors to calculate the following 
parameters: 1) the fraction that is bioavailable to the fish in water (ф), which was termed FD; 
2) the gill uptake rate constant (K1); and 3) elimination rate constant (K2) (Table 3.4). Based 
on experimental measurements, new values for the dissolved organic carbon content (CDOC) 
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and the particulate organic carbon content (CPOC) are recommended for the calculation of 
ф/FD. Based on the comparison performed for PBTK models (Table 3.9), values of ф, K1 and 
K2 for CNB and BaP were compared according to the mass balance model used, assuming no 
metabolism (KMET = 0) (Table 3.11). The analysis of the data showed that lower values of ф 
and K1 for CNB and BaP were obtained by the Nichols mass balance model with respect to 
the EPI-mass balance model, resulting in a strong impact on the outcome of BCF for 
hydrophobic compounds such as BaP (Table 3.11). It should be noted that a value of BCF of 
11469 for BaP is more “realistic” than a value of 21010 based on the evidence of the lack of 
in vivo BCF values for the chemical compiled in Chapter 2 higher than 21000. This finding 
indicates that the new parameters used for ф calculation by the Nichols mass balance model 
improve the BCF predictions for non-metabolised hydrophobic compounds.  
Table 3.11 Parameters comparison for 1-chloro-2-nitrobenzene (CNB) and benzo(a)pyrene (BaP) for 
each of the mass balance models assuming no metabolism (KMET = 0) 
Parameter Chemical 
 
Nichols mass 
balance 
model  
EPI-mass balance 
model  
ф/FD CNB  0.99 0.99 
BaP  0.52 0.78 
K1 
(L/Kg/d) 
 
CNB  74.25 106.55 
BaP  99.99 137.50 
K2 
(1/d) 
CNB  5.15 3.37 
BaP  < 0.01 < 0.01 
Predicted BCF 
(L/kg fish) 
CNB  14 19 
 BaP  11469 21010 
An interesting observation is apparent from the comparison of predicted BCF data (Table 
3.10). Generally, BCF values predicted by the EPI-log KOW-based model were lower than those 
made by EPI- and Nichols mass balance models (Table 3.10). This may occur because the EPI-
log KOW-based model was built from BCF values that were measured in warm water fish 
species [50], mainly for fathead minnow, and the majority of the reported data in this study 
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were determined in rainbow trout, a cold species. From a kinetic processes scenario, warm 
water fish species are likely to achieve the steady state earlier than cold water species, which 
may result in lower BCFs than those reported for cold water fish [121]. A similar finding was 
found when comparing the common chemicals with data for common carp and rainbow 
trout in the creation of the reference list (Chapter 2). 
Finally, the analysis of the relationship between in vivo and predicted log BCF data, according 
to each model, revealed that the EPI-mass balance model incorporating KMET made better 
predictions (r2 = 0.92) than the other predictive approaches (r2  < 0.60) (as is shown in Figure 
3.7). Interestingly, the reported KMET data from such a model were determined, and not 
based on predictions as was expected initially. KMET data calculated based on experimental 
HLs are shown in parenthesis in Table 3.10, and differed from the KMET predicted by EPI-QSAR 
model developed by Arnot et al. [57] (see Table 3.8). It should be stressed that no 
information was found in the EPI Suite Software (http://www.epa.gov) related to the original 
source of experimental HL data and the method followed to transform the experimental HL 
into rate constants. It is hypothesised, however, that these experimental HL were measured 
in the whole body fish and then transformed into metabolic rate constants following 
Equations 3.5 and 3.6. 
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Figure 3.7 Predicted log BCF vs in vivo log BCF for each predictive BCF models investigated. The 
lines plotted represent the QSAR as stated in the figure legend. 
3.3.6 Alternatives for KMET and BCF: Challenges and Future Perspectives 
The challenge of the in silico KMET models reviewed in this study was to obtain reliable data 
for metabolic rates of test chemicals.  This could be explained as predictive models for KMET 
were not developed from in vivo metabolic data, since only a few studies have been 
conducted so far (see section 2.3.3 for more details). In order to build reliable KMET models, 
more in vivo studies will be required to measure the whole body metabolic rates in fish for 
chemicals covering a broad range of log KOW. Nonetheless, the whole body metabolic rates 
may follow a similar trend to those reported between branchial absorption rates and log KOW 
for guppy [137], as shown in Figure 3.8. This is because a compound needs to be absorbed 
and distributed to the target tissue before being metabolised. A question remains, however, 
concerning the metabolic clearances of hydrophilic chemicals measured in in vivo conditions. 
Based on the in vitro results obtained (Table 3.6), very low metabolic rates are expected for 
these compounds. It should be noted that obtaining reliable KMET data will be also relevant 
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for mass balance BCF models, since the analysis showed that even low variations of 
metabolic activity had a strong impact on BCF for hydrophobic test chemicals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 Relationship between branchial uptake rate constant in guppies and log KOW adapted 
from Saarikoski et al. [137]. 1: Butyric acid; 2: Phenol; 3: Benzoic aicid; 4: 4-Phenylbutyric acid; 5:2,4-
Dichlorophenol; 6: 2-sec Butyl-4,6-dinitrophenol; 7: 3,4-Dichlorobenzoic acid; 8: 2,6-Dibromo-4-
nitrophenol; 9: 2,4,5-Trichlorophenol; 10: 2,4,6-Trichlorophenol; 11: 2,3,4,6-Tetrachlorophenol; 12: 
Tetrachloroverathrol; 13: Pentachlorophenol; 14: Pentachloroanisol; 15: 2,4,6-Trichloro-5-
phenylphenol; 16: DDT. 
Different challenges were found depending on the in silico BCF models evaluated. For 
example, the main challenge of log KOW-based models was the comparison of BCF data for 
different fish species. It is expected that the development of log KOW-based models for single 
fish species, such as those developed for rainbow trout and common carp in Chapter 2, will 
allow for an accurate BCF data comparison. The main challenge of mass balance models was 
associated with the use of different fish weights. For instance in this study, clearance data 
determined using fish donors with weights ranging from 220 to 320 g were incorporated into 
a PBTK model design for a fish of 1 Kg to predict KMET, and such predicted KMET data were then 
integrated into a mass balance model normalised to a 10 g fish for BCF prediction. The 
extrapolation factors of both PBTK and mass balance models should be normalised to a 1 Kg 
to avoid the uncertainty associated with the fish mass. This would also involve the data 
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normalisation of the in vitro CLINT values determined for a specific weight of the fish donor 
to 1 Kg. In order to do that, more effort from experimental approaches will be required with 
a two-fold purpose: 1) to corroborate the correlation between CLINT and the weight of the 
fish donors observed for BaP in this study (Figure 3.4); and 2) to develop a QSAR model to 
estimate the CLINT value in a 1 Kg fish for a specific compound.  
3.4 Conclusion 
The potential of a compound to accumulate in aquatic organisms is usually expressed by 
bioconcentration factor (BCF). Traditionally, data for BCF for organic chemicals were 
determined in the whole fish according to the OECD TG 305 [31]. Due to metabolism reducing 
chemical bioaccumulation significantly, the potential of a compound to undergo metabolism 
has been identified as another key measurement in risk assessment. Over the last decade, 
there has been an increase in the number of alternatives proposed to in vivo testing in fish, 
necessitating a comprehensive analysis of their potential use in chemical bioaccumulation 
assessment.  This Chapter has accordingly reviewed and compared the most common 
alternatives including an in vitro clearance assay using fresh hepatocytes and in silico models 
to predict KMET and BCF of chemicals. Results showed that the in vitro clearance assay using 
freshly isolated trout hepatocytes represents a powerful tool to identify readily metabolic 
chemicals as well as to investigate the impact of significant metabolism processes on their 
maximal BCF. A high variability in KMET predictions was obtained when different models were 
compared, suggesting that further developments and improvements are needed. With 
regards to BCF models, a kinetic mass balance model incorporating KMET predicted based on 
experimental HL represents a potential surrogate to in vivo bioaccumulation studies with 
respect to traditional log KOW-based and a mass balance model defined for a 10 g fish. As a 
consequence of this work, an in-depth analysis of the current challenges and future 
perspectives of the examined alternative methods to in vivo testing was also provided. 
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Chapter 3 has reviewed and compared the most common alternative methods used for the 
estimation of BCF and KMET for a set of reference compounds selected from the reference list 
established in Chapter 2. Compared to toxicity tests, the assessment of chemical 
bioaccumulation is more complex as diverse processes are involved, i.e. Absorption, 
Distribution, Metabolism and Excretion (ADME). Therefore, considerable work was 
undertaken in this thesis towards the development of alternative methods for chemical 
bioaccumulation. Non-animal methods for aquatic toxicity will be covered in Chapter 4, by 
conducting a mechanistic analysis of the toxicity of cyclic compounds. Chapter 4 also 
highlights the importance of integrating different alternative methods to provide a high level 
of confidence regarding the toxic mechanism of cyclic compounds.  
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Chapter 4. In silico Mechanistic Analysis of the Toxicity of 
Cyclic Compounds2 
4.1. Introduction 
Under the Registration, Evaluation, Authorisation and restriction of Chemical substances 
(REACH) legislation, animal testing might be required for the registration of about 35,000 
chemicals produced, used or imported in the European Union for which sufficient 
toxicological information is lacking [13]. REACH has accordingly advocated the use of 
alternative methods to in vivo toxicity tests to assess the toxicity of chemicals.  Some of the 
alternatives to in vivo tests in fish are based on the use of aquatic invertebrates to assess the 
toxicity of chemicals. Amongst all, the growth inhibition assay with the ciliated protozoan 
Tetrahymena pyriformis represents a potential fish surrogate due to the good correlation 
between T. pyriformis and fish acute toxicities [138]. In addition, toxicity tests in aquatic 
surrogates are frequently used as part of Integrated Testing Strategies (ITS) to prioritise 
chemicals for further fish toxicity testing [74].  
Non-testing strategies rely on the use of Quantitative Structure-Activity Relationship (QSAR) 
models to predict the adverse effect of chemicals. The majority of QSAR models for 
ecotoxicology have been built on descriptors for hydrophobicity (expressed by the logarithm 
of the octanol-water partition coefficient, log KOW), for instance the non-polar narcosis QSAR 
model developed by Ellison et al. [139] to predict the 50% inhibition of growth concentration 
(IGC50) to T. pyriformis. However, chemicals interacting by electrophilic mechanisms with 
biological macromolecules can exhibit excess toxicity above the baseline of narcosis, and 
therefore their toxicity cannot be predicted easily from QSARs based on log KOW alone [140]. 
Common approaches for the prediction of chemical reactivity involve the use of quantum 
                                                 
2 This Chapter is based on a published article whose link to the source is provided in the Appendix III. 
 
  
90 
 
mechanical descriptors for modelling chemical reactivity [141, 142] and the identification of 
chemicals for potential protein binding based on structural alerts [68]. Structural alerts that 
are associated with toxicological activity [25,26] have been encoded computationally into in 
silico profilers within the OECD QSAR Toolbox (www.qsartoolbox.org). There are two sets of 
protein profilers: the Organisation for Economic Cooperation and Development (OECD) set 
and the Optimised Approach based on Structural Indices Set (OASIS), which are used for 
various purposes such as forming categories. The most common approach to build a category 
is based on the principle that similar chemicals should have a common reactive centre 
[27,143]. Recent studies have shown that one of the better ways to define a chemical 
category for toxicological assessment is setting the structural boundaries of the category by 
applying mechanistic chemistry and grouping chemicals by their ability to undergo a common 
Molecular Initiating Event (MIE) [68]. MIE refers to the toxicant-biological target interaction 
that leads to toxicological responses at higher levels of biological organisation (see Figure 1.3 
for more details). Therefore, it is important to verify the applicability domain of chemical 
reactions to correctly assign a chemical to a category, and thus allowing for filling data gaps 
for untested chemicals when applying read-across [144]. 
The Michael addition domain is one of the most important mechanistic applicability domains 
relating to reactive toxicity [68,144]. Michael acceptors are soft electrophiles containing a 
polarised ,-unsaturated carbonyl or carbonyl fragment. The common characteristic of the 
structural alert for Michael acceptors is a C=C or C≡C group with a neighbouring electron-
withdrawing moiety. Figure 4.1 shows an example of the reaction between a Michael 
acceptor (acrolein) with a soft nucleophile resulting in a chemical-protein adduct. 
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Figure 4.1 Michael addition reaction between glutathione (nucleophile) and acrolein (Michael 
acceptor) (electrophile). The curly arrow indicates the direction of electron movement from the 
nucleophile to the β-carbon (positive charge) of the electrophile. Representation based on Figure 1 
published by Enoch et al. [25].  
The reactivity of Michael acceptors can be measured under standardised experimental 
conditions using techniques known as in chemico methods [145]. In chemico techniques 
employ the use of biological nucleophiles (e.g. peptides or proteins) to quantify the reactivity 
of a compound [69]. In in chemico assays, the measured endpoint is the effect concentration 
of electrophile that depletes 50% of glutathione (GSH) (RC50)  after 120 min incubation time 
at 25 C and pH 7.4 [134,146]. This protocol has been employed to establish an extensive 
database quantifying the reactivity of Michael acceptors and other electrophiles 
(www.qsartoolbox.org).  
In chemico reactivity data play an important role in the verification of the prediction of 
chemical reactivity. For example, Schultz et al. [67] verified the structural alerts for a list of 
Michael acceptors using in chemico reactivity data. However, the Michael addition domain 
should cover a larger range of chemicals than considered so far since Michael acceptor 
compounds are very important industrial chemicals including polymers, textiles and auxiliary 
materials in medicine [147]. Recent investigations have also used T. pyriformis toxicity data 
to refine the applicability domain of selected structural alerts [148-150]. This multiple data 
integration not only offers the possibility of the verification of in silico predictions of chemical 
Glutathione Acrolein Chemical-protein adduct
Ione pais of electrons
α carbon
Electron deficient, β carbon 
-
Lone pair of electrons 
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reactivity, but also could allow for the development of an ITS to prioritise chemicals for 
aquatic toxicity testing. 
Therefore, the aims of this study were: 1) to verify the extension of the applicability domain 
for Michael acceptors within the in silico profilers of the OECD QSAR Toolbox using 
experimental data. The applicability domain of the structural alerts for cyclic compounds that 
are potential Michael acceptors was probed using the in chemico GSH reactivity and T. 
pyriformis growth inhibition assays; and 2) to develop an ITS by combining data from the 
above in silico, in vitro and in chemico methods to prioritise chemicals for in vivo toxicity 
testing. 
4.2. Materials and Methods  
This work was undertaken in collaboration with Professor Terry W Schultz from the 
University of Tennessee (United States). Professor Schultz and colleagues conducted the 
experimental work, i.e. the in chemico testing and T. pyriformis growth inhibition assays, 
whereas the in silico analysis and the development of an ITS were conducted at LJMU as part 
of this research. 
4.2.1 Test Compounds  
Thirty cyclic chemicals containing a range of six-membered cyclic chemicals with different 
substituents were selected for evaluation; the structures of these compounds are 
summarised in Figure 4.2. All chemicals were purchased from commercial sources (Sigma-
Aldrich.com or Alfa.com) in the highest purity available (95% minimum) and were not further 
purified prior to testing. 
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Figure 4.2 Chemicals considered in this study. Identification number related to Table 4.1. Group 1: 
polarised alkanes or non-polarised-alkenes; Group 2: polarised ,-unsaturated alkenes; Group 3:  
polarised ketones substituted at the -carbon; Group 4: ,-unsaturated alkenes with substituents 
at the α- and/or β-carbon atoms; Group 5: ,-unsaturated heterocyclics. 
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The chemicals tested were classified into five groups depending on the presence or absence 
of the polarised ,-unsaturated fragment, the general structural alert for Michael acceptors 
(Figure 4.3), and other structural features in the molecule that may affect the reactivity with 
GSH.  
                                           
      
Figure 4.3 Polarised ,-unsaturated fragment. 
 Group 1. The first group were polarised alkanes or non-polarised alkenes. It was 
expected that these chemicals would not be reactive with GSH as they do not contain 
the general structural alert for a Michael acceptor in their structure. 
 Group 2. This group contains polarised ,-unsaturated alkenes with no substituents 
at the α- or β-carbon atoms (Figure 4.3). It was hypothesised that these chemicals 
would be reactive with GSH as they do not have any mitigating factors which may 
affect reactivity.  
 Group 3. The third group of chemicals were acyclic polarised ketones substituted at 
the -carbon by a sterically hindered cyclohexene ring. These chemicals were of 
interest due to the potential for a displaced steric effect as a result of the substituted 
cyclohexene ring. 
 Group 4. Chemicals in this group were ,-unsaturated alkenes with substituents at 
the α- and/or β-carbon atoms. Although these chemicals may react with GSH as they 
meet the general structural alert for a Michael acceptor, it was hypothesised that 
electron-donating substituents at the - and/or -carbon would affect reactivity.  
 Group 5. The fifth group of chemicals is the polarised ,-unsaturated heterocyclics, 
either O-containing pyranones or N-containing chemicals. It was hypothesised that 
although these chemicals may be reactive with GSH due to the general structural 
X=CO,CN and NO2 groups
A
B
X= CO, CN, NO2 groups 
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alert for a Michael acceptor, heterocyclic features may be a mitigating factor 
affecting reactivity.  
4.2.2 Protein Binding Prediction 
The cyclic test chemicals were profiled for protein binding using the OASIS and OECD profilers 
contained within version 3.1 of the OECD QSAR Toolbox (www.qsartoolbox.org). Chemical 
structures were entered into the OECD QSAR Toolbox as SMILES string notations. The SMILES 
strings of each compound were previously obtained and verified in the KOWWIN v 1.68 
software (www.epa.gov). If a structural alert was triggered for a particular chemical within 
one, or both, of the profilers this information was recorded. Chemical transformation due to 
metabolism and/or autoxidation was not considered in this investigation.   
4.2.3 In Chemico GSH Reactivity 
Reactivity with the thiol group of GSH was measured using a simple and rapid 
spectrophotometric-based assay [147]. Briefly, free thiol was quantified after its reaction 
with 5,5’-dithio-bis(2-nitrobenzoic acid) (DTNB) with the absorption of the product measured 
at 412 nm. Experiments were performed with freshly prepared GSH (1.375 mM; 0.042 g of 
reduced GSH into 100 ml of phosphate buffer at pH 7.4) and freshly prepared stock solutions 
in dimethyl sulfoxide (DMSO). By combining the correct amounts of GSH solution, stock 
solution, and buffer the final concentration of thiol was brought to 0.1375 mM, in a manner 
that the concentration of DMSO in the final solution was always < 10%. Following range-
finding experiments, definitive experiments were performed with concentrations adjusted 
to 90, 80, 60, 40, 20 and 10% of the stock solutions. Associated with each assay was a control 
containing GSH and a blank without GSH.  
The RC50 values (the concentration giving 50% reaction in a fixed time of 2 h) were 
determined from nominal chemical concentrations (dependent variable) and absorbance 
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normalised to the control (independent variable) using Probit Analysis in the Statistical 
Analysis System (SAS) software (SAS Institute, Cary, NC). Chemicals with a RC50 value of 
greater than 135 mM were considered to be non-reactive due to the fact that a contaminant 
at the level of 1% could be the cause of such reactivity. Similarly, RC50 values of greater than 
70 mM were treated as “suspect” as a contaminant at the 2% level could be the cause of 
such reactivity. 
4.2.4 In Vitro Toxicity Data 
The protocol described by Schultz [138] was used to measure the 50% inhibition of growth 
concentration (IGC50) to T. pyriformis of the cyclic compounds after a 40 h exposure period. 
The population density of T. pyriformis was quantified spectrophotometrically at 540 nm. 
Following range-finding experiments, definitive experiments were performed with 
concentrations adjusted to cover the highest concentration eliciting no effect on population 
growth to the lowest concentration inhibiting population growth completely. 
Coupled to each assay, a control containing no test material and T. pyriformis and a blank 
containing neither test material nor T. pyriformis [139] were used in order to indicate the 
suitability of the medium and also to help interpret the results produced under test 
conditions. The IGC50 value was calculated (in millimolar units) by absorbance normalised to 
controls (independent variable) and the nominal concentration of the toxicant (dependent 
variable) using the Probit Analysis in SAS software (SAS Institute, Cary, NC). 
4.2.5 In Silico Analysis to Identify Excess and Baseline Toxicities 
The QSAR model for non-polar narcosis published by Ellison et al. [139], shown as Equation 
4.1, was used to calculate the baseline toxicity of the cyclic chemicals. The log KOW for all 
chemicals was calculated using the KOWWIN v1.68 software. 
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Log 1/IGC50 = 0.78 log KOW - 2.01  (4.1) 
n = 87, r2 = 0.96, s = 0.20, F = 2131 
Where, n is the number of observations, r2 is the square of the correlation coefficient 
adjusted for degrees of freedom, s is the standard error on the estimate and F is Fisher’s 
statistic. 
The residual value for each compound was obtained from the difference between the 
experimental values and the predicted toxicity calculated from Equation 4.1. Since the 
standard error of the estimate for the baseline model for the IGC50 (Eq. 1) is 0.2 log units, 
experimental toxicity values with residuals < 0.4 log units (twice the s value for Eq. 4.1) were 
considered not different from narcosis-level compounds. In a similar manner, chemicals 
more toxic than this limit (residuals > 0.4 log units) were classified as exhibiting excess 
toxicity. 
4.2.6 Development of an ITS to Prioritise Cyclic Compounds for In Vivo Testing  
The development of an ITS was conducted to classify cyclic compounds into different 
categories to prioritise chemicals for further in vivo aquatic toxicity testing. This strategy was 
built based on: 1) previous ITS proposed for environmental toxicity testing [69,74]; and 2) a 
classification approach that combined a QSAR analysis and the presence of structural alerts 
to identify chemicals with different priorities for experimental testing [140]. The in silico, in 
vitro and in chemico results were combined in a decision tree strategy to prioritise cyclic 
compounds for further in vivo testing.  
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4.3. Results and Discussion 
4.3.1 Verification of Structural Alerts 
The integration of in vitro and in chemico data is becoming more important to verify 
predictions of chemical reactivity [148-150]. Based on the combination of non-animal assays, 
the first aim of this Chapter was to verify the structural alerts for Michael acceptors in 
existing protein binding profilers.  
A total of 30 chemicals were profiled using the in silico OASIS and OECD profilers in the OECD 
QSAR Toolbox. The results are summarised in Table 4.1. The results showed 22 chemicals 
contained a structural alert (in a least one of the profilers), of which 19 were identified as 
being experimentally reactive with GSH. A further eight chemicals failed to trigger an alert in 
either profiler, these chemicals were all experimentally non-reactive. The analysis of the 
relationship between log 1/IGC50 and log KOW (Figure 4.4) revealed that 12 chemicals exhibit 
excess toxicity. A detailed discussion of the results for each group of chemicals is provided 
below.  
 
 
 
 
 
 
 
Figure 4.4 Relationship between log KOW and log 1/IGC50 for the cyclic compounds. The solid line:  
QSAR model for non-polar narcosis published by Ellison et al. [139]. Dashed-line: QSAR model + 0.4 
log 1/IGC50 units. 
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Table 4.1 Summary of experimental and in silico data  
ID(G) Chemical name Log KOW 
In silico profiler 
Log 
1/RC50 
In chemico 
 Log 
1/IGC50 
Toxicity to       
T. pyriformis 
TC 
OASIS OECD 
1(1) Cyclohexanol 1.64 None None 
NR at 
100mM 
NR -0.77 NSDB 3 
2(1) Cyclohexanone 1.13 None None 
NR at 
100mM 
NR -1.23 NSDB 3 
3(1) Nitrocyclohexane 2.23 None None 
NR at 
15mM 
NR -0.28 NSDB 3 
4(1) Cyclohexene 2.96 None None 
NR at 
2.5mM 
NR -0.01 NSDB 3 
5(1) 4-Vinyl-1-cyclohexene 3.73 None None 
NR at 
0.5mM 
NR 0.71 NSDB 3 
6(1) 3-Methy-1-cyclohexanone 1.54 None None NRAS NR -0.43 NSDB 3 
7(1) 1-Methyl-1-cyclohexene 3.51 None None NRAS NR 0.84 NSDB 3 
8(1) Cyclohexanecarbonitrile 2.12 None None 
NR at 
100mM 
NR -0.03 NSDB 3 
9(1) 3-Cyclohexene-1-carboxyaldehyde 1.89 SB SB 
NR at 
22mM 
NR 0.29 XS 1 
10(1) 
3,5-Dimethyl-3-cyclohexene-1-   
carboxaldehyde 
2.85 SB SB 
NR at 
2mM 
NR 0.11 XS  1 
11(2) 
2-Cyclohexen-1-one 1.2 MA MA -0.49 Reactive 0.61 XS 1 
AC: acylation; ID: Identification number; G: chemical group; MA: Michael addition; NR: no reactive; NSDB: not significantly different from baseline; TC: Testing category (1: priority 
for acute toxicity tests; 2: priority for chronic toxicity tests; 3: no priority for experimental testing); SB: Schiff base formation; XS: excess toxicity. 
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Table 4.1 Summary of experimental and in silico data (cont.) 
AC: acylation; ID: Identification number; G: chemical group; MA: Michael addition; NR: no reactive; NSDB: not significantly different from baseline; TC: Testing category (1: priority 
for acute toxicity tests; 2: priority for chronic toxicity tests; 3: no priority for experimental testing); SB: Schiff base formation; XS: excess toxicity. 
 
 
 
ID(G) Chemical name Log KOW 
In silico profiler Log 
1/RC50 
In chemico 
Log 
1/IGC50 
Toxicity to       
T. pyriformis 
TC 
OASIS OECD 
12(2) 
 
1-Cyclohexene-1-carboxaldehyde 
 
2.02 
 
SB 
 
SB/MA 
 
0.98 
 
Reactive 
 
0.12 
 
XS 
 
1 
13(2) 1-Cyanocyclohexene 2.04 MA MA 0.68 Reactive -0.43 NSDB 2 
14(2) 4,4-Dimethyl-2-cyclohexen-1-one 2.07 MA MA 0 Reactive 0.4 XS 1 
15(2) 1-Nitro-1-cyclohexene 2.15 MA MA -1.6 Reactive 2.33 XS 1 
16(2) 1-Acetyl-1-cyclohexene 2.24 MA MA 0.32 Reactive 0 NSDB 2 
17(2) Methyl-1-cyclohexene-1-carboxylate 2.56 MA MA 0.23 Reactive 0.24 NSDB 2 
18(2) 
4-Isopropenyl-cyclohexene-1-  
carboxaldehyde 
3.14 SB SB/MA 0.75 Reactive 0.67 NSDB 2 
19(3) 
4-(2,6,6-Trimethyl-2-cyclohexen-1-yl-)3- 
buten-2-one 
4.29 MA MA 
NR at 
0.2mM 
NR 0.95 NSDB 2 
20(3) 
4-(2,6,6-Trimethyl-1-cyclohexen-1-yl)-3- 
buten-2-one 
4.42 None MA 
NR at 
0.2mM 
NR 1.17 NSDB 2 
21(4) 3-Methyl-2-cyclohexen-1-one 1.75 MA None 1.1 Reactive -0.52 NSDB 2 
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Table 4.1 Summary of experimental and in silico data (cont.) 
ID(G) Chemical name     Log KOW 
In silico profiler Log 
1/RC50 
In chemico 
Log 
1/IGC50 
Toxicity to   
T.pyriformis 
TC 
OASIS OECD 
22(4) 3,5-Dimethyl-2-cyclohexen-1-one 2.16 MA None 1 Reactive -0.57 NSDB 2 
23(4) 3,5,5-Trimethyl-2-cyclohexen-1-one 2.62 MA None 1.4 Reactive -0.57 NSDB 2 
24(4) 5-Isopropenyl-2-methyl-2-cyclohexen-1-one 3.07 MA MA 
NR At 
8mM 
NR 0.23 NSDB 2 
25(4) 2-Isopropylidene-5-methylcyclohexan-1-one 3.2 MA None 
NR at 
10mM 
NR 1.01 XS 1 
26(5) Methylcoumalate -0.65 MA AC/MA -0.04 Reactive 0.89 XS 1 
27(5) 1-Methyl-2-pyridone -0.05 MA AC/MA 2 
Reactive 
(suspect) 
-1.41 XS 1 
28(5) 5,6-Dihydro-2H-pyran-2-one -0.03 MA AC/MA 
NR at 
100mM 
NR 0.42 XS 1 
29(5) 2H-Pyran-2-one -0.24 MA AC/MA 
NR at 
200mM 
NR 0.43 XS 1 
30(5) 4,6-Dimethyl-a-pyrone                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       0.85 MA AC/MA 1.9
Reactive 
(Suspect) 
-0.93 XS 1
AC: acylation; ID: Identification number; G: chemical group; MA: Michael addition; NR: no reactive; NSDB: not significantly different from baseline; TC: Testing category (1: priority 
for acute toxicity tests, 2: priority for chronic toxicity tests, 3: no priority for experimental testing); SB: Schiff base formation; XS: excess toxicity. 
  
102 
 
Cyclic Polarised Alkanes and Cyclic Non-polarised Alkenes (Group 1)  
Ten cyclic chemicals contained either a polarised alkane moiety or non-polarised alkene unit 
(see Table 4.1). No structural alerts for protein binding were identified in Group 1 compounds 
with the exception of 3-cyclohexene-1-carboxyaldehyde (9) and 3,5-dimethyl-3-
cyclohexene-1-carboxaldehyde (10). These two cyclic aldehydes triggered a structural alert 
for Schiff base formation in both protein binding profilers due to the presence of the carbonyl 
moiety (see compounds 9 and 10 in Table 4.1). The lack of GSH reactivity for the two Schiff 
base formers (aldehydes) is expected as this mechanism requires a nucleophilic nitrogen 
atom, rather than the sulphur, attacking the carbonyl carbon as shown in Figure 4.5 for 
compound 9 [151]. In addition, these Schiff base formers showed excess toxicity towards T. 
pyriformis in the QSAR analysis (Figure 4.4), which could be a result of the depletion of 
proteins containing nitrogen reacting with them.  The absence of structural alerts triggered 
for Michael acceptors for this group of chemicals was verified by the lack of reactivity 
towards GSH, as expected initially based on their lack of an α, β-unsaturated fragment (see 
Figure 4.2). 
 
Figure 4.5 Schiff base reaction between 3-cyclohexene-1-carboxyaldehyde (ID 9) and a nitrogen 
containing nucleophile. 
 
Electron 
deficient carbon
protein
3-cyclohexene-1-carboxyaldehyde
-
Chemical-protein adduct
protein
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Unsubstituted Cyclic Polarised Alkenes (Group 2) 
There are eight cyclic chemicals in the dataset that contain an un-substituted polarised 
alkene moiety (where the alkene is part of the ring system polarised by either an aldehyde, 
ketone, ester, cyano or nitro group; see Figure 4.1 for more details). All of these chemicals 
triggered a structural alert related to Michael addition for covalent protein binding in at least 
one of the profilers (Table 4.1). In addition, compounds 12 and 18 in which the alkene is 
polarised by an aldehyde moiety also trigger an alert for Schiff base formation (Table 4.1). As 
expected these in silico predictions were verified by the results of the in chemico data that 
showed all of the chemicals to be reactive towards GSH. In addition, four of the Group 2 
compounds (11,12,14,15) exhibited excess toxicity towards T. pyriformis (Figure 4.4).  
Acyclic α,-unsaturated Polarised Ketones (Group 3) 
There were two acyclic α,-unsaturated polarised ketones in the dataset that feature a 
cyclohexene ring attached to the -carbon atom (compounds 19, 20). Although these 
chemicals were both profiled as being capable of reacting via Michael addition, neither 
exhibited either reactivity towards glutathione nor showed excess toxicity (Table 4.1). Their 
lack of reactivity could be explained by a steric hindrance at the -carbon atom caused by 
the methyl substituents present on the cyclohexene ring [142,151]. These compounds are 
also relatively hydrophobic (log KOW > 4) which leads to low water solubility potentially 
limiting the usefulness of the reactivity assays. Aqueous methanol reaction conditions would 
be needed to assess the reactivity of chemicals with poor solubility. 
Substituted Cyclic Alkenes Polarised by a Ketone (Group 4) 
All substituted cyclic alkenes polarised by a ketone had a methyl substituent at the β-carbon, 
with the exception of compound 24 whose methyl group was at the α-carbon (see Figure 1). 
All these chemicals were identified as being reactive by the OASIS protein binding profiler, 
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whereas only compound 24 was predicted to be reactive by the OECD profiler via Michael 
addition (Table 4.1). This is due to the restricted applicability domain in the OECD profiler 
that excludes chemicals that are di-substituted at the -carbon atom. The evaluation of the 
experimental reactivity data showed that only three of these chemicals were reactive 
towards GSH (compounds 21, 22, 23) and none of them showed excess toxicity. Interestingly, 
the reactive chemicals with a methyl group at the -carbon were those in which the alkene 
double bond was within the ring system (for example, compare the ring systems of 
compound 21 and 25 in Figure 4.1). The difference in reactivity can be explained by the 
release of the ring strain energy in chemicals of this type that has the effect of lowering the 
energy of activation [142]. Finally, the experimental data showed that the presence of a 
methyl group at the α-carbon atom results in the loss of Michael addition reactivity, which is 
in agreement with a number of studies [68,142,153]. 
Polarised,-unsaturated Heterocyclics (Group 5) 
The final five chemicals in the dataset were six-membered ring systems containing either a 
nitrogen or oxygen atom. Whilst all these chemicals were profiled by the protein binding by 
OASIS profiler as being reactive via Michael addition, the OECD profiler identified potential 
reactivity via either a Michael addition mechanism or an acylation mechanism (Table 4.1). 
With the exception of compound 26, none of these chemicals were positively identified as 
being reactive in the in chemico glutathione-based assay. The ester group attached to the 
heterocyclic ring could be responsible for the GSH reactivity shown for compound 26 [151]. 
All five heterocyclic compounds exhibited excess toxicity towards T. pyriformis (Figure 4.4). 
This finding suggests that these chemicals prefer to react via the acylation mechanism. The 
acylation mechanism involves the attack of a carbonyl moiety by proteins containing 
nitrogen atom as a nucleophilic centre [25] and, therefore, such reactivity would not be 
expected to be observed in a thiol-based GSH assay. 
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Structural Alert Refinement  
The analysis above suggests that several refinements are required to the structural alerts in 
the protein binding profilers of the OECD QSAR Toolbox for some chemicals of groups 3, 4 
and 5. The suggested refinements are summarised in Table 4.2 and discussed in more detail 
below.  
In the analysis of the third group of chemicals, there is strong evidence that the presence of 
a substituted cyclohexene ring system attached to the -carbon inhibits the reactivity via the 
Michael addition mechanism. Thus, chemicals containing such a moiety should be excluded 
from the Michael addition alert for acyclic polarised alkenes. A further restriction in the 
domain of the structural alerts present in both profilers was suggested from the analysis of 
the Group 4 chemicals. This is required to reflect the lack of Michael addition reactivity when 
the α-carbon is substituted by an alkyl group.  For this group of chemicals, this study also 
showed the need for an expansion of the domain of the structural alert present in the OECD 
profiler to reflect the reactivity of cyclohexanones substituted by an alkyl group at the -
carbon. The experimental data suggest that Group 5 of chemicals react via acylation instead 
of Michael addition. The applicability domain of both profilers needs a restriction to exclude 
these chemicals from the Michael acceptor domain. 
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   Table 4.2 Suggested refinements to the protein binding profilers in the OECD QSAR Toolbox 
Group Profiler Structural alert Applicability domain 
3 Both 
 
Restrict the Michael acceptor 
domain to exclude chemicals 
matching the alert. R = alkyl 
N.B. any substituted cyclohexene is 
included 
4 Both 
 
Restrict the Michael acceptor 
domain to exclude chemicals 
matching the alert. 
R = alkyl 
4 OECD 
 
Expand the Michael acceptor domain 
to include chemicals matching the 
alert. 
R = alkyl 
5 Both 
 
Restrict the Michael acceptor 
domain to exclude chemicals 
matching the alert. 
X = O, NH, NR (R = alkyl) 
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4.3.2 Proposed ITS to Prioritise Cyclic Compounds for In Vivo Testing 
The applicability and acceptance of ITS for regulatory purposes are becoming essential with 
the introduction of REACH legislation [154]. The second objective of this Chapter was, 
therefore, to provide an example of an ITS for aquatic ecotoxicology studies to prioritise 
chemicals for experimental testing. Such a strategy was developed based on previous ITS that 
included the following steps: 1) collection of available toxicity data on the query compound; 
2) the use of in silico methods to make predictions on its toxicity; 3) performing in vitro assays 
(e.g. fish surrogates tests, fish cells and fish embryos); 4) WoE evaluation on all data; and 5) 
finally determination as to whether it is required to perform fish toxicity OECD tests [74,69].  
The strategy developed for the classification of cyclic compounds into three categories to 
prioritise chemicals for further aquatic toxicity testing is represented as a decision-tree 
diagram in Figure 4.6. In brief, the first step of the strategy proposed in this study was the 
identification of compounds exhibiting excess toxicity and narcotic (baseline) toxicity based 
on their absolute residuals values from Equation 4.1 (see above). Once compounds with 
excess and narcotic toxicity were identified, in silico data (i.e. the presence of a structural 
alert triggered by either profiler) and in chemico data (reactivity with GSH) were used. Whilst 
all compounds with excess toxicity were considered as a priority for experimental testing, 
only those that showed baseline toxicity and GSH reactivity and/or triggered an alert by 
either profiler were considered as the highest priority for chronic experimental testing 
(Figure 4.6). The identification of compounds relevant for chronic studies was conducted on 
the basis of the assumption that slow reactions between xenobiotics and proteins could have 
a potential hazardous effect to aquatic organisms when such interaction is persistent in the 
long term. In comparison to acute toxicity studies, chronic toxicity tests are not frequently 
conducted due to the high cost and long period involved [24]. The prediction of the chronic 
toxicity of a compound is usually based on the Acute-Chronic Toxicity (ACT) ratio [155]. The 
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ACT ratio refers to the median lethal or effective acute concentration divided by chronic 
value. This study has accordingly integrated acute and chronic toxicity tests in the same 
classification scheme to identify both potential short and long term hazards, thus 
representing the first ITS where both types of tests are integrated in the same scheme.  
As has been explained previously in the verification of structural alerts for some cyclic 
compounds (e.g. group 3), the presence of a structural alert in a chemical structure does not 
guarantee that the reaction will take place [25]. Steric hindrance and electronic effects 
caused by substituents at, or near, the reaction site can affect partially, or even totally, the 
reaction between GSH (or another nucleophile) and the toxicant. In particular, it has been 
reported that steric hindrance effects can influence at least 25% of the overall reaction rate 
of the Michael addition reaction [152]. As a consequence, reactivity data with GSH provided 
crucial information on the MIE of the Michael type reaction (e.g. the existence of mitigating 
factors) which was used to refine the prediction of chemical reactivity. In the ITS proposed, 
such information is framed by a dashed line and was crucial to identify compounds that do 
not require further experimental testing (non-reactive baseline toxicants without alert 
triggered) (see Figure 4.6). 
The proposed strategy could be taken as a foundation to develop future ITSs based on other 
fish surrogates (e.g. Daphnia, fish embryo) and toxicological endpoints (e.g. lethal 
concentration), both frequently used in risk assessments. According to the classification 
scheme illustrated in Figure 4.6, 12 chemicals were considered as having the highest priority 
for acute toxicity tests, 10 other chemicals as being relevant for chronic toxicity tests and 
eight chemicals were identified as compounds without a need to undergo experimental 
testing. Categories for each of the examined compounds are provided in Table 4.1 and 
explained in more detail below.    
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Figure 4.6 Proposed ITS for Michael acceptors to prioritise cyclic compounds for further testing. GSH: Glutathione; QSAR: Quantitative Structure-Activity 
Relationship; MA: Michael Acceptor; WoE: Weight of Evidence.
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Compounds with the Highest Priority for Acute Toxicity Tests 
Compounds with the highest priority for acute toxicity tests were all chemicals that exhibited 
excess toxicity towards T. pyriformis. Interestingly, all compounds with excess toxicity 
triggered a structural alert by either profiler (Table 4.1), supporting the reliability of in silico 
profilers to identify reactive compounds. Of these chemicals, compounds 9, 11, 12, 14 and 
15 were highly reactive with GSH. In the analysis of their chemical structure, no methyl 
substituents were found at the α, -C atoms suggesting a greater accessibility to the reaction 
site. In contrast, compounds 27-30 did not react with GSH. Such compounds were associated 
with the acylation mechanism by the OECD protein binding profiler indicating that the 
electrophilic toxic mechanism involved a nitrogen atom as the nucleophilic centre rather than 
sulphur as explained before. A lysine-based depletion assay would be required to clarify the 
type of electrophilic reaction of these chemicals.  
Chemicals showing excess toxicity should be considered as compounds of environmental 
concern since their reaction with biological macromolecules is irreversible [25]. Testing such 
compounds through a variety of in vitro toxicity assays such as the Fish Embryo Test (FET) 
[14] and fish cells test systems (both primary and cell lines cultures) would be necessary to 
generate more data to support their excess toxicity observed to T. pyriformis. Finally, if the 
in vitro data generated are not conclusive enough on the potential acute toxicity of the 
examined compound, the acute fish toxicity test [6] should be conducted. 
Compounds with the Highest Priority for Chronic Toxicity Tests 
Compounds with the highest priority for chronic toxicity tests were baseline compounds that 
showed either in chemico GSH reactivity or a structural alert triggered. Generally, these 
compounds included all the chemicals containing mitigating factors affecting reactivity such 
as a steric hindrance to the site of reaction (Group 3) and methyl group acting as electron-
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donating substituents at the α and β C -atoms (Group 4). This finding shows how combining 
different non-animal test methods can provide an insight into the mechanism of the reaction. 
It is expected that even slow reaction rate with GSH of these chemicals could be toxic towards 
aquatic organisms in a long term exposure.  Conducting additional in vitro and in vivo chronic 
toxicity tests would be of interest to expand the knowledge of the long term toxic effect of 
such chemicals. 
Compounds with No Need for Experimental Testing 
Compounds with no need for experimental testing were narcotic compounds that neither 
triggered a structural alert by the in silico profilers nor were reactive with GSH. All these 
chemicals belong to the Group 1 (polarised alkanes and non-polarised alkenes). For these 
chemicals, there is enough WoE of the lack of their reactivity to biological targets, and 
therefore further in vitro and in vivo testing should be not required. Alternatively, QSARs or 
read-across can be used to predict the toxicity of these non-reactive chemicals. 
4.4. Conclusion 
The integration of alternative methods is becoming more important in regulatory toxicology. 
This study has showed two outcomes of integrating in vitro, in chemico and in silico methods 
to provide relevant information on the Michael addition electrophilic mechanism of action. 
Firstly, this study has verified the structural alerts present in the in silico profilers within the 
OECD QSAR Toolbox using experimental data. The results showed that the applicability 
domain of some of the structural alerts required refinement and improvement, and therefore 
suggestion are given. Secondly, an ITS was developed based on the combination of multiple 
pieces of information to identify: 1) chemicals with a high priority for acute toxicity tests; 2) 
chemicals with a high priority for chronic toxicity tests; and 3) chemicals with no need for 
experimental testing. The results showed a good concordance between in silico, in chemico 
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and in vitro data, which could be integrated into ITS to make a decision whether a query 
compound will require in vivo fish toxicity testing. 
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Chapter 5. Discussion and Suggestions for Future Work 
To conclude this thesis, a summary and discussion of the research undertaken will be 
provided in the first section of this Chapter. A description of three proposed plans for future 
research will be described in the second section. The suggestions for future work were 
derived from the identification of knowledge gaps from the research conducted in this thesis, 
and they are expected to provide a basis for ongoing research. Finally, a thesis overview and 
final thoughts on alternative methods are provided in the last section. 
5.1. Summary and Discussion of the Work Undertaken 
Chapter 1: Introduction 
The development of non-animal methods to assess the toxicity and bioaccumulation 
potential of organic chemicals in fish is the central theme of this thesis. In Chapter 1, a 
description is given of different in vitro and in silico techniques used in aquatic ecotoxicology 
with a particular emphasis of why these methods have become important in risk assessment.  
To provide a better understanding of the research topic, Chapter 1 also introduced the origin 
of the pollutants that enter into the aquatic environment, the aspects that should be taken 
into account for the design of toxicity tests and the process of validation for the 
implementation of alternative methods. 
Chapter 2: Development of a List of Reference Compounds to Evaluate Alternative Methods 
to In Vivo Fish Bioaccumulation Tests 
The validation of alternative methods is the key for their implementation in risk assessment 
to reduce the number of animals required to assess the bioaccumulation potential and 
toxicity of chemicals [76,77]. To enable the validation of alternatives, lists of reference 
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compounds supported by high quality in vivo data are required to enable data comparison. 
Whilst lists of reference compounds have been provided to develop different alternatives to 
animal (eco)toxicity studies [79,98], no reference list has been proposed for in vivo 
bioaccumulation in fish. This knowledge gap led to the development of a reference list of 
chemicals to develop and validate alternative methods for predicting bioaccumulation with 
a particular focus on metabolic assays, as part of this thesis. 
It should be stressed that a considerable effort was made to establish a step-wise approach 
to select reference compounds for chemical bioaccumulation, as there is no official guidance 
of chemical selection procedures in general. Initially, it was planned to perform a similar 
approach to the compound selection strategy provided by Olah et al. [156] for drug discovery, 
which would have implied the use of in silico tools employed in industrial research. Generally, 
chemical selection procedures for drug discovery rely on a random selection of a structurally 
diverse set of chemicals based on a broad chemical space distribution resulting from the 
structure-biological activity relationship [95]. Examples of in silico techniques used for 
compound selection include clustering, cell-based and dissimilarity-based compounds 
selection methods [157,158]. Such methodology was rejected, however, due to two main 
reasons: 1) the heterogeneity of the data, since one of the selection criteria was that 
compounds supported by three in vivo measurements related to bioaccumulation should be 
included in the reference list; and 2) the intrinsic difficulty in selecting different chemical 
classes identified by employing a random selection. It was expected that the chemical 
selection could be biased for those classes containing a minority of chemicals, since different 
chemical classes can have a similar coverage for a given descriptor. Consequently, a list of 
selection criteria was established to minimise random compound selection as much as 
possible. In doing this, the criterion of the inclusion of different chemical classes was 
prioritised to ensure a broad range of key chemical properties (see Figure 2.1). Such selection 
criteria were integrated into a three-tier strategy. Tier I consisted of the selection of: 1) 
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relevant in vivo bioaccumulation endpoints (bioconcentration factor (BCF), whole body 
biotransformation rates (KMET) and measurements related to metabolite identification); 2) 
fish species (common carp and rainbow trout); and 3) and chemical classes that are shown 
in Table 2.2. Tier II involved data collection, evaluation and analysis of the chemicals 
supported by in vivo data for the selected in vivo endpoints. Tier III was based on a refinement 
selection process to guarantee a broad range of chemical domain in terms of physico-
chemical, molecular and metabolic properties. From the use of the above selection strategy, 
144 chemicals were selected for BCF, another eight for KMET and five compounds were 
supported by in vivo data for metabolism.  
The availability and the quality of in vivo data were key issues for compound selection. For 
example, to provide a representative list, the selection was focused on the fish species that 
possessed more measurements for bioaccumulation, i.e. rainbow trout and common carp. 
Another relevant aspect resulting from the creation of a relevance list was the identification 
of compounds whose BCF values showed poor correlation with the logarithm of octanol-
water coefficient (KOW). Such compounds were considered to be of interest for in vitro 
metabolic assays based on the rationale that significant metabolic biotransformation can 
reduce the maximal bioconcentration of chemicals. To identify compounds that may 
potentially be metabolised, maximal log BCF models (log BCFmax) were built from the 
relationship between in vivo log BCF and log KOW for rainbow trout and common carp, 
representing the first models that have been developed for these fish species.  
It should be added that although the list of reference compounds mainly addresses the 
development and validation of non-animal approaches for bioaccumulation studies in fish, 
other benefits can be derived from its common use, as for instance: 1) the investigation of 
the Absorption, Metabolism, Distribution and Excretion (ADME) properties of reference 
chemicals based on the integration of study results derived from various in vitro assays; and 
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2) the development of other chemical selection strategies for other fish species and/or 
toxicity endpoints based on the chemical selection strategy proposed. In particular, a list of 
reference compounds could be developed for chronic toxicity studies based on the data 
compiled by Raimondo et al. [155]. 
Chapter 3: A Review and Comparison of Alternative Methods to In Vivo Bioaccumulation 
Studies in Fish 
Over the last decade, various non-animal methods have been developed to assess the 
bioaccumulation of chemicals. Whilst some of these methods involved the use of fish 
hepatocytes or subcellular fractions (e.g. microsomes, S9) to assess the xenobiotic 
biotransformation based on a depletion approach, others use in silico models to estimate 
KMET and BCF of chemicals [30,116]. Predictive KMET approaches include Physiologically-Based 
ToxicoKinetic (PBTK) and Quantitative Structure-Activity Relationship (QSAR) models. 
Predictive BCF approaches include log KOW-based and kinetic mass balance models. Before 
alternatives become implemented in risk assessment to meet the Registration, Evaluation, 
Authorisation and Restriction of Chemicals (REACH) legislation [13], an in-depth analysis of 
their potential use as a surrogate and/or complement to in vivo bioaccumulation testing is 
likely to be required.  
As a consequence, Chapter 3 reviewed and compared the current alternatives for 
bioaccumulation for a set of compounds selected from the reference list developed in 
Chapter 2.  The non-animal methods examined were: 1) the in vitro clearance assay using 
freshly isolated hepatocytes from rainbow trout; 2) three PBTK calculation models and a 
QSAR model to predict KMET; and 3) log KOW-based and mass balance models for estimating 
BCF. Results showed that the rainbow trout clearance assay can be used to identify readily 
metabolised chemicals and investigate the effect of metabolic processes on the maximum 
bioconcentration of chemicals.   High variability in predicted KMET data was obtained from the 
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comparison between three PBTK models with an established QSAR model, suggesting further 
development and improvement needs. With regards to predictive BCF models, a kinetic mass 
balance model incorporating KMET predicted based on experimental half-lives (HL) represents 
a potential surrogate to in vivo bioaccumulation studies. Overall, although a significant effort 
is being conducted to develop non-animal methods to enable their use in risk assessment, 
further experimental work is still needed to: 1) set up a feasible protocol for the in vitro 
clearance assay to increase its sensitivity; 2) explore the biological factors of the fish donors 
(e.g. age) that can affect the variability of in vitro data; and 3) investigate the in vivo whole 
body metabolic rates of compounds covering a broad range of hydrophobicity (log KOW). 
Chapter 3 also highlighted the importance of the fish body mass in mass balance models for 
predicting BCF of chemicals, suggesting a need for consensus in selecting a single fish mass 
for future in vitro-in vivo data extrapolations.   
Chapter 4: In Silico Mechanistic Analysis of the Toxicity of Cyclic Compounds 
There is an increasing desire in (eco)toxicology to integrate various tests to elucidate the toxic 
mechanism of chemicals. In a regulatory toxicology context, a set of alternative methods are 
usually integrated into decision trees that are termed as Integrated Testing Strategies (ITS), 
which are used to make a conclusion as to whether or not a compound represents a toxic 
hazard before conducting animal tests  [69,74]. The combination of different experimental 
results has also been used for the verification of in silico predictions to define their 
applicability domain. This has been shown for the experimental verification of the structural 
alerts within protein profilers of the Organisation for Economic Co-operation and 
Development (OECD) QSAR Toolbox (www.qsartoolbox.org) by combining in chemico 
(reaction with Glutathione (GSH)) and Tetrahymena pyriformis toxicity data [148-150].  
Chapter 4 described two different outcomes derived from the integration of multiple 
methods when investigating the toxic mechanism of 30 cyclic compounds acting by the 
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Michael addition reaction. The first section involved the verification of structural alerts 
encoded into the two in silico protein profilers of the OECD QSAR Toolbox by using in chemico 
GSH and T. pyriformis toxicity data. The results showed that the applicability domain of some 
of the structural alerts required refinement and improvement; and hence, more work is 
required in this area. In particular, the following cyclic compounds should be excluded from 
Michael addition domain: 1) compounds with a ring system attached to the β-carbon; 2) 
cyclic compounds containing an alkyl group at the α-carbon; and 3) heterocyclic compounds 
containing either a nitrogen or oxygen atom in the ring system.  
The second section consisted of the development of an ITS for aquatic toxicity testing to 
classify cyclic compounds into: 1) chemicals with a high priority for acute toxicity tests; 2) 
chemicals with a high priority for chronic toxicity tests; and 3) chemicals with no need for 
experimental testing. To classify examined compounds into these categories, a decision tree 
was built from: 1) the QSAR analysis of the toxicity data to T. pyriformis; 2) the 
presence/absence of a structural alert for Michael addition domain; and 3) in chemico GSH 
data. Overall, a good concordance between in silico, in chemico and in vitro data was found 
when applying the ITS proposed, which can be used as a foundation to develop other 
prioritisation strategies for different aquatic species and/or endpoints. 
5.2. Suggestions for Future Work 
Suggestions for future work following this thesis are discussed below. 
5.2.1 Investigation of the Factors Affecting In Vivo BCF Data Variability 
It is expected that a large number of chemicals will be tested according to the recent OECD 
305 TG guideline [10] to meet the new REACH legislation. It should be noted that although a 
review of BCF for organic chemicals has been provided [32], the effect of experimental 
variables on chemical bioconcentration is not well understood. Moreover, ambiguous results 
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have been reported in the literature concerning the influence of test concentration on BCF. 
For example, while no significant differences between BCF data measured at the lowest and 
highest test concentrations were reported by Creton and colleagues [159], BCF data 
variability according to test concentration was found for chemicals whose coefficient of 
variance was higher than 50% when developing a reference list (see Figure 2.2 for more 
details). Similar to in vivo toxicity studies [58], there is also a knowledge gap in the potential 
effects of other abiotic factors such as the temperature and the pH of the test system on the 
bioconcentration of a compound. The latter has been identified as a key variable for the 
bioaccumulation of ionisable compounds [80,134,135].  
The biological features of test organisms also have an impact on chemical bioconcentration. 
The body weight of test animals is one of the most important variables in bioaccumulation 
studies due to its influence on Absorption, Distribution, Metabolism and Excretion (ADME) 
processes. In particular, previous work has reported that small fish have higher rates of 
absorption, metabolism and excretion of chemicals than larger fish [29]. It is believed that 
such physiological differences, depending on body mass, may affect the time required to 
attain the steady state (equilibrium) of chemical bioconcentration. For example, compounds 
tested in small fish may reach steady state earlier as a result of their higher rates of 
absorption, metabolism and excretion than those test chemicals measured in larger fish. This 
aspect should be considered as crucial for the bioconcentration of hydrophobic chemicals, 
due to the fact these chemicals require a significant amount of time to attain effective 
equilibrium [160]. 
Therefore, an in-depth analysis of in vivo BCF data is required to investigate the effect of both 
experimental conditions and the body mass of test fish on chemical bioconcentration. It is 
expected that a better understanding of the sources of BCF data variability will not only allow 
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for the development and improvement of alternatives to whole body fish testing, but also 
will help to select appropriate conditions for future in vivo BCF assessment.  
5.2.2 Future Directions of In Vitro Methods to Study Xenobiotic Metabolism 
The following aspects are considered as being relevant for the development and 
improvement of in vitro clearance assays using freshly isolated rainbow trout hepatocytes.  
Expand the Work Undertaken in Chapter 3 
As explained in Chapter 3, a total of nine chemicals were tested using cells from the same 
fish donor to minimise the influence of the biological variables on experimental data, which 
implied, however, the use of two replicates per test substance in order to test all chemicals 
at one time. Therefore, future experiments could consist of testing fewer chemicals with 
three replicates per compound to obtain lower intra-assay data variability. Of the compounds 
examined, 1,3-dichloro-5-nitrobenzene, dibenzofuran and pentachlorophenol should be 
rejected for future experiments as they were not cleared by the hepatocytes (see results in 
Tables 3.6). It should be noted that test concentration higher than 0.5 µM are required to 
test pentachloronitrobenzene to avoid its low detection limit for analysis, and exposure 
periods shorter than 5 hours should be used to reduce the number of samples per chemical. 
Another important question that remains unanswered is whether hepatocytes isolated from 
younger fish donors have higher metabolic rates than those isolated from older fish, as 
described in section 3.3.2.  In order to investigate this more thoroughly, the measurement of 
metabolic activity of enzymes from hepatocytes isolated from different aged fish donors 
should be conducted. Key metabolic enzymes to be measured are 7-ethoxyresorufin-O-
dealkylation (EROD), testosterone 6β-hydroxylation, 1-chloro-2,4-dinitrobenzene (CDNB)-
glutathione conjugation and p-nitrophenol-glucuronidation [39].  
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Development of a Protocol for Daily Routine 
As observed in Chapter 3, the in vitro clearance protocol used to study the biotransformation 
of chemicals involved several steps and materials: 1) the metabolic incubation in borosilicate 
glass tubes; 2) the aliquot of subsamples to stop the reaction into 1.5 mL Eppendorf tubes; 
and 3) finally the transfer of supernatant to vials for chemical analysis through Gas 
Chromatography Mass Spectrometry (GC-MS). The ideal experiments to study the 
metabolism of xenobiotics would be those in which the biological test system and chemical 
analysis are integrated in the same material, similar to the methodology conducted with an 
effect-directed analysis (EDA). EDA combines bioassays with analytical chemistry in 96-well 
plates to analyse environmental pollutants in risk assessment [161].  Another advantage of 
such analysis is that chemical analysis is performed using Liquid Chromatography Mass 
Spectrometry (LC-MS) that can be coupled to High Resolution Mass Spectrometry (HR-MS). 
LC-MS offer several advantages in comparison with GC-MS, such as a rapid chemical analysis 
with a very high sensitivity [161]. However, some types of chemicals such as essential oils, 
fragrances and non-polar compounds are particularly well-suited to GC-MS as they do not 
ionise well by LC-MS. 
Figure 5.1 shows an example of a 96 well-plate test system that could be used to study 
xenobiotic biotransformation, being suitable for both GC-MS and LC-MS analysis. For the 
analysis of certain types of chemicals (e.g. non-polar and volatile chemicals), an additional 
step will be required to extract some supernatant for the analysis of parent compound by 
GC-MS (see Figure 5.1). The use of such a test system could offer several advantages with 
respect to the current experimental procedure including: 1) higher reproducibility and 
reliability, as a result of the use of a greater number of replicates and multi-channel pipettes 
to stop the reaction, thus reducing the time gaps amongst sub-samples; and 2) elucidating 
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the metabolic pathways of test chemicals by analysing the resulting metabolites of test 
compound by LC-MS.  
 
Figure 5.1 Experimental system proposed to study xenobiotic biotransformation. Open circles: Test 
compound A, Solid circles: Test compound B; Crossed circles: control samples 
The use of the above, or a similar, test system is expected to expand the knowledge of the 
metabolism of structurally diverse chemicals. We believe that data on CLINT and metabolites 
identified for a broader chemical domain will allow for the construction of in silico models to 
predict CLINT and metabolic pathways of chemicals. Such metabolic data generated could also 
be incorporated into the log BCFmax models developed for rainbow trout and common carp 
to correct for the effect of metabolism on maximal bioconcentration.  
It should be noted that the clearance assays performed in this thesis consisted of an 
incubation of test compounds with freshly prepared hepatocytes in suspension. Research is 
also needed to develop clearance assays in other cell-based systems such as monolayers and 
aggregates cultures [41,128]. It is expected that clearance data generated in other test 
systems may differ from those determined in a suspension system. For instance, a 
comparative study showed that clearance rates of well-metabolised compounds were lower 
in monolayers than in suspension due to the relatively small surface area for chemical 
diffusion in monolayer test systems [162]. 
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The Use of Cryopreserved Hepatocytes in the Clearance Assays 
The use of cryopreserved hepatocytes in clearance assays is important to comply with the 
3Rs for animal use. Previous work has shown that cryopreserved hepatocytes are suitable for 
bioaccumulation risk assessment, as they maintain metabolic activities comparable to freshly 
isolated hepatocytes [39]. Initially, it was aimed to use cryopreserved cells together with 
freshly isolated hepatocytes in the clearance assays to reduce the number of fish for 
experimentation. As a consequence, preliminary experiments were undertaken to 
investigate the feasibility of cryopreserved hepatocytes for use in clearance assays. Freshly 
isolated hepatocytes with 95% viability from two isolations were cryopreserved following the 
protocol included as Appendix I, and then thawed according to protocol provided as 
Appendix II in the following days. For all thawed cells batches, low percentages of cell viability 
(~ 50%) and yield recovery (~ 25%) were obtained. The low percentage of cell viability could 
be a result of an inappropriate use of cryobox, as the foam was not removed, and/or a toxic 
effect caused by the DMSO (from the cryopreservation buffer). The low percentage of cell 
viability obtained in this study was similar to the yield recovery of 37% reported in previous 
studies [39]. It was concluded that further experimental work will be required to obtain a 
higher percentage of both cell viability and recovery in order to use cryopreserved 
hepatocytes for in vitro clearance assays.   
5.2.3 Establishment of a List of Reference Compounds for Developing AOPs 
A list of reference compounds can be established for aquatic ecotoxicology to provide a 
better understanding of toxic mechanisms of chemicals through the development of Adverse 
Outcome Pathways (AOPs). Investigating the AOP of chemicals is becoming a crucial topic of 
research in (eco)toxicology [26, 163], and recommendations for their appropriate 
development and assessment have been provided in the recent OECD guideline [164]. 
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Different applications for developing non-animal methods can be derived from established 
AOPs including: 1) the establishment of (Q)SAR, facilitating predictive and mechanism-based 
toxicology; 2) the elaboration of prioritising strategies to reduce animal use;  and 3) the 
development of novel in vitro toxicity screening tests [165]. As a consequence, a list of 
reference compounds selected from high quality toxicity data might be needed for future in 
vitro testing aimed at establishing AOPs. 
A variety of molecular test systems can be used to study the toxic mechanism of chemicals 
at cellular and molecular levels. Amongst them, the microarray test represents a powerful 
tool in research to study the gene expression of the toxic effects in organisms.  Of relevance 
is that changes in gene expression are toxicant specific and can be linked to their mechanism 
of toxic action [62,166]. Furthermore, microarray assessment could be a potential alternative 
to median effective concentration (EC50) and median lethal concentration (LC50) standardised 
tests [62]. Therefore, not only can a proposed list of reference chemicals contribute to the 
development of AOPs, but it can also be used for the evaluation and validation of the 
microarray test as an alternative to animal toxicity testing.  
The following steps describe the methodology that could be used for the development of 
such a reference list. 
Step 1: Starting Points for Chemical Selection  
Similar to the strategy taken in Chapter 2, the selection of relevant fish species, toxicity 
endpoints and chemical classes for aquatic ecotoxicology should be conducted before data 
compilation. Danio rerio (zebrafish) and Oryzias latipes (medaka) could be fish species 
candidates for two reasons: 1) their embryos are frequently used to assess the toxicity of 
chemicals as they present several advantages with respect to the whole fish [3,4]; 2) their 
genomes have been sequenced [167-169].  The selection of appropriate toxicity endpoints 
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should be established using expert judgment and considering relevant aspects such as data 
availability. It should be noted here that in vitro toxicity endpoints may be chosen instead of 
in vivo measurements due to the larger data availability [14]. Additionally, a good correlation 
between whole fish and embryo acute toxicities has been shown for zebrafish [14]. The EC50 
and LC50, both determined from 24 to 96 hours, represent endpoints of interest due to their 
wide use in ecotoxicology. It is expected that relevant chemical classes for ecotoxicology may 
cover those proposed for bioaccumulation (Chapter 2, Table 2.1) as well as compounds 
exhibiting: 1) non-polar narcosis; 2) polar narcosis; and 3) all electrophilic reactions involved 
in protein and DNA binding [25,26]. 
Step 2: Data Compilation, Evaluation and Chemical Classification 
Data for EC50 and LC50 determined in zebrafish and medaka embryos could be compiled from 
different publicly available sources such as the ECOTOX database (cfpub.epa.gov/ecotox), 
ECETOC (www.ecetoc.org) and ECHA (echa.europa.eu). Recent scientific publications, such 
as the list of chemicals supported by zebrafish toxicity data compiled by Lammer et al. [14] 
could also be taken into account.  Once all experimental data are collated and organised, 
assessment of the quality of the data should be performed according to the Klimisch criteria 
or the scheme for data quality provided by Przybylak et al. [22]. It should be stressed that 
only compounds assessed with the highest reliability score should be considered for the 
reference list. After this, the classification of compiled chemicals according to the chemical 
classes established in Step 1 should be conducted. A further sub-classification would be 
expected for those classes containing a large number of chemicals. Due to the difficulty in 
classifying chemicals with multiple functional groups in the molecule, special considerations 
should be given for such chemicals. 
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Step 3: In Silico Analysis 
A set of physico-chemical, molecular and toxicological properties should be calculated for the 
chemicals compiled in Step 2. Log KOW, logarithm of Henry’s Law Constant (log HLC) and water 
solubility may account for key chemical properties; molecular weight (MW) and maximum 
molecular diameter (Dmax) should be designated for molecular properties; the toxic 
mechanism of action and the presence/absence of structural alerts for protein and DNA 
binding should account for toxicological properties. The mechanism of action of chemicals 
should be predicted according to the following Verhaar classes [170,171]: 1) non-polar 
narcotics; 2) polar narcotics; 3) reactive chemicals; 4) specifically acting chemicals; and 5) 
unknown. Examples of some specific mechanisms of toxic action that should be considered 
include Acetylcholinesterase (Ach E) inhibition and oxidative phosphorylation [172]. Another 
aspect of interest should be predicting metabolism for the examined compounds, since some 
resulting metabolites can be more toxic than the parent compound [173]. Some of the above 
properties may be calculated by using the OECD QSAR Toolbox (www.qsartoolbox.org), EPI 
Suite software (www.epa.gov) and commercial software such as Meteor Nexus 
(www.lhasalimited.org) 
For compounds with sufficient data, QSARs could be developed from the linear regression 
between the inverse of the logarithm of the selected endpoint and log KOW. Such analysis 
aims to discriminate narcosis-level compounds and chemicals exhibiting excess toxicity. In 
addition, baseline narcotics and compounds with excess toxicity could be split into different 
groups depending on their predicted toxic mechanism of action and structural alert triggered, 
based on a similar approach to the Integrated Testing Strategy (ITS) proposed for Michael 
acceptors shown in Figure 4.6. 
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Step 4: Refinement of Chemical Domain  
A final selection process would be conducted by using a similar methodology to that 
employed in Chapter 2. For each of the chemical classes identified in Step 2, a selection 
should be performed to achieve a broad chemical domain for log KOW, molecular properties 
(MW, Dmax) and toxic mechanism. Additionally, the final list should include the following: 1) 
common compounds for established endpoints and fish species, as they represent chemicals 
of interest for exploring the link between EC50 and LC50 as well as interspecies differences; 
and 2) compounds supported by a high weight of evidence on the toxic mechanism. For 
instance, compounds predicted to be reactive with an alert triggered by the protein/DNA 
profilers, and conversely predicted narcotic compounds with no structural alert triggered by 
the OECD profilers.   
It is expected that in vitro data generated for such reference chemicals by using a battery of 
in vitro test systems, and subsequently incorporated into a common database, will make a 
significant contribution for aquatic ecotoxicology. 
5.3. Thesis Overview and Future Directions of Alternative Methods for Aquatic Toxicology 
This thesis has been centred on the development and improvement of non-animal methods 
to assess the toxicity and bioaccumulation potential of organic chemicals. This involved the 
use of multiple disciplines in the area of aquatic toxicology including: 1) the analysis and 
evaluation of in vivo data for chemical bioaccumulation; 2) the development of in silico 
models for bioaccumulation and the refinement of structural alerts for protein binding; and 
3) the establishment of an in vitro clearance assay to study xenobiotic biotransformation.   
In order to reduce the number of fish required for experimentation, further work is still 
needed for the final implementation of alternative methods. The use of a holistic approach 
might be the key to develop and improve non-animal methods. Similar to musicians of the 
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orchestra playing together, the integration of multiple results obtained from different assays 
could play an important role in providing accurate information concerning the mechanism of 
toxic action of chemicals.  
More experimental efforts are expected in the coming years to develop and validate in vitro 
assays for aquatic bioaccumulation. This is because in vitro methods to study xenobiotic 
metabolism for fish are being currently developed and no assays have been proposed to 
determine the absorption of chemicals.  The validation of these methods will be crucial for 
their appropriate implementation in risk assessment. It is expected that the list of reference 
compounds established in Chapter 2 will assist in this process.  
Finally, more in vivo testing using the whole fish is also likely to be required for the suitable 
development of alternative methods. This is because the effect of biological and 
experimental factors on in vivo data are not well-understood in both toxicity and 
bioaccumulation studies. A better understanding of the influence of these factors on in vivo 
data variability could not only allow for a rational development of in vitro assays, but also it 
could explain the data variability reported for in vivo studies.     
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Appendix I: Cryopreservation of Trout Hepatocytes 
This protocol is exemplified for a final concentration of 15 million cells per vial and a total of 
10 vials. 
1. Determine the concentration and viability of freshly isolated hepatocytes. 
2. Transfer 150 million of hepatocytes into a 50 mL centrifuge tube. 
3. Centrifuge cells at 50 g for 3 min at 4 °C to sediment cells. Aspirate supernatant to 
just above cell pellet and add cryopreservation buffer up to 5 mL. 
4. Suspend cells in solution and then slowly add 2.5 mL of cryopreservation buffer 
containing 12% Dimethyl Sulfoxide (DMSO) while gently shaking cells. 
5. After 5 minutes on ice, slowly add 7.5 mL of cryopreservation buffer containing 16% 
DMSO while gently shaking cells. Final volume is 15 mL at 1 million cells/mL. 
6. After 5 minutes on ice, suspend cells by gently shaking and transfer 1.5 mL of 
hepatocytes suspension to cryovials. 
7. Place vials into the freezing container (previously filled up with isopropanol) and keep 
it at – 80 °C overnight (not recommendable for more than 2 days). 
8. After the controlled rate freezing is completed by the freezing container, place the 
cryovials into a liquid nitrogen storage tank. Removing cells from freezer to storage 
tank should take less than 1 minute.  
 
Additional notes 
 Keep cells and medium on ice throughout entire procedure and always shaking when 
adding a new medium. 
 DMSO is required to protect cells and is added in a two-step gradient to adapt cells 
to DMSO. The final concentration of DMSO should be less than 10%. 
Cryopreservation Buffer (DMEM with 20% FBS and 0.25% BSA) 
 40 mL Dulbecco's Modified Eagle Medium (DMEM) 
 10 mL Fetal Bovine Serum (FBS) 
 0.125 g Bovine Serum Albumin (BSA) 
Mix and adjust to 7.8 
Cryopreservation Buffer w/12% DMSO 
 4.4 mL cryopreservation buffer 
 0.6 mL DMSO 
 
Cryopreservation Buffer w/16% DMSO 
 10.5 mL cryopreservation buffer 
 2 mL DMSO 
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Appendix II: Thawing of Cryopreserved Trout Hepatocytes 
This protocol is exemplified for thawing a total of 45 million frozen cells contained in 3 
cryovials (15 million cells/vial). 
1. Prepare recovery medium at a room temperature using sterile conditions. The 
recovery medium contains Dulbecco's Modified Eagle Medium (DMEM), 10% of Fetal 
Bovine Serum (FBS) and 0.25 % of Bovine Serum Albumin (BSA).  For a total volume 
of 150 mL, the amounts for each reagent are: 
 
                                                        Reagent 
DMEM                            135 mL 
                                                  FBS                                   15 mL 
  Low Fatty Acid (BSA)     0.375 g 
 
2. Mix the recovery medium for approximately 5 min in the incubator refrigerated at 
28 °C, adjust its pH to 7.8 and then filter the recovery medium with a sterile filter.  
3. Adjust the pH of Leibovitz medium (L-15) (without phenol) to 7.8. 
4. Aliquot 42 mL of recovery medium into a 50 mL centrifuge tube for thawing 2 vials 
containing approximately 30 million frozen cells, and aliquot 21 mL in another 
centrifuge tube for 1 vial (15 million frozen cells). 
5. Set up an area for thawing cryovials using a room-temperature bath.  
6. Once the cryovials are taken from the liquid nitrogen storage tank, place them 
immediately into a water bath with gentle shaking for 2 minutes or until their 
contents freely move and/or a small ice crystal remains.  
7. Pour the contents of cryovials into the recovery medium in centrifuge tubes. Once 
you poured the content of cryovials, pipette 1 mL of recovery medium to each 
cryovial to re-suspend any remaining cells, invert once to mix and then pour the re-
suspended 1 mL into the centrifuge tubes. 
8. Invert tubes once and centrifuge them at 500 rpm for 5 minutes at 4 °C. 
9. Aspirate supernatant being careful not to disturb cell pellet. 
10. Quantify sufficient to make a volume of 5 mL with L-15 medium and re-suspend cell 
pellet by tapping side of centrifuge tube against finger/hand. Note: If there are more 
than 2 centrifuge tubes (based on the number of vials thawed), combined cells into 
2 centrifuge tubes and quantify sufficient to make a volume of around 45 mL with L-
15 medium for each. 
11. Invert tubes once and centrifuge at 500 rpm for 5 minutes at 4 °C. 
12. Aspirate supernatant being careful not to disturb cell pellet. 
13. Quantify sufficient to make a volume of 5 ml with L-15 and re-suspend cell pellet by 
tapping side of centrifuge tube against finger/hand. Combine cells into one 
centrifuge tube and quantify sufficient to make a volume of 45 mL with L-15 medium. 
14. Invert tube once and centrifuge at 500 rpm for 3 minutes at 4 °C. 
15. Aspirate supernatant and suspend cells in approximately 0.75 mL of L-15 medium per 
cryovial thawed.   
16. Count cell density and cell viability using Trypan blue. Note: the cell viability should 
be higher than 80%. 
17. Calculate the percentage of recovery: total number of cells/total number of cells 
cryopreserved) x 100. Note: the recovery percentage should be around 20%.  
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